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SUMMARY 
Hepatocyte in vitro systems represent a well-accepted tool in many fields of research. 
Despite their widespread use, research with primary hepatocytes remains challenging. Relevant 
for the field of in vitro studies, isolation and cultivation of hepatocytes induces massive 
transcriptional responses. To date, great efforts have been spent to control or attenuate 
alteration of hepatocytes in vitro. However, expression levels or activities comparable to the 
liver in vivo have rarely been achieved and the precise mechanisms controlling de-
differentiation are still poorly understood.  
To obtain a comprehensive overview of the expression alterations caused by various 
culture conditions and after radically different interventions, a time-resolved gene array 
analysis of mouse hepatocytes in sandwich and monolayer cultures was carried out. The results 
were compared to livers in vivo after treatment with carbon tetrachloride (CCl4), 
lipopolysaccharide (LPS) or partial hepatectomy (PHx). Global gene expression profiling exposed 
profound alterations within the first 24 hours that orchestrate the cellular response of primary 
mouse hepatocytes in vitro. Time-resolved analysis revealed a strong and rapid expressional 
responses with the lowest total number of differentially expressed genes in sandwich cultures 
(n = 3296) compared to monolayer confluent and subconfluent cultures (n = 4002 and n = 4287, 
respectively). All cultivation systems - sandwich, monolayer confluent and subconfluent - 
expressed similar pattern of up-regulation for lipocalin-2 (Lcn2), metallothionein-2 (Mt2) and 
serum amyloid A3 (Saa3) and down-regulation of the bile salt export pump (Bsep), multidrug 
resistance-associated protein 2 (Mrp2) and cholesterol 7 alpha-hydroxylase (Cyp7a1). The 
sandwich system offers clear advantages over monolayers by maintaining a more stable profile 
of expressional changes and preserving more of the in vivo-like features.  
Bio-statistical analysis identified a stereotypic gene expression response, which was 
similar for all the different types of stress tested: isolation by collagenase perfusion, 
intoxication with CCl4 or lipopolysaccharide as well as after partial hepatectomy, namely an 
upregulation of inflammation and proliferation as well as a downregulation of metabolism-
associated genes. Additionally, gene expression profiling showed that comparison of 
deregulated genes between all three in vitro and three in vivo models revealed a large overlap 
in their expression profiles, with lipocalin-2 being among the most up-regulated genes in all 
systems. The CCl4 model shares the highest overlap with cultivation systems when comparing 
the total number of deregulated genes. In addition, genes in vivo that responded after one day 
of exposure to CCl4, lipopolysaccharide or partial hepatectomy show a relatively large (<60%) 
overlap with in vitro deregulated genes at day one.  
Metagene analysis of highly correlated gene clusters between the in vitro and in vivo 
models resulted in three biological motifs: proliferation, metabolism and inflammation. The 
‘inflammation consensus cluster’ comprises 19 strongly up-regulated genes including the well-
SUMMARY 
VI 
 
known acute phase response genes Lcn2 and Saa3, which were more than 40-fold up-regulated 
after all interventions. The ‘metabolism-consensus cluster’ includes 28 strongly down-regulated 
genes with Bsep as a well-known lead gene. Transcription Factor Binding Site analysis of the 
promoter regions of deregulated transcripts identified hepatocyte nuclear factor 4  and -1  
among the overrepresented transcription factors for the metabolism-associated genes and Sp1, 
Elk1, ETF for the inflammation and proliferation gene clusters.  
Luminex screening showed rapid and strong activation of stress-associated signaling 
kinases during isolation of hepatocytes suggesting a new time frame for possible interventions. 
An inhibitor screening demonstrated a prominent role of c-Jun N-terminal kinases which when 
inhibited during liver perfusion or subsequent cultivation resulted in a strongly repressed 
inflammation response. In contrast, none of the tested inhibitors was able to rescue the 
profound repression of metabolism-associated genes, indicating that yet undiscovered 
pathways control this response. 
Other interventions, such as the further purification of hepatocytes-enriched fraction 
from non parenchymal cell remnants or co-culture, use of different matrixes or the 
hepatocyte’s own matrix in spheroids, did not ameliorate the overall gene expression response. 
However, the spheroid culture slightly improved the metabolism gene cluster compared to 
sandwich cultures, which may represent an advantage of the spheroid system.  
A remarkable feature of the described stereotypical expression response is that its basic 
features were conserved across species including human. My study demonstrates that both 
human and rodent hepatocytes respond to the isolation procedure with a conserved stress 
response that includes features of inflammation and a decline in expression of metabolism-
associated genes. However, there is a major quantitative difference and some alterations in 
human hepatocytes are only transient. This illustrates the need of a similarly comprehensive 
human study comprising isolated hepatocytes and liver tissue, both healthy and inflamed, ex 
vivo. 
Elucidation of the molecular anatomy of gene expression patterns in stressed 
hepatocytes presented in my thesis suggests that the broadly applied hepatocyte in vitro 
systems do not represent a model system of the healthy liver but rather a critically inflamed 
state. In line with this knowledge, unveiling the molecular anatomy of gene expression also 
demonstrates that cultivated hepatocytes may be used to study pathological situations. For 
example, the gene expression changes observed in sandwich culture resemble those observed 
in inflamed liver tissue, such as after hepatectomy or in response to CCl4 or lipopolysaccharide. 
In conclusion, my work identifies remarkable similarities between inflamed livers in vivo and 
cultivated hepatocytes, which opens new paths for mechanistic studies on liver inflammation 
and a more accurate use of hepatocyte in vitro systems. 
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ZUSAMMENFASSUNG 
Obgleich kultivierte Hepatozyten bereits in vielen Forschungsgebieten Einsatz finden, 
stellt die Forschung über primäre humane Hepatozyten nach wie vor eine große 
Herausforderung dar. Bei in vitro Studien gilt zu berücksichtigen, dass sowohl die Isolierung als 
auch die Kultivierung von Hepatozyten bereits massive Veränderungen auf Transkriptionsebene 
induzieren. Bis heute ist unmöglich Veränderungen von Hepatozyten in vitro zu kontrollieren 
bzw. möglichst gering zu halten. Dabei sind Proteinexpression oder Enzymaktivitäten mit der in 
vivo Situation in der Leber selten vergleichbar und präzise Mechanismen, welche die 
Dedifferenzierung kontrollieren, nur wenig verstanden. 
Um einen umfassenden Überblick über Expressionsveränderungen zu erhalten, welche 
durch diverse Kultivierungsbedingungen und durch grundlegende Eingriffe entstehen, wurden 
zeitaufgelöste Gene Array Analysen von primären Maus-Hepatozyten in Collagen Sandwich 
bzw. Collagen Monolayer Kultur durchgeführt. Diese Ergebnisse wurden verglichen mit in vivo 
Daten nach Tetrachlorkohlenstoff (CCl4) bzw. Lipopolysaccharid (LPS) Behandlung 
beziehungsweise nach partieller Hepatektomie (PHx). Vollständige Genexpressionsprofile in 
primären Maus-Hepatozyten zeigten, dass innerhalb der ersten 24 Stunden umfangreiche 
Veränderungen auf zellulärer Ebene in Hepatozyten induziert werden. Zeitreihen von 
Hepatozyten in vitro zeigten eine starke und schnelle Expressionsantwort nach dem 
Ausplatieren. Dabei wurden in der Collagen Sandwich Kultur eine kleinere Zahl an exprimierten 
Genen beobachtet (3296 Gene) im Vergleich zu Collagen Monolayer konfluent (4002 Gene) 
bzw. Subkonfluent (4287 Gene). Alle Kultivierungssysteme – Collagen Sandwich, Monolayer 
konfluent und subkonfluent – zeigten ähnliche Expressionsmuster bezüglich der Induktion von 
Lipocalin-2 (Lcn2), Metallothionin-2 (Mt2) und Serum Amyloid A3 (SAA3), sowie die 
Herabregulation von Bsep (Bile salt export pump), Mrp2 (Multidrug resistance-associated 
protein 2) und der Cholesterol 7 alpha-Hydroxylase (Cyp7a1). Die Sandwich-Kultur bietet 
gegenüber der Kultivierung im Monolayer klare Vorteile. Sie ist deutlich stabiler gegenüber 
expressionellen Veränderungen und bewahrt zudem mehr in vivo-ähnliche Eigenschaften. 
Biostatistischer Analysen zeigten eine stereotypische Genexpressionsantwort, welche 
für alle getesteten Arten von Zellstress ähnlich war: Isolatierung durch Perfusion mit 
Kollagenase, Vergiftung mit CCl4 und LPS als auch partieller Hepatektomie. Besonders auffällig 
waren die Induktion von Entzündungsmarkern und Proliferation, als auch die Herabregulierung 
von metabolismusassoziierten Genen. Weiterhin zeigte ein Vergleich über alle 
herunterregulierten Gene der drei in vitro und drei in vivo Modelle eine große Überlappung der 
Genexpressionsprofile, wobei Lipocalin-2 das am stärksten induzierte Gen in allen Systemen 
war. Im Vergleich der Gesamtzahl der differenziert exprimierten Gene zeigte das CCl4 Modell 
die gröβten Gemeinsamkeiten mit den Kultivierungssystemen. Weiterhin wiesen Gene in vivo, 
welche nach einem Tag CCl4 oder LPS Exposition bzw. partieller Hepatektomie detektiert 
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wurden, eine recht große (>60%) Überlappung mit den in vitro deregulierten Genen nach einem 
Tag in Kultur auf.  
Metagenanalysen von stark korrelierenden Gengruppierungen zwischen den in vitro und 
in vivo Modellen ergaben drei biologische Motive: Proliferation, Metabolismus und 
Entzündung. Die Gengruppierung „Entzündung“ umfasst 19 stark heraufregulierte Gene, 
darunter bekannte Entzündungsmarker wie Lcn2 und SAA3, welche nach allen Interventionen 
mehr als 40-fach induziert waren. Der „Metabolismus“ Konsensus Cluster beinhaltet 28 stark 
herunterregulierte Gene wie z.B. Bsep. Eine Analyse der Transkriptionsfaktorbindestellen 
innerhalb der Promotorregionen herunterregulierter Transkripte, identifizierte hepatocyte 
nuclear factor 4  und -1  (HNF4  bzw. HNF1 ) als überrepräsentierte Transkriptionsfaktoren 
für die metabolismusassoziierten Gene und Sp1, Elk1 und ETF für die Gene des Entzündungs- 
und Proliferationsclusters. 
Mittels Luminex Screening wurde eine starke und rasche Aktivierung von 
stressassoziierten Signalkaskaden während der Isolierung der Hepatozyten beobachtet, 
wodurch nur ein kurzes Zeitfenster für mögliche Interventionen optimal erscheint. Ein 
Inhibitorscreening hat ergeben, dass in diesem Zusammenhang c-Jun N-terminale Kinasen eine 
prominente Rolle spielen. Die Inhibierung von c-Jun Kinasen während der Leberperfusion bzw. 
während der anschließenden Kultivierung ergab eine stark unterdrückte Antwort der 
Entzündungsmarker. Dennoch konnte kein getesteter Inhibitor die massive Herabregulierung 
von metabolismusassoziierten Genen abschwächen, was darauf hindeutet, dass diese Antwort 
von bisher nicht bekannten Signalwegen kontrolliert wird.  
Weitere Eingriffe, wie z.B. die weitere Aufreinigung von hepatozytenreichen Fraktionen 
von den restlichen nicht-parenchymalen Zellen oder Co-Kulturen, die Verwendung 
unterschiedlicher Matrizes oder auch die Kultivierung von Hepatozyten in Sphäroid konnten die 
allgemeine Genexpressionsantwort nicht verbessern. Dennoch konnte in Sphäroiden im 
Vergleich zur Collagen Sandwich Kultur eine leichte Optimierung innerhalb des „Metabolismus“ 
Clusters beobachtet werden, was einen Vorteil des Sphäroid-Systems repräsentiert. 
Eine bemerkenswerte Eigenschaft der beschriebenen stereotypischen 
Expressionsantwort ist, dass grundlegende Eigenschaften zwischen den einzelnen Spezies, 
inklusive Mensch, konserviert sind. Diese Studie zeigte, dass Hepatozyten vom Menschen als 
auch von Nagetieren auf den Isolierungsprozess mit einer konservierten Stressantwort 
reagieren, welche Eigenschaften von Entzündungsprozessen wiederspiegelt und zudem ein 
Absinken der Expression metabolismusassoziierter Gene mit sich bringt. Dennoch bestehen 
quantitativ enorme Unterschiede und manche Veränderungen in den menschlichen 
Expressionsprofilen sind nur vorrübergehend. Das veranschaulicht den Bedarf für 
gleichermaßen umfassende Studien für den Menschen, in welche sowohl isolierte Hepatozyten 
als auch Lebermaterial aus gesundem als auch entzündetem Gewebe ex vivo mit einbezogen 
werden sollten. 
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Die Darlegung der molekularen Anatomie von Genexpressionsmustern in gestressten 
Hepatozyten, welche in dieser Arbeit hier erläutert wird, zeigt deutlich, dass die gängig 
angewandten Hepatozyten in vitro Systeme keine Modellsysteme einer gesunden Leber 
repräsentieren, sondern vielmehr eines kritisch entzündeten Zustands. Unter Berücksichtigung 
dieses Wissens über die Details der Genexpression könnten die kultivierten Hepatozyten des 
weiteren auch zur Untersuchung von pathologischen Situationen herangezogen werden. Zum 
Beispiel ähneln die Genexpressionsveränderungen, welche im Sandwich System beobachtet 
werden, denen, die in entzündetem Gewebe auftreten, wie es z.B. nach partieller 
Hepatektomie oder ausgelöst durch CCl4 und LPS der Fall ist. Zusammengefasst identifiziert 
diese Arbeit bemerkenswerte Ähnlichkeiten zwischen entzündeten Lebern in vivo und 
kultivierten Hepatozyten, was zum einen neue Wege für mechanistische Studien in entzündeter 
Leber, zum anderen aber auch eine präzisiere Verwendung von Hepatozyten in vitro Systemen 
eröffnet. 
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1. INTRODUCTION 
 
1.1 LIVER  
The liver is the largest visceral organ of the body and plays a central role in metabolism. 
Over 500 metabolic functions have been described, including the uptake of nutrients absorbed 
from the digestive tract, and the metabolism of lipids, carbohydrates and proteins. A critical 
role of the liver is the production of bile, which is needed to support digestion. In addition, the 
liver synthetizes a large number of plasma proteins, including albumin and immune factors, 
such as acute-phase proteins. As the main detoxifying organ of the body, the liver inactivates 
toxins and xenobiotics by converting them from hydrophobic compounds into water-soluble 
products that can be more readily eliminated [2-5]. 
With two major sources of the blood, the liver has a blood supply network that is unique 
among other organs.Approximately 75% of the liver’s blood supply comes from the portal vein 
that provides venous blood rich in nutrients from the digestive system. The hepatic artery 
provides the liver with oxygenated blood from the heart. In most mammalian species, the liver 
is multi-lobed, with each lobe composed of architectural, microcirculatory and functional units 
that are hexagonally–shaped, the so–called hepatic lobule (Figure 1). Portal triads consisting of 
a bile duct, a hepatic artery and a portal vein are located at the periphery of a lobule. Lobules 
consist of plates of liver cells – hepatocytes - radiating outward from the portal triads to meet 
the central vein. Hepatocytes, the parenchymal cell component of the liver, form tubular, apical 
spaces called bile canaliculi between adjacent cells along the hepatic plate. Hepatocytes secrete 
the bile into the bile canaliculi that run parallel to the sinusoids, but opposite in direction to the 
blood flow. The bile from the bile canaliculus drains into the bile ducts of the liver. The portal 
vein and hepatic artery empty together, thus mixing venous and oxygen-rich blood as it 
enters specialized capillaries, called the liver sinusoids.  The sinusoids are porous vascular 
channels lined with fenestrated endothelial cells. As blood flows through the sinusoids, a rapid 
exchange of oxygen and nutrients occurs between the sinusiods and the adjacent liver cells. 
The sinusoids converge into the central vein, which then drains in the hepatic vein [1, 6, 7].  
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FIGURE 1: BASIC STRUCTURE OF A HEPATIC LOBULE  
Three-dimensional architecture of the liver between a portal triad and the central vein. Figure adapted and 
modified from: http://illuminationstudios.com/archives/150/structure-of-a-hepatic-lobule  
 
 
The directionality of the blood flow through the lobular units from the portal triad to the 
central vein creates various chemical gradients (oxygen and nutrients) and microenvironments 
[8]. In order to perform several metabolic functions simultaneously, the liver tissue exhibits a 
noticeable heterogeneity and functional plasticity, known as ‘‘metabolic zonation’’ [9]. The 
regional compartmentalization of metabolic capacities is characterized by the microcirculatory 
functional unit called the hepatic acinus and can be divided into three zones: a periportal zone 
1; a transitional zone 2 and a pericentral zone 3 (Figure 2) [6, 10]. Such characteristic cyto-
architecture of the liver supports diverse metabolic pathways within the different zones. The 
hepatocellular zonation is regulated by chemical gradients of oxygen, hormones, growth factors 
and metabolites, which are generated and maintained as a result of the specific characteristics 
of the extracellular matrix (ECM) and of the distribution of liver cells [8, 11]. Additionally, a 
biochemical gradient present in all three zones influences not only the metabolism but also the 
gene expression patterns of the liver tissue [12-14].  
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FIGURE 2: STRUCTURAL AND FUNCTIONAL ZONATION OF THE LIVER  
Discrete zones of the liver between the portal vein and central vein illustrating the differences in cell size, 
phenotype and gradients in oxygen tension and metabolism. Figure adapted and modified from [15].  
1.2 LIVER CELLS TYPES 
The liver is comprised of several diverse cell types (Figure 3 and Figure 4). Hepatocytes, 
the liver parenchymal cells, account for 80% of liver mass. The other 20% comprises the non-
parenchymal cells, including the liver sinusoidal endothelial cells, Kupffer cells, hepatic stellate 
cells (called also Ito or fat-storing cells), cholangiocytes (biliary epithelial cells), hepatic 
progenitor cells (bi-potential stem cells also known as oval cells), lymphocytes of various 
phenotypes (e.g. natural killer lymphocytes also called Pit cells), and neutrophils. All of the NPC 
are arranged in a matrix that facilitates their cooperative interaction [4, 16, 17].   
 
FIGURE 3: MAJOR CELL TYPES OF THE LIVER  
The liver is comprised of several diverse cell types: hepatocytes, liver sinusoidal endothelial cells, Kupffer cells, 
hepatic stellate cells, cholangiocytes, hepatic progenitor cells, lymphocytes and neutrophils. Figure adapted and 
modified from [18]. 
 
The space of Disse is located between the hepatocytes and the sinusoids. It separates 
the hepatic epithelium from the sinusoidal endothelium. It is a thin reticular basement 
membrane, composed of a variety of extracellular matrix proteins such as fibronectin, laminin, 
proteoglycan, collagen IV, and collagen I. Hepatic architecture and sinusoidal organization are 
essential for proper and differentiated function of all resident liver cells [19-21]. 
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The parenchymal cells or hepatocytes are highly specialized epithelial cells that line the 
sinusoids in the liver. They are cuboidal in shape (20–25 μm in diameter) with two distinct 
surfaces and possess one or more nuclei [1]. Hepatocytes perform most of the synthetic and 
metabolic functions of the liver. They are rich in various organelles: mitochondria (∼1700 per 
cell on average), peroxisomes (∼370 per cell), lysosomes (∼250 per cell), Golgi complexes (∼50 
per cell), and aggregates of rough and smooth endoplasmic reticulum (∼15% of cell volume) 
[22].  
The liver sinusoidal endothelial cells (LSEC) line the walls of the hepatic sinusoids of the 
liver and contain numerous open pores in their membrane, called fenestra, which provide a 
large surface area for nutrient absorption of large macromolecules [1]. The Kupffer cells (KC) 
are the liver’s specialized macrophages residing in the sinusoids and are essential for the 
effective phagocytosis of old erythrocytes, foreign particles and infecting organisms from the 
circulation. The Kupffer cells produce cytokines upon stimulation e.g. during tissue injury, 
stimulate the activation of the liver’s acute phase reaction, and coordinate the responses of 
other liver cell types [1]. The hepatic stellate cells (HSC) are vitamin A-storing perivascular 
mesenchymal cells of the liver (previously called Ito cells, or fat-storing cells). Hepatic stellate 
cells synthesize, secrete, and degrade components of the peri-sinusoidal extracellular matrix. 
Through inflammatory processes during tissue injury, stellate cells become activated acquiring a 
myofibroblast-like phenotype, which allows them to become capable of both increasing 
collagen and DNA synthesis [5, 19, 23, 24]. Lymphocytes of various phenotypes are the liver-
centered innate immune system to help resist infections. The cholangiocytes are epithelial cells 
that line the bile duct [1, 2, 7, 25]. Hepatic progenitor cells (short HPC also known as liver stem 
cells or oval cells) are bi-potential stem cells capable of differentiation towards both 
hepatocytes and cholangiocytes. The HPC reside within the most peripheral branches of the 
biliary tree, the so-called canals of Hering [26, 27].  
 
FIGURE 4: MORPHOLOGY OF NON-PARENCHYMAL CELL TYPES OF THE LIVER IN VITRO  
(A) Liver Sinusoidal Epithelial Cells (LSEC) showing typical morphology in vitro. (B) Isolated quiescent HSC showing 
storage of vitamin A as bright “floating” vesicles within the cell body. Upon activation or injury the HSC undergo 
extensive morphological and biochemical changes, which include the synthesis, secretion and restructuring of ECM 
molecules. (C) Kupffer cells showing their dynamic morphology. Cells are loaded with vesicles containing cytokines 
and other secretory factors. Figure adapted and modified from [15]. 
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1.3 LIVER EXTRACELLULAR MATRIX 
The peculiar composition of the extracellular matrix (ECM) directs and maintains the 
architecture and differentiated phenotype of liver cells [20, 28]. The ECM is distributed in the 
Space of Disse and consists of collagen (types I–IV), laminins, fibronectin, glycosaminoglycans 
and proteoglycans, among many others [20, 28, 29] (Figure 5). Hepatocytes are in close contact 
with several extracellular matrix proteins. The ECM composition typically follows a pattern of 
gradients from the periportal zone 1 to pericentral zone 3 (Figure 2). The zonal composition of 
the ECM between the portal triad and the central vein is determined by multiple factors, e.g. 
the influence of other cell types, the gradient of oxygen and nutrients [27, 30]. 
 
FIGURE 5: DISTRIBUTION OF THE EXTRACELLULAR MATRIX (ECM) IN THE LIVER  
The composition of the different ECM zones between the portal triad and central vein is partially determined by 
factors in the microenvironment, such as other cell types, oxygen, nutrients, and endogenous/endogenous 
substrates. Figure adapted and modified from [10].  
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1.4 HEPATOCYTES AND THEIR METABOLIC FUNCTION 
The unique vascular organization of the liver exposes hepatocytes to a lobular gradient of 
oxygen, nutrients, toxins and other biologically active molecules. To ensure the liver’s exocrine, 
endocrine and blood filtering functions, the hepatocytes as highly specialized epithelial cells are 
characterized by a distinct polarity [1].  
The hepatocytes’ polarity represents a unique and complex cyto-architecture compared 
with the polarity of most epithelial cells [31] (Figure 6). Typically, an epithelial cell exhibits one 
apical and one basolateral side on opposing surfaces of an epithelial sheet. In contrast, 
hepatocytes possess two basolateral (sinusoidal) domains that interface with the space of Disse 
on opposite sides of the cell plates, and an apical (canalicular) domain between adjacent 
hepatocytes [10]. The basolateral sides of hepatocytes are in contact with the blood, where the 
uptake of recycled bile salts and secretion of various components into the circulation occur. The 
neighboring hepatocytes secrete the bile into a belt-like structure formed at the apical side, 
called bile canaliculi (BC). These tubular compartments of ~0.5–1.0 μm in diameter constitute a 
continuous network throughout the cell plates of the liver lobule. Both the apical and the 
basolateral sides are separated by tight junctions and desmosomes that seal off the border of 
bile canaliculi at apical sides. The networks of BC from a liver lobule terminate at the portal 
triad and merge via the canals of Hering with the bile ducts, finally leading into the common 
bile duct and the gall bladder [10, 15, 32]. 
 
FIGURE 6: THE STRUCTURE OF EPITHELIAL AND HEPATOCYTE CELL POLARITY 
Epithelial cells exhibit one apical and one basolateral side on opposing surfaces of an epithelial sheet. In contrast, 
hepatocytes possess two basolateral domains that interface with the space of Disse on opposite sides of cell 
plates. The apical side (surface marked in green) in hepatocytes is separated from the basolateral pole by tight 
junctions (orange marks). BC (bile canaliculi), N (nucleus). Figure adapted and modified from [32].  
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The apical and basolateral surface membranes of hepatocytes are polarized by special 
membrane protein distribution, including receptors, pumps, transport channels, and carrier 
proteins [33] (Figure 7). The directional transport of the bile acids from the blood through 
hepatocytes into the bile canaliculi is a multistep process [1]. Mainly, NTCP (Na+ /taurocholate 
co-transporting polypeptide) and the family of organic anion-transporting polypeptide proteins 
(OATPs) together with the organic anion transporter (OATs) and the organic cation transporter 
(OCTs) families mediate the uptake of the bile acids from the portal circulation. The uptake is 
driven as a result of electrical and ionic gradients generated by the Na+/K+ ATPase and 
diffusion of K+ ions through potassium channels [34]. The bile, which plays an essential role in 
the digestion of lipids from the diet, is a complex aqueous secretion composed of bile salts, 
organic anions, phospholipids, cholesterol and bilirubin [35]. In the classic pathway, the bile 
acids can be synthesized de novo from cholesterol that is converted to 7α-hydroxycholesterol 
via the microsomal cytochrome P450 enzyme, cholesterol 7α-hydroxylase (CYP7A1), belonging 
to the P450 superfamily of mono-oxidases metabolizing organic compounds of endo- and 
exogenous origin [36]. The secretion of de novo synthetized bile acids into bile canaliculi is 
mediated by several apical ATP-binding cassette (ABC) transport proteins, primarily via Bsep 
(bile-salt-export pump), but also by Mrp2 (multidrug-resistance-associated protein 2), Mdr1 
and -3 (multidrug-resistance protein 1 and 2). Bsep is the main transporter ensuring bile 
secretion [37, 38]. Cholestatic conditions activate compensatory mechanism of basolateral 
efflux of bile salts and organic anions from hepatocytes into blood by Mrp3 and Mrp4 [39, 40]. 
 
FIGURE 7: SCHEMATIC BILE ACID METABOLISM AND ELIMINATION IN THE HEPATOCYTE 
Uptake of bile acids from the portal circulation is mediated mainly by NTCP and OATP family. Additionally, 
cholesterol is converted into bile acids by CYP7A1 and eliminated into the bile canaliculi by Bsep and other 
canalicular transporters, such as Mrp2 which mediates excretion of bilirubin,  ABCB4, which exports phosphatidyl-
choline, and the multidrug transporters Mdr1 together with ABCG2 which mediate excretion of a wide variety of 
xenobiotics. During cholestasis bile acids can also be excreted back into the circulation via Mrp3 and 4. Figure 
adapted from [41]. 
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The liver metabolizes various endogenous and exogenous substances by a series of 
complex, chemical reactions called biotransformation. The biotransformation process can lead 
to detoxification, and excretion, or to bioactivation of the chemical compound [42], which is 
achieved in three metabolic phases: phases I and II, and transport phase III.  The phase I 
reactions alter the basic structure of a compound to a more polar metabolite by means of 
oxidation, reduction or hydrolysis. The main enzymes responsible for metabolism of phase I are 
members of the cytochrome P450 (CYPs) superfamily. Cytochrome P450 enzymes, located in 
the smooth endoplasmic reticulum, function as mono-oxygenases that insert one atom of 
oxygen into the substrate molecule [43]. Products of phase I metabolism that are sufficiently 
water soluble are eliminated by biliary or renal excretion or they may form substrates for phase 
II enzymes. Phase II metabolism involves the conjugation of a water-soluble chemical moiety to 
a phase I metabolite by transferases [44, 45]. The products of phase II reactions are generally 
detoxifying. However, some conjugates can cause adverse effects [46]. Phase III involves bile 
secretion through active membrane transporters (Figure 7) such as ABC transporter proteins 
and families of OATs, OCTs and OATPs [47, 48].  
1.5  IN VITRO CULTURE SYSTEMS & IMPROVEMENTS 
The liver plays a major role in metabolism and clearance of digested compounds, but is 
however susceptible to toxicity that may arise from the biotransformation of the compounds 
[1]. Exogenous compounds such as medicinal drugs may affect the liver in various ways. 
Compounds causing liver injury are generally termed hepatotoxicants. More than 900 drugs are 
known to cause liver injury [49]. Moreover, drug-induced liver injury (DILI) is responsible for 50 
% of all acute liver failures [50]. DILI is not only an important cause of morbidity and mortality 
but also is the most common reason for withdrawing newly tested drugs [51] giving liver a 
unique and central role in toxicological studies.  
The purpose of modern toxicology is to investigate and evaluate toxic effects of chemicals 
and drugs. The standard approach to fully understand potential hepatotoxic effects involves the 
use of complex and costly in vivo models based on animal testing [52]. This approach 
contradicts the simultaneous effort of reducing the number of animals used in experiments for 
ethical and cost reasons based on the principle of the three ”Rs” [53]. The 3 ”Rs” refers to the 
improvement of ethical standards by reducing the number of tests and animal used (use of in 
vitro, ex vivo and in silico approaches), the refinement of existing procedures to reduce animal 
tests or replace them entirely. Due to concerns about the animal welfare and concerns about 
the predictive accuracy of rodent in vivo testing for human adverse health effects, a large 
number of in vitro systems were developed as an alternative to in vivo models and are currently 
applied in not only toxicological, but also in pharmacological studies together with basic and 
applied research. The use of in vitro systems has many advantages including reduced numbers 
of animal and costs, shortening the time needed for analysis as well as conduction of analyses 
under well-defined conditions [54]. Well-established in vitro systems include the isolated 
perfused liver, precision-cut liver slices, 3D bioreactors and organoids (spheroids), primary 
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hepatocyte culture from various species, co-cultures, suspension cultures, immortalized cell 
lines and sub-cellular fractions. However, each model has advantages and limitations (Figure 8). 
The currently available in vitro tests are not entirely adequate to replace animal testing. In 
order to fully elucidate the mechanisms of hepatotoxicity of substances and drugs, a 
combination of various in vitro models should be used for a thorough validation of a chemical.  
 
FIGURE 8: OVERVIEW OF LIVER IN VITRO SYSTEMS 
Well-established in vitro systems include the isolated perfused liver, precision-cut liver slices, 3D bioreactors and 
organoids (spheroids), primary hepatocyte cultures from various species, co-cultures, suspension cultures, 
immortalized cell lines and sub-cellular fractions. However, each model possesses advantages and limitations, 
making available in vitro tests not entirely adequate to replace animal testing. Figure adapted and modified from 
[52]. 
 
Primary hepatocytes cultures from various species continue to be the most relevant in 
vitro tool to assess liver functions as well as transport, metabolism and toxicity of drugs [55, 
56]. However, the limited life span and the rapid decrease in liver-specific functionality over 
culture time in vitro are common shortcomings for primary cultures [57]. The improvement of 
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primary cultures of hepatocytes regarding cell density, the composition of the culture medium 
or the use of different matrixes on which to seed hepatocytes are continuously developed to 
foster retention of hepatocyte function.  
Traditional primary hepatocyte cultures involve the method of plating cells as a 
monolayer on surfaces coated with extracellular matrix proteins (e.g. collagens type I, III or IV, 
fibronectin and laminin) as substrata. In such culture system, primary hepatocytes rapidly 
undergo changes in cell morphology, polarity, gene expression, and liver-specific functions [58-
61] in a process referred as de-differentiation.  
Remarkably, primary hepatocytes cultured between two layers of gelled collagen-I or 
other extracellular matrix such as MatrigelTM (basement membrane preparation extracted from 
the Engelbreth-Holm-Swarm mouse sarcoma, a tumor rich in extracellular matrix) in so called 
3D sandwich configuration, restore functional polarity, maintain differentiated morphology, 
liver-specific metabolic activity and longevity in culture [62-68]. Despite the significant 
improvements attributed to the sandwich culture method, expression of many liver-specific 
functions decreases over time in culture [69]. 
In order to provide a more physiological environment for cultured liver cells, co-culture 
conformation and other forms of organotypic microenvironments were further incorporated to 
preserve liver-specific morphology and functionality beyond those provided by standard 
cultures. The co-culture configuration supports the maintenance of normal hepatic structure 
and function [70, 71]. Similarly, primary hepatocytes cultured as spheroid aggregates forming 
sphere-shaped “spheroids” over several days [72, 73] exhibit improved cell survival and 
prolonged maintenance of differentiated functions [74, 75]. Additional examples of methods 
aiming at in vitro culture improvement include generation of transplantable liver grafts using 
de-cellularized liver matrix [76] and culture with improved oxygen supply [77]. Although some 
advancement has been achieved by all mentioned techniques, they were in most cases limited 
to a small number of readouts and usually did not rescue functions to the level of hepatocytes 
in vivo. 
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1.6 DE-DIFFERENTIATION IN CULTURE 
The differentiation status of a cell can be evaluated by its genome wide gene expression 
pattern. Cultivation causes major alterations in gene expression of primary hepatocytes during 
the first 24 h of culture when compared to the liver in vivo [78]. The de-differentiation process 
that is triggered in cultures of primary hepatocytes leads to a rapid change in mRNA and 
protein levels of phase I and phase II biotransformation enzymes (e.g. CYPs 450 enzymes) 
together with the down-regulation in expression of bile acid transporters (e.g. Bsep and Mrp2) 
that taken together resembles the features of cholestasis [61, 79].  
The extracellular environment has been shown to play a critical role in regulating both 
liver-specific function in culture and activation of liver transcription factors maintaining 
differentiation [58, 64, 80]. Such alterations can be partly explained by a drastic decrease in 
expression of hepatic master regulators, such as liver-enriched transcription factors (LETFs) [60, 
81] or nuclear receptors [82, 83] (Figure 9).  
The liver-enriched transcription factors (LETF) consist of six families of evolutionary 
conserved transcription factors: HNF-1, HNF-3, HNF-4, HNF-6, C/EBP, and D-binding protein 
(DBP) [84]. The C/EBP family of transcription factors is known to regulate not only hepatic 
functions but also the inflammatory response of the liver [85, 86]. The HNFs belong to the 
nuclear hormone receptor family and are required for cellular differentiation and metabolism 
[87]. HNF-1 has been shown to be one of the transactivators of liver-specific albumin 
transcription [88] and CYP7a1 [89]. HNF-4 regulates diverse metabolic pathways and 
developmental processes determining the hepatic phenotype [90, 91].  
Nuclear receptors (NR) are a large family of ligand-dependent transcription factors that 
regulate many hepatic functions, including toxicologic processes and metabolic homeostasis 
[92]. The key nuclear receptors include farnesoid X receptor (FXR), short heterodimeric partner 
(SHP), pregnane X receptor (PXR), liver X receptor (LXR), peroxisome proliferator-activated 
receptor alpha (PPARa), and constitutive androstane receptor (CAR). These nuclear receptors 
are controlled by the action of small molecules such as steroid hormones, bile acids, fatty acids, 
thyroid hormones, certain vitamins and prostaglandins. Activated by small moelcules, nuclear 
receptors in the form ofa heterodimer with retinoid X receptor (RXR) [93], bind their DNA 
response elements located within a gene’s promoter region and regulate gene expression of 
their targets, e.g. the superfamily of CYPs 450 enzymes [83]. Additionally, nuclear receptors 
cause adaptive changes of hepatic transporter expression at a transcriptional level in response 
to bile acids and proinflammatory cytokines [94]. For example, the transcriptional control of the 
Bsep and Mrp2 genes has been shown to be mediated by a group of nuclear hormone receptors 
including FXR, RAR, PXR, and CAR [95-97]. Overall, the transcriptional regulation of hepatic 
transporters comprises a complex interacting network of nuclear receptors and LEFT [37, 98].  
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FIGURE 9: REGULATION OF TRANSCRIPTION OF TRANSPORTERS IN RAT LIVER 
NR together with RXR as obligatory partner and LETF mediate the transcriptional regulation of hepatobiliary 
transporter systems. HNF1α, which is under positive feedback control of HNF4α is the common master regulator of 
basolateral Ntcp and Oatp1, 2 and 4. FXR positively regulates the canalicular bile acid transporters Bsep and Mrp2. 
The RARα: RXRα heterodimer again positively regulates Ntcp and also Mrp2. Adapted and modified from [94].  
1.7 STRESS RESPONSE DURING ISOLATION AND CULTURE 
During the isolation procedure, hepatocytes lose their normal microenvironment and cell-
to-cell interactions thus undergoing ischemia-perfusion injury that together trigger responses in 
gene expression. A possible cause for the dramatic decrease in expression of LEFTs and nuclear 
receptors might come from the activation of various stress signaling pathways during the 
isolation procedure [99]. Indeed, it has been shown that isolation-induced stress initiates rapid 
activation of signaling cascades leading to proliferative and inflammatory responses that 
contributes to the de-differentiated cell phenotype [61, 100, 101].  
 Among the signaling pathways contributing to the altered gene expression of primary 
hepatocytes are the mitogen-activated protein kinases (MAPK) transduction pathways 
comprising the Extracellular Signal-Regulated Kinases (ERKs) 1 and 2 (ERK1/2); the Stress-
Activated Protein Kinases/c-Jun amino-terminal kinases (SAPK/JNKs) 1, 2, and 3; the p38 
isoforms α,β, γ, and δ , inflammatory pathways such as the Nuclear Factor-Kappa B (NF-kB); 
Janus Kinase/Signal Transducers and Activators of Transcription (JAK/STAT); the 
phosphatidylinositol 3-kinase (PI3K)/Akt and protein kinase C (PKC) signaling-pathway.  
The MAPK signal transduction pathway is a highly conserved and widespread 
mechanism of eukaryotic cell regulation involved in various cellular functions such as cell 
proliferation, differentiation and migration (Figure 10). The MAPKs are serine/threonine kinases 
that mediate intracellular phosphorylation events in response to a wide variety of different 
INTRODUCTION 
13 
 
stimuli such as growth factors, hormones and environmental stresses acting through diverse 
receptor tyrosine kinase families [102, 103].  
ERK1/2 is preferentially activated in response to growth factors, while the JNK and p38 
are activated in response to stress stimuli: heat and osmotic shock, ionizing radiation, 
endotoxin encounter, and cytokine stimulation [104, 105]. However, ischemia and reperfusion 
activate JNK and p38 in various ways. Inactive JNK during ischemia gets activated during 
reperfusion, whereas the p38s are activated during ischemia and remain active during 
reperfusion [106, 107]. 
Recognition of extracellular stimuli activates a kinase cascade consisting of a MAPK 
kinase kinase (also known as MAP3K or MAPKKK) which phosphorylates and activates a MAPK 
kinase (also known as MAP2K, MEK, or MKK) which then phosphorylates and increases the 
activity of one or more MAPKs. This cascade is common to all MAPKs. Activated MAPKs further 
phosphorylate an array of targets including transcription factors, nuclear pore proteins, 
membrane transporters, cytoskeletal elements, and other protein kinases [103]. A dynamic 
balance between the ERK1&2/JNK/p38 pathways is vital to determining the fate of the cell 
(Figure 10) [108].  
The JNK members (JNK 1, 2, and 3) are strongly activated by all the inflammatory 
cytokines of the TNF family such as tumor necrosis factor (TNF), interleukin (IL)-1, Fas ligand, 
receptor activator of NF-kB [109]. Activation of JNK requires dual phosphorylation on tyrosine 
and threonine residues within a conserved Thr-Pro-Tyr (TPY) motif catalyzed by MEK4 and 
MEK7, which are themselves phosphorylated and activated by several MAPKKKs, including 
MEKK1-4, MLK2 and -3, TAO1 and -2, TAK1, and ASK1 and -2. In turn, these are activated by 
GTP-binding proteins of the Rho family. Activated JNK phosphorylates c-Jun leading to an 
activation of the activator protein-1 (AP-1), as well as several other transcription factors, such 
as Elk-1, ATF-2, , NFAT, and STAT3 [103, 110]. It has been also suggested that the activation of 
JNK during the isolation procedure inhibits liver-specific gene transcription through inactivation 
of HNF-4α leading to a rapid loss of the cytochrome P450 enzymes [111]. 
The activation of the p38 members (α, β, δ, γ and p-38-2) has been observed in 
response to various physical and chemical stresses, such as oxidative stress, UV irradiation, 
hypoxia, ischemia, and cytokines, including IL-1 and TNF [112]. Activation of p38 requires dual 
phosphorylation on tyrosine and threonine residues within a conserved Thr-Gly-Tyr (TGY) dual 
phosphorylation motif catalyzed by MEK3 and MEK6 that are themselves phosphorylated and 
activated by a plethora of MAPKKKs, including TAK1 and ASK1. In turn, these are activated by 
GTP-binding proteins of the Rho family. Activated p38 phosphorylates several cellular targets, 
including transcription factors ATF1 and -2, MEF2, Elk-1, and NF- kB [103, 113]. 
The ERK members (ERK1 and ERK2) are strongly activated by mitogenic and growth 
factors. Activation of ERKs requires phosphorylation on tyrosine and threonine residues within 
a conserved Thr-Glu-Tyr (TEY) motif catalyzed by activated MEK1 and MEK2, which are 
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themselves phosphorylated and activated by Raf and Mos. In turn, these are activated by the 
induction of the small GTPase Ras. Activated ERK1/2 phosphorylates a vast array of substrates 
localized in all cellular compartments including signaling effectors, receptors, cytoskeletal 
proteins and nuclear transcriptional regulators transcription factors, such as Elk1 and c-Myc, 
and protein kinases, such as ribosomal S6 kinase (RSK) [114]. ERK1/2 signaling has been shown 
to be strongly activated during the isolation procedure [100, 115]. Moreover, primary 
hepatocytes in monolayer cultures acquire a de-differentiated and proliferative phenotype via 
activation of ERK1/2 signaling [78, 115]. ERK1/2 activation has been additionally shown to 
down-regulate the HNF-4α expression mediated by loss of C/EBPα and disruption of HNF-4α 
enhancer-promoter complex [116]. All these data suggests a pivotal role of ERK signaling in 
determining the fate of the cell.   
 
FIGURE 10: FLOW CHART REPRESENTING ACTIVATION AND CELLULAR RESPONSES OF MAPK MODULES (ERK, JNK 
AND P38) 
Recognition of the extracellular stimuli activates a kinase cascade consisting of a MAPK kinase kinase (also known 
as MAP3K or MAPKKK) which phosphorylates and activates a MAPK kinase (also known as MAP2K, MEK, or MKK) 
which in turn phosphorylates and increases the activity of one or more MAPKs. In turn, activated MAPKs can 
further phosphorylate an array of targets including transcription factors, nuclear pore proteins, membrane 
transporters, cytoskeletal elements, and other protein kinases. A dynamic balance between the ERK1&2/JNK/p38 
pathways is vital for determining the fate of the cell. Figure adapted and modified from: 
http://www.komabiotech.co.kr/pdf/mapk_signaling_review.pdf 
NF-kB is a conserved transcription factor important for mediating the inflammatory 
response of the immune system. NF-kB regulates the expression of cytokines, growth factors 
and inhibitors of apoptosis. The five members of the NF-kB family are RelA (p65), RelB, c-Rel, 
p50/p105, and p52/p100 that are maintained in the cytoplasm as dimers bound to IkB family 
proteins [117]. In the canonical NF-kB pathway (Figure 11), the NF-kB dimer of p50/RelA 
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subunits is maintained in the cytoplasm by interacting with an independent IkBα molecule. 
Binding of the pro-inflammatory cytokine (e.g. TNF, IL-1 type pro-inflammatory cytokines, 
bacterial products such as lipopolysaccharides, reactive oxygen species and viral products) 
activates the IKK complex (containing the α and β catalytic subunits and two molecules of the 
regulatory scaffold protein called NF-kB essential modulator-NEMO). In turn, IKK 
phosphorylates IkBα at two serine residues, which leads to its subsequent ubiquitination and 
degradation by the proteasome. As a consequence, the NF-kB dimer is enabled to enter the 
nucleus to activate expression of many genes involved in inflammation [118]. NF-kB has also 
been shown to be activated within 20 min of the isolation procedure with collagenase 
indicating that NF-kB causes hepatocytes to undergo a pro-inflammatory response [100].  
 
FIGURE 11: MECHANISM OF NFkB ACTIVATION 
The NF-kB dimer of p50/RelA subunits is maintained in the cytoplasm by interacting with the IkBα molecule. Pro-
inflammatory signals activate the IKK complex, that in turn phosphorylates IkBα leading to its subsequent 
ubiquitination and degradation by the proteasome. As a consequence, the NF-kB dimer enters the nucleus to 
activate expression of many genes involved in inflammation. Figure adapted and modified from [118].  
The Janus kinase/signal transducers and activators of the transcription (JAK/STAT) 
pathway is the principal signaling mechanism for a plethora of cytokines (e.g. IL-6 type 
cytokines) and growth factors. Its activation stimulates cell proliferation, differentiation, cell 
migration and apoptosis and has an important role in the control of immune responses [119]. 
Binding of a cytokine to its surface receptor induces receptor dimerization (Figure 12), which in 
turn subsequently activates two JAK tyrosine kinases associated with the receptor allowing 
trans-phosphorylation of the cytoplasmic transcription factors STATs. Phosphorylated STATs 
dimerize and subsequently leave the receptor and translocate to the nucleus, where they bind 
specific regulatory sequences leading to the activation or repression of target genes providing a 
direct mechanism to translate an extracellular signal to a transcriptional response [120].   
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FIGURE 12: MECHANISM OF JAK/STAT ACTIVATION 
Binding of a cytokine to its surface receptor induces receptor dimerization, which in turn subsequently activates 
two JAK tyrosine kinases associated with the receptor allowing trans-phosphorylation of the cytoplasmic 
transcription factors STATs. Phosphorylated STATs dimerize and subsequently leave the receptor and translocate 
to the nucleus, where they bind specific regulatory sequences to activate or repress transcription of target genes 
providing a direct mechanism to translate an extracellular signal into a transcriptional response. Figure adapted 
and modified from [121].  
The phosphatidylinositol 3-kinase (PI3K)/Akt signaling cascade plays a central role in 
many physiological processes which include cell proliferation, differentiation, apoptosis, 
cytoskeletal rearrangements and metabolism [122, 123].  Activation of growth factor receptor 
protein tyrosine kinases results in auto-phosphorylation on tyrosine residues, which in turn 
recruits PI3K to the membrane. PI3K belongs to a conserved family of lipid kinases that 
generate the second messenger phosphatidylinositol-3,4,5-trisphosphate (PIP-3) at the inner 
side of the plasma membrane. The generated PIP-3 binds and activates different cellular 
proteins, by targeting them to membranes or modulating their enzyme activities. In this way, 
PIP-3 activates Akt that subsequently translocates to the nucleus to modulate activation of 
growth, survival and proliferation signaling [124].  
The protein kinase C (PKC) family of multifunctional and phospholipid-dependent 
protein kinases is characterized by their ability to phosphorylate serine and threonine residues 
of receptors, enzymes, cytoskeletal proteins, and transcription factors. Activation of G protein-
coupled receptors, tyrosine kinase receptors, or non-receptor tyrosine kinases by an array of 
extracellular signals induces phospholipase C (PLC) to hydrolyze the membrane lipid PIP2, 
producing IP3 and diacylglycerol (DAG). Subsequently, the IP3 diffuses to the ER inducing 
release of calcium stores from inside the ER into the cytoplasm. Together the interaction of 
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both DAG and calcium modulates PKC kinase activity allowing phosphorylation of many protein 
targets affecting cellular signal processing, cell proliferation, differentiation, survival and death 
[125, 126].  
Importantly, these stress activated signaling pathways are also known to occur in 
different in vivo stress conditions, such as bacteria (i.e. lipopolysaccharide (LPS)-induced 
inflammation, sterile inflammation, and surgical resections. This suggests that metabolism may 
also be severely affected in those in vivo situations. Hence, it is important to gain a deeper 
understanding of the signaling processes occurring in vivo during stress responses. 
1.8 LPS-INDUCED INFLAMMATION AND ACUTE PHASE RESPONSE 
Liver inflammation results from hepatocyte damage caused by acute or chronic liver 
injury or by diseases. The immune system responds to pathogens with a complex set of defense 
mechanisms and is divided into two branches: innate (first line of the defense against a harmful 
stimulus and consisting of the innate immune cells such as monocytes, macrophages, mast 
cells, neutrophils and natural killer cells and dendritic cells) and the adaptive immunity 
(elimination of the harmful stimulus and the generation of immunological memory). The innate 
immune system recognizes microbial components ( LPS, glycolipids, viral RNA and bacterial DNA 
among others), known as pathogen-associated molecular patterns (PAMPs) via pattern-
recognition receptors (PRRs) such as Toll-like receptors. Recognition of the PAMPs activates 
immune cells leading to intracellular signaling cascades that elicit strong pro-inflammatory 
responses [127, 128].  
The tissue injury or infection can cause an orchestrated inflammatory response of the 
liver, known as the acute phase response (APR). APR leads to an altered expression of a specific 
group of plasma proteins, collectively known as acute phase proteins, which attempts to 
restore liver homeostasis. Acute phase proteins consist of various plasma proteins synthesized 
in the liver, such as C-reactive protein (CRP), serum amyloid P (SAP), serum amyloid A (SAA), 
inhibitors of proteases, coagulation factors, transport proteins (lipocalin-2) [129, 130], and 
complement components [131]. 
LPS, a glycolipid located on the outer membrane of Gram-negative bacteria, is cleared 
from the circulation primarily by Kupffer cells, liver sinusoidal endothelial cells and hepatocytes 
[132]. Recognition of LPS occurs during bacterial encounter in the gastrointestinal track causing 
dimerization of Toll-like receptor 4 (TLR4) and myeloid differentiation factor 2 (MD-2) that 
results in an induction of innate immunity responses [133]. As a consequence, activated Kupffer 
cells release a variety of pro-inflammatory messengers such as TNF, IL-1β, and IL-6 [134, 135]. 
Binding of TNF and IL-1β to their respective receptors activates NF-kB that promotes 
transcription of acute-phase genes [136]. Many of the acute phase genes have DNA binding 
sites that are recognized by the family of liver specific transcription factors CCAAT/ Enhancer 
binding protein (C/EBP) [137]. IL-6, IL-1β, and TNF stimuli strongly induce two isoforms of C/EBP 
(C/EBPβ and –δ) and concurrently down-regulate C/EBPα [138]. C/EBPα activity is also 
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regulated by NF-kB, protein kinase C and MAPKs signaling [139]. Additionally, stimulation of 
macrophages with LPS activates other signaling pathways, such as ERK members (ERK1 and 
ERK2) [140], p38 [141] and both isoforms of JNK [104], indicating their importance in mediating 
LPS action in macrophages. 
1.9 LIVER REGENERATION MODELS 
1.9.1 CCl4-INDUCED HEPATOTOXICITY  
 
Carbon tetrachloride (CCl4) belongs to the haloalkanes known to cause hepatic damage 
[142]. CCl4-induced hepatotoxicity is the most widely studied model of liver injury. In this 
model, exposure to CCl4 causes impairment of a number of cellular functions leading to acute 
and reversible necrosis of centri-lobular hepatocytes followed by liver regeneration. In the liver, 
CCl4 requires metabolic activation by P450 enzymes of the endoplasmic reticulum, primarily by 
the isoform CYP2E1 (Figure 13). Biotransformation generates the highly reactive and 
hepatocyte-toxic trichloromethyl free radical (CCl3*) which in turn interacts with various 
biologically important substances. Furthermore, the CCl3* radical can be converted in the 
presence of oxygen to a more reactive trichloromethylperoxy radical, CCl3OO*. As a result, lipid 
peroxidation and covalent binding of CCl4- derived reactive metabolites affects cellular 
homeostasis causing severe oxidative stress and cell damage.  
Additionally, secondary liver injury following CCl4 administration can result from 
inflammatory processes mediated by activated Kupffer cells and stellate cells. Following CCl4 
exposure, Kupffer cells release a variety of pro-inflammatory messengers (TNF, nitric oxide, 
TGF-ß, and IL-1, IL-6, and IL-10) [142] and stellate cells display a typical acute-phase response 
[143]. The intraperitoneal injection of CCl4 activates various molecular processes and signaling 
cascades such as ERK2 and causes down-regulation of liver- specific genes through suppression 
of LETFs, and induction of NF- kB signaling [144].  
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FIGURE 13: BIOTRANFORMATION OF CCL4 LEADING THE LIVER DAMAGE 
CCl4 requires metabolic activation by P450 enzymes, primarily the isoform CYP2E1. Biotransformation generates 
the highly reactive and hepatocyte-toxic trichloromethyl free radical (CCl3*) that can react with various biologically 
important substances. The CCl3* radical can be converted in the presence of oxygen to a more reactive 
trichloromethylperoxy radical, CCl3OO*. As a result, lipid peroxidation and covalent binding of CCl4- derived 
reactive metabolites affects cellular homeostasis causing severe oxidative stress and cell damage. Figure adapted 
and modified from [142].  
1.9.2 LIVER REGENERATION AFTER PARTIAL HEPATECTOMY (PHx)  
Liver regeneration represents an orchestrated response induced by specific external 
stimuli and is associated with changes in gene expression, signaling cascades involving growth 
factors, cytokines, as well as matrix remodeling, and alteration of morphologic structures [145]. 
The most widely used model for the study of liver regeneration is a technique known as 2/3 
partial hepatectomy (PHx) [146]. In this model, three of the five liver lobes (representing 2/3 of 
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the liver mass) are removed surgically, without damage to the residual two lobes. The 
remaining liver provides full support for body homeostasis during the entire regenerative 
process of about 7 days and enlarges until the original mass is restored. In the normal adult 
liver, the quiescent hepatocytes rarely proliferate [147]. However, following partial 
hepatectomy, all cellular populations of the resected liver rapidly re-enter the cell cycle. The 
first peak of DNA synthesis in murine hepatocytes occurs at about 36 hours followed by a 
smaller peak between 36 and 48 hours for the other cell types [4]. Moreover, PHx induces rapid 
induction of more than 100 genes not expressed in normal liver [4] substituting for preparative 
events for the entry of hepatocytes into the cell cycle. NFκB, STAT3 and AP1, are rapidly 
activated in remnant hepatocytes minutes after partial hepatectomy and may be a major part 
of the intracellular signaling cascade leading to DNA synthesis [147]. Similarly, intracellular-
signalling pathways as MAPK and JNK are rapidly activated after PHx providing clues to the 
initiating signals [4]. Simultaneously with the induction of proliferation, hepatocytes maintain 
all essential metabolic functions needed for homeostasis. Functionality of hepatocytes during 
liver regeneration can be partly explained by the essentially unchanged levels of transcription 
factors such as hepatic nuclear factor 1, 3 and 4 [147]. Additionally, the C/EBPα isoform is 
down-regulated during liver regeneration, whereas expression of the C/EBPβ isoform increases 
[148, 149]. Although most of the signaling responses described above take place in 
hepatocytes, several ligands triggering these pathways are released by non-parenchymal cells, 
such as sinusoidal endothelial cells, Kupffer cells and stellate cells. 
1.9.3   NPC AND THEIR ROLE DURING LIVER DAMAGE 
Non-parenchymal cells (NPC) are responsible for producing a range of cytokines and 
chemokines that modulate not only liver function but also contribute to the response to acute 
hepatocyte injury (Figure 14) [150]. Various types of stress-induced stimuli can lead to the 
activation of non-parenchymal cells such as LSEC and Kupffer cells causing a release of diverse 
pro-inflammatory mediators, which recruits and activats other inflammatory cells including 
natural killer cells, natural killer T cells, T cells, dendritic cells and macrophages [150, 151]. 
Released cytokines control cellular homeostasis of other cell types by binding to highly 
specific cell-surface receptors triggering differentiation, proliferation, migration, adhesion or 
apoptosis processes. Cytokines consist of a variety of interleukins, growth factors, interferons 
and chemokines and are classified as pro- (e.g. IL- 1, IL-12, IL-18, TNF, and interferon-γ (IFN-γ)) 
or anti-inflammatory (e.g. IL-4, IL-10, IL-13, IFN-α, and transforming growth factor-β (TGF-β)) 
[152].  
Activated Kupffer cells (KC) produce nitric oxide, reactive oxygen species and 
inflammatory cytokines to provoke liver inflammation upon liver injury. The released cytokines 
locally control the function of hepatocytes that bear a variety of cytokine receptors as well as 
other NPC under both normal and pathological conditions [153]. Activated KCs are capable of 
modulating cell death by inducing apoptosis of affected cell types. The interplay between 
INTRODUCTION 
21 
 
actions of pro-inflammatory (TNF, IL-1β and IL-6) and anti-inflammatory (IL-10) cytokines 
produced by KC is strictly regulated and modulates response to liver injury [3, 150].   
 
FIGURE 14: AUTOCRINE AND PARACRINE SIGNALS SECRETED BY NPC MODULATE HEPATOCYTE FUNCTIONS IN 
HEALTHY AND DISEASED LIVER TISSUE 
The activation of non-parenchymal cells causes a release of diverse pro-inflammatory mediators. Figure adapted 
and modified from [15].  
1.9.4 CHOLESTATIS IN MODELS OF LIVER INJURY 
Cholestasis or impaired bile secretion frequently result from defects in transporter 
expression caused by inflammatory disorders [94, 154]. LPS-induced pro-inflammatory 
cytokines (TNF, IL-1β and IL-6) secreted by Kupffer cells [134] have been characterized as the 
key mediators regulating hepatic expression and activity of transporters (Figure 15) [97, 155, 
156]. It has been shown that experimental administration of LPS, TNF, IL-1β or IL-6 reduces 
expression of several hepatic transporters at the basolateral or canalicular membrane [157-
159]. Interestingly, the down-regulation of hepatic transporters during LPS-induced cholestasis 
can be viewed as part of the negative acute-phase response [98].  
Hepatic transporters are regulated at both the transcriptional and post-transcriptional 
level [37]. The transcription factors such as families of LETF and nuclear receptors have a pivotal 
role in the transcriptional regulation of hepatic transporters (Figure 15) [37]. Moreover, LPS 
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treatment activates MAPK stress signaling pathways, including JNK [160] that leads to a 
decrease in expression of nuclear receptors [161, 162]. NR are known to regulate gene 
expression of hepatic transporters such as Bsep and Mrp2 [95, 97, 98]. Additionally, IL-1β 
induction after LPS-treatment in vivo seems to be the major regulator of rat Mrp2 expression 
[163]. In contrast to the down-regulation in rodent models, expression of hepatic transporters 
BSEP and MRP2 in humans have been shown to be regulated mainly by post-transcriptional 
mechanisms [164, 165]. 
 
FIGURE 15: TRANSPORTER REGULATION IN INFLAMMATION-INDUCED CHOLESTASIS 
LPS-mediated signals reduce the expression of several hepatic transporters at the basolateral or canalicular 
membrane. IL-1b is the major regulator of Ntcp and Mrp2 expression. The function of the RXRa component is 
thereby affected by RNA degradation and JNK-dependent phosphorylation. The transcriptional control of Bsep and 
Mrp2 is mediated by a decreased expression of nuclear hormone receptors including FXR, PXR, and CAR. Figure 
adapted and modified from [94].  
 
Liver regeneration induces a coordinated down-regulation of basolateral transport 
systems while maintaining expression of canalicular transporters (Figure 16). In the model of 
partial hepatectomy, expression of basolateral transporters is reduced and the canalicular 
transporters Bsep and Mrp2 remain stably expressed at the protein level 24 h after surgery 
[166, 167]. Similar changes in both the canalicular and the basolateral transporter expression 
have been observed in CCl4-induced liver damage [164, 168]. Such patterns of alteration can be 
partly explained by the massive induction of TNF occurring in both models of liver regeneration 
[168-170] since TNF has been shown to be the master regulatory cytokine for basolateral 
transporter gene expression during liver regeneration [164].  
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FIGURE 16: TRANSPORTER REGULATION DURING LIVER REGENERATION AND TOXIC LIVER INJURY 
Models of liver regeneration induce a coordinated down-regulation of basolateral transport systems while 
maintaining expression of canalicular transporters. Tumor necrosis factor represents the master regulatory 
cytokine for the basolateral transporter gene expression during liver regeneration.  Figure adapted and modified 
from [94].  
 
Altogether, it is clear that common stress responses may occur in profoundly different 
conditions such as perfusion and culture (in vitro) and also in vivo. Therefore, it is crucial to fully 
understand these processes in order to establish proper in vitro systems. 
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  AIM OF THIS WORK 1.10
The aim of this work was to gain insight into the molecular consequences of hepatocyte 
isolation and cultivation by comparing gene expression changes of hepatocytes cultivated in 
collagen sandwich cultures (S), confluent (MC) as well as subconfluent (MS) monolayer cultures 
with reference to their similarities and differences over time.  
For this purpose, a time resolved global gene expression profiling of primary mouse 
hepatocytes was carried out using Affymetrix microarrays. A combination of gene array 
analyses, bioinformatics and knowledge-based interpretation of the identified deregulated 
genes was then used to identify mechanisms responsible for the observed transcriptional 
alterations. In the next step, the identified biological motifs associated with the deregulated 
genes were validated using qRT-PCR and Western blot. These analyses identified a strong 
upregulation of inflammation and proliferation as well as a downregulation of metabolism-
associated genes in hepatocytes in vitro. The changes in the identified biological motifs were 
compared to those in stressed-hepatocytes after different types of hepatic injury, namely after 
treatment with CCl4, lipopolysaccharide (LPS) or partial hepatectomy (PHx). Subsequently, I 
performed a series of experiments validating the contribution of other liver cell subpopulations, 
extracellular matrix and alternative culture configuration on the aforementioned transcriptional 
responses. Finally, I compared the transcriptional alterations observed in the mouse model with 
those in rat and human primary hepatocytes.  
The specific aims of the present study are to: 
 perform a time resolved global gene expression profiling of primary mouse hepatocytes 
by Affymetrix microarrays 
 use a combination of gene array analyses, bioinformatics and knowledge-based 
interpretation of the identified deregulated genes in order to identify mechanisms 
regulated by the observed transcriptional alterations 
 validate the identified biological motifs by qRT-PCR and western blot 
 compare the observed transcriptional responses to livers in vivo after treatment with 
CCl4, lipopolysaccharide (LPS) or partial hepatectomy (PHx) 
 dissect signaling activities throughout the culture time by means of Luminex analysis 
 study the effect of other liver cell subpopulations, extracellular matrix and spheroid 
configuration on the aforementioned transcriptional responses  
 validate and compare the observed transcriptional responses of the mouse model with 
models of rat and human primary hepatocytes  
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2. MATERIALS AND METHODS 
  MATERIALS 2.1
2.1.1 CHEMICAL REAGENTS AND KITS 
TABLE 1: CHEMICAL REAGENTS AND KITS 
Chemical Company Catalog No 
2-propanol Carl Roth, Karlsruhe, Germany AE73.1 
Aminoacid solution (Costumer formulation) PAN Biotech GmbH, Aidenbach, Germany SO-33100 
APS  Sigma-Aldrich Corp., St. Louis, MO, USA 3678-25g 
Basement Membrane Matrix, Growth Factor 
Reduced (GFR), Phenol Red-free 
BD Bioscience, San Jose, USA 
 
356231 
 
Bio-Plex Cell Lysis Kit  Bio-Rad Laboratories, Munich, Germany 171-304011 
Bovine Albumin Fraction V (BSA) Carl Roth, Karlsruhe, Germany 8076.4 
BrdU Sigma-Aldrich Corp., St. Louis, MO, USA B5002 
Bromphenol Blue Merk, Darmstadt, Germany 108122 
Buffer concentrate A  Carl Roth, Karlsruhe, Germany L510.1 
Buffer concentrate K  Carl Roth, Karlsruhe, Germany L511.1 
Collagenase from Clostridium hystolyticum Sigma-Aldrich Corp., St. Louis, MO, USA C2674 
Complete feed for Rats&Mice - 
Maintenance 
Ssniff Spezialdiaeten, Soest, Germany 
 
V1534-000 
 
DAPI Invitrogen GmbH, Darmstadt, Germany D3571 
DEPC Treated Water Invitrogen GmbH, Darmstadt, Germany 46-42224 
di-Sodium Hydrogen Phosphat anhydrous 
(Na2HPO4) 
Carl Roth, Karlsruhe, Germany 
 
P030.2 
 
DMSO Sigma-Aldrich Corp., St. Louis, MO, USA 472301 
DTT (DL-Dithiothreitol) Sigma-Aldrich Corp., St. Louis, MO, USA D9779 
Easycoll Separating Solution 1.124g/mL Biochrom AG, Berlin, Germany L6143 
EDTA Carl Roth, Karlsruhe, Germany 8040.3 
EGTA Carl Roth, Karlsruhe, Germany 3054.2 
Eosin Y disodium salt Sigma-Aldrich Corp., St. Louis, MO, USA E4382 
Ethanol Merk, Darmstadt, Germany 100983 
Ethanol, 70% Walter CMP, Kiel, Germany WAL10506 
FluorPreserve™ Reagent Calbiochem, Darmstadt, Germany. 345787 
Glycerin Carl Roth, Karlsruhe, Germany 3783.2 
Glycine Carl Roth, Karlsruhe, Germany HN07.3 
GravityPLUS™ 3D Culture and Assay 
Platform 
InSphero, Schlieren, Switzerland 
 
CS-06-001 
 
High Capacity cDNA Reverse Transcription 
Kit 
Applied Biosystems, Karlsruhe, Germany 
 
4368813 
 
Hydrochloric Acid, 32% Carl Roth, Karlsruhe, Germany P074.4 
Ketamin-ratiopharm® 50 mg O.K. Injection 
Solution 
Ratio pharm, Ulm, Germany 
 
N64477.04 
 
Magic Mark XP Western Protein Standard Invitrogen GmbH, Darmstadt, Germany LC5602 
Mayer´s Hemalum solution Merk, Darmstadt, Germany 1.09249.0500 
Methanol Sigma-Aldrich Corp., St. Louis, MO, USA 322415 
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Microscopy Entellan Merk, Darmstadt, Germany 1.07960.0500 
Mouse Laminin BD Bioscience, San Jose, USA 354232 
Nonidet P-40 (NP-40) Roche Diagnostics GmbH, Manheim, 11754599001 
Phosphatase Inhibitor Cocktail II  Sigma-Aldrich Corp., St. Louis, MO, USA P5726 
Phosphatase Inhibitor Cocktail III  Sigma-Aldrich Corp., St. Louis, MO, USA P0044 
Pierce BCA Protein Assay Kit Thermo Scientific, Braunschweig, Germany 23225 
PMSF Carl Roth, Karlsruhe, Germany 6367.2 
Ponseau S Carl Roth, Karlsruhe, Germany 5938.1 
Potassium Chloride (KCl) Carl Roth, Karlsruhe, Germany 6781 .1 
Potassium dihydrogen phosphate (KH2PO4) Carl Roth, Karlsruhe, Germany 3904.1 
Precision Plus Protein standards Bio-Rad Laboratories, Munich, Germany 161-0374 
Protease Inhibitor Cocktail  Sigma-Aldrich Corp., St. Louis, MO, USA P8340 
Qiazol Lysis Reagent Qiagen, Hilden, Germany 79306 
Rompun 2% Bayer Health Care, Leverkusen, Germany 
 
Roti Histofix 4% Carl Roth, Karlsruhe, Germany P087.5 
Roti-Histol  Carl Roth, Karlsruhe, Germany 6640.1 
Rotiphorese
®
 Gel 30 (37,5:1) Carl Roth, Karlsruhe, Germany 3029.1 
SDS pellets Carl Roth, Karlsruhe, Germany CN30.1 
Sera Plus (Special Processed FBS) PAN Biotech GmbH, Aidenbach, Germany 3702-P103009 
Sodium chloride Carl Roth, Karlsruhe, Germany 3957.2 
Sodium deoxycholate Sigma-Aldrich Corp., St. Louis, MO, USA D6750 
Sodium hydroxide pellets  Merk, Darmstadt, Germany 1.06482 
TaqMan® Universal Master Mix II, with UNG Applied Biosystems, Karlsruhe, Germany 4440038 
TEMED Carl Roth, Karlsruhe, Germany 2367.1 
Trichloroacetic Acid Carl Roth, Karlsruhe, Germany 8789.2 
Trichloromethane/Chloroform  Carl Roth, Karlsruhe, Germany 7331.2 
TRIS  Carl Roth, Karlsruhe, Germany 4855.2 
Tris-HCl  Sigma-Aldrich Corp., St. Louis, MO, USA T3253 
Triton X-100 Carl Roth, Karlsruhe, Germany 3051 
Trizma base  Sigma-Aldrich Corp., St. Louis, MO, USA 33742 
Trypan Blue Sigma-Aldrich Corp., St. Louis, MO, USA T6146 
Tween 20 Sigma-Aldrich Corp., St. Louis, MO, USA P7949 
Western Lightning® Plus-ECL, Enhanced 
Chemiluminescence Substrate  
Perkin-Elmer, Massachusetts, USA 
 
NEL105001EA 
 
 
2.1.2 CONSUMABLES 
TABLE 2: CONSUMABLES 
Consumable Company Catalog No 
Biosphere Filtered Tip, 1000uL Sarstedt, Numbrecht, Germany 70.762.211 
Biosphere Filtered Tip, 100uL Sarstedt, Numbrecht, Germany 70.760.212 
Biosphere Filtered Tip, 200uL Sarstedt, Numbrecht, Germany 70.760.211 
Biosphere Filtered Tip, 20uL Sarstedt, Numbrecht, Germany 70.1116.210 
Blotting Paper Grade 703, 46x57cm VWR international, Darmstadt, Germany 732-0591 
Cell Scraper, 25cm Sarstedt, Numbrecht, Germany 83.183 
CHROMA SPIN™-100 Clontech, Mountain View, USA 636089 
Cover glass, 18mm Menzel, Braunschweig, Germany CB00180RA1 
Disposable semi-micro cuvette, 1.5mL  BRAND, Mannheim, Germany 7591 15 
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Embedding cassettes Carl Roth, Karlsruhe, Germany K113.1 
FACSClean BD Bioscience, San Jose, USA 340345 
FACSFlow BD Bioscience, San Jose, USA 342003 
FACSRinse BD Bioscience, San Jose, USA 340346 
Falcon tube, 15mL Sarstedt, Numbrecht, Germany 62.554.512 
Falcon tube, 50mL Sarstedt, Numbrecht, Germany 62.547.254 
GeneChip 3' IVT Express kit  Affymetrix, Santa Clara, USA 901229-D 
GeneChip Human Genome U133 Plus 2.0  
Array 
Affymetrix, Santa Clara, USA 520019 
GeneChip Mouse Genome 430 2.0 Array Affymetrix, Santa Clara, USA 900497 
Gentle Skin Classic Laboratory Gloves Meditrade, Kiefersfelden, Germany 1221R 
GravityPLUS™ 3D Culture and Assay 
Platform 
InSphero, Schlieren, Switzerland 
 
CS-06-001 
 
Hypodermic Needle, 26G BD Bioscience, San Jose, USA 304300 
Integra 300uL Tips Viaflo, INTEGRA, Zizers, Switzerland 44343 
Kimtech Science Delicate Task Wipes Kimberly-Clark Professionals, Roswell, USA 7216 
MicroAmp Optical 96-well Reaction Plate Applied Biosystems, California, USA N801-0560 
Mouse Genome 430 2.0 Affymetrix 
genechips  
Affymetrix, Santa Clara, USA 900497 
Multiwell Flat-Bottom 12-Well Plate BD Bioscience, San Jose, USA 353043 
Parafilm Wrap Cole-Parmer, Kehl/Rhein, Germany PM-992 
Pipette Tips, 1000uL Sarstedt, Numbrecht, Germany 70.762 
Pipette Tips, 200uL  Sarstedt, Numbrecht, Germany 70.760.002 
Pipette Tips, 20uL  Sarstedt, Numbrecht, Germany 70.1116 
Polyscreen PVDF Tranfer Membrane Perkin-Elmer, Massachusetts, USA NEF1002001PK 
Polystyrene round-bottom tube with cell-
strainer cap, 5mL 
BD Bioscience, San Jose, USA 
 
352235 
 
RNase-free Microfuge Tubes 1.5 mL 
 
Ambion, Thermo Fischer Scientific, 
Waltham, USA 
AM12400 
 
RNaseZap® RNase Decontamination Solution 
 
Ambion, Thermo Fischer Scientific, 
Waltham, USA 
AM9780/AM9782 
 
SafeSeal 0.5mL microtube Sarstedt, Numbrecht, Germany 72.699 
SafeSeal 1.5mL micotube Sarstedt, Numbrecht, Germany 72.706 
SafeSeal 2.0mL microtube Sarstedt, Numbrecht, Germany 72.695.500 
Serological Pipette, 10mL  Sarstedt, Numbrecht, Germany 86.1254.001 
Serological Pipette, 25mL  Sarstedt, Numbrecht, Germany 86.1685.001 
Serological Pipette, 5mL  Sarstedt, Numbrecht, Germany 86.1253.001 
SuperFrost Plus® microscopic slides Thermo Scientific, Braunschweig, Germany J1800AMNZ 
Syringe, 1mL Luer BD Bioscience, San Jose, USA 300013 
Tissue Culture Plate Flat-Bottom 6-Well 
Plate 
Sarstedt, Numbrecht, Germany 
 
83.1839 
 
Vacuum Filtration Unit, 0.22um, 250mL Sarstedt, Numbrecht, Germany 83.1822.001 
Wash and Stain (HWS) kit  Affymetrix, Santa Clara, USA 900720 
WypeAll L30 wipes Kimberly-Clark Professionals, Roswell, USA 7301 
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2.1.3 TECHNICAL EQUIPMENT 
TABLE 3: EQUIPMENT 
Equipment  Description, Company 
Array scanner Gene-Chip Scanner-3000-7G, Affymetrix  
Array scanner software GeneChip Operating Software GCOS, Affymetrix 
Array washing station  GeneChip Fluidics Station 450, Affymetrix 
Autoclave 5075 ELV, Tuttenauer 
Balance EW, Kern 
Bio-Plex system  Bio-Rad 
Bright Field Microscope Eclipse TS 100  
Bunsen Burner IBS Fireboy Plus, Integra Bioscences 
Centrifuge Megafuge 1.0R, Thermo Scientific 
Centrifuge  Centrifuge 5415 R, Eppendorf 
Centrifuge with cooling function 5424R, Eppendorf 
Centrifuge with cooling function Biofuge Fresco, Heraeus 
Channel pipette 8 Channel Vision Pipette Viaflo, INTEGRA 
Flow Cytometer FACSCalibur, BD Bioscence 
Freezer, -20 degrees Comfort NoFrost, Liebherr 
Freezer, -80 degrees HeraFreeze, Heraeus 
Hybridization Oven Gene-Chip Hybridization Oven 645, Affymetrix 
Ice Flaker AF 100, Scotsman 
Image acquisition system Fusion Fx7, Vilber Lourmat 
Incubators Co2 Incubator C150 R Hinge 230, Binder 
Laminar Flow Hood Electronics FAZ 2, Waldner 
Low Voltage Power Supply Standard Power Pack P25, Biometra 
Magnetic stirrer IKAMAG RCT, IKA 
Microcentrifuge  Mini Spin Plus, Eppendorf 
Minicentrifuge  FVL-2400N Combi-Spin, Biosan 
Minishaker MS 2, IKA 
pH meter CG 842, Schott 
Pipetteboy Integra 
Pipettes Research and Reference, Eppendorf 
Precision balance EW 150-3M, Kern 
Real Time PCR System 7500 Real-Time PCR System, Applied Biosystems 
RNA quality  analyser Agilent 2100 Bioanalyzer 
Safety Cabinet HERA-Safe, Heraeus 
Shaker KS 260 basic, IKA 
Shaker Orbital Shaker S03, Stuart Scientific 
Shaker Rocking Platform, VWR 
Sonicator Bandelin, SONOPLUS 
Spectrometer  NanoDrop 2000, Thermo Scientific 
Thermocycler TGRADIENT, Biometra 
Thermoshaker HTM 130, HLC 
Thermoshaker PHMT Grant-bio, Keison 
Transfer chamber  Fastblot B44, Biometra 
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UV/Vis Spectrometer V-530,  Jasco 
Vacuum pump Diaphragm Vacuum Pump, Vacuumbrand  
Vortex Vortex-Genie 2, Bender&Hobein 
Water purification system Maxima Ultra-Pure Water, ELGA 
Waterbath GFL 1083, Gesellschaft für Labortechnik 
Western blot Chamber Bio-Rad Mini PROTEAN Tetra System 
Cell culture microscope: 
Bright Field Microscope Primo Vert, Zeiss 
Microscope CCD-Camera AxioCam ICm 1 
Software ZEN, Zeiss 
Epi-fluorescence microscope: 
Fluorescence Microscope Olympus BX  41 
Microscope CCD-Camera Olympus ColorView 
Video system Olympus U-CMAD3; Olympus U-TV1x-2 
Mercury Lamp Lamp Olympus U-RFL-T 
Software Olympus Cell^F  
Confocal Laser Scanning Microscope: 
Microscope Olympus BX61 microscope 
LSM Scanning Unit Olympus Fluoview FV1000  
Mercury Lamp Lamp Olympus U-RFL-T 
Laser Combiner  Olympus FV10-MCPSU 
Software Olympus Fluoview Ver. 4.0b 
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2.1.4 PERFUSION BUFFERS 
TABLE 4: PERFUSION BUFFERS 
Buffer Chemical Amount 
Collagenase buffer 
Amino acid solution 30 ml 
CaCl2 solution  (19 g/l CaCl2* 2 H2O) 10  ml 
Collagenase Type 1  100 mg 
Glucose solution (9 g/l)  155 ml 
Glutamine (7 g/ml) 2.5 ml 
HEPES (60 g/l) (pH 8.5)  25 ml 
KH buffer  25 ml 
EGTA buffer 
Amino acid solution  60 ml 
EGTA solution (47.5 g/l) 1.6 ml  
Glucose solution (9 g/l)  248 ml 
Glutamine (7 g/l)  4 ml 
KH buffer 30 ml 
HEPES (60 g/l) (pH 8.5)  30 ml 
KH buffer 
Potassium chloride (KCl)  1.75 g 
Potassium dihydrogene phosphate  1.6 g 
Sodium chloride 60 g/L 60 g 
filled to 1l with H2O  
 set pH to 7.4 
 
Suspension buffer 
Albumin Fraction V 400 mg  
Amino acid solution  30 ml 
CaCl2 solution (19 g/l CaCl2* 2 H2O) 1.6ml  
Glucose solution (9 g/l) 124 ml 
Glutamine (7 g/ml) 2 ml 
HEPES (60 g/l) (pH 7.6)  20 ml 
KH buffer  20 ml 
MgSO4 solution  (24,6 g/L MgSO4 * 
7H2O) 0.8 ml 
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2.1.5 CELL CULTURE 
2.1.5.1 CELL CULTURE MEDIUM 
TABLE 5: CELL CULTURE MEDIUM 
Additives for cell culture 
medium 
Final 
Concentration 
For 500mL 
Medium 
Company Catalog No 
William’s Medium E - - 
PAN Biotech GmbH, Aidenbach, 
Germany 
P04-29510 
Dexamethasone 100 nM 
20 µl from 2.5 
mM stock in 
EtOH 
Sigma-Aldrich Corp., St. Louis, 
MO, USA 
D4902-25MG 
Gentamycin 10 µg/ml 500uL 
PAN Biotech GmbH, Aidenbach, 
Germany 
P06-13001 
Insulin (ITS) 100x 2 ng/ml 5uL 
Sigma-Aldrich Corp., St. Louis, 
MO, USA 
I3146 
Penicillin/Streptomycin 
100 U/ml Pen; 100 
U/ml Strep 
5mL PAN Biotech GmbH, Aidenbach, 
Germany 
P06-07100 
Stable L- Glutamine 2 mM 5mL 
PAN Biotech GmbH, Aidenbach, 
Germany 
P04-82100 
Sera Plus (Special 
Processed FBS) 
10% (Full Media 
only) 
50 mL PAN Biotech GmbH, Aidenbach, 
Germany 
3702-
P103009 
 
2.1.5.2 CELL CULTURE CHEMICALS 
TABLE 6: CELL CULTURE CHEMICALS 
Other Chemicals Company Catalog No 
Acetic acid glacial Carl Roth, Karlsruhe, Germany 3738.5 
Basement Membrane Matrix, Growth Factor 
Reduced (GFR), Phenol Red-free 
BD Bioscience, San Jose, USA 
 
356231 
Collagen Sandwich - Collagen lyophilize (rat-
tail), 10mg 
Roche Diagnostics GmbH, Manheim, 11171179001 
Collagen Monolayer - Collagen lyophilize (rat-
tail), 10mg 
Roche Diagnostics GmbH, Manheim, 11171179001 
Dexamethasone Sigma-Aldrich Corp., St. Louis, MO, USA D4902-25MG 
DMEM low glucose 1.0 g/L 10x BioConcept, Allschwil, Switzerland 1-25K03-I 
DMSO Sigma-Aldrich Corp., St. Louis, MO, USA 472301 
Easycoll Separating Solution 1.124g/mL Biochrom AG, Berlin, Germany L6143 
Gentamycin 
PAN Biotech GmbH, Aidenbach, 
Germany 
P06-13001 
Insulin (ITS) 100x Sigma-Aldrich Corp., St. Louis, MO, USA I3146 
Mouse Laminin BD Bioscience, San Jose, USA 354232 
Penicillin/Streptomycin 
PAN Biotech GmbH, Aidenbach, 
Germany 
P06-07100 
Sera Plus (Special Processed FBS) 
PAN Biotech GmbH, Aidenbach, 
Germany 
3702-P103009 
Sodium hydroxide pellets  Merk, Darmstadt, Germany 1.06482 
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Stable L- Glutamine 
PAN Biotech GmbH, Aidenbach, 
Germany 
P04-82100 
William’s Medium E 
PAN Biotech GmbH, Aidenbach, 
Germany 
P04-29510 
 
TABLE 7: SMALL CHEMICAL INHIBITORS 
Pathway Chemical Company Catalog No Concentration used 
JNK SP600125 Sigma-Aldrich Corp., St. Louis, MO, USA S5567-10MG 10uM, 25uM, 50uM 
ERK 
 
U0126 
monoethanolate 
Sigma-Aldrich Corp., St. Louis, MO, USA 
U120-1MG 
 
10uM, 25uM, 50uM 
 
JAK Jak inhibitor I Calbiochem, Darmstadt, Germany. 420097 5nM, 10nM, 25nM 
NF-kB 
 JSH_23 
Santa Cruz Biotechnology, Inc., 
California, USA 
sc-222061 
 
5uM, 10uM, 25uM 
 
p38 SB 203580 Sigma-Aldrich Corp., St. Louis, MO, USA S8307-1MG 10uM, 25uM, 50uM 
PI-3K LY-294 Sigma-Aldrich Corp., St. Louis, MO, USA L9908 5uM, 10uM, 25uM 
PKC GF109203X Enzo Life Sciences, Lörrach, Germany ALX-270-049 5nM, 10nM, 25nM 
 
2.1.6 TAQMAN ASSAYS 
TABLE 8: TAQMAN ASSAYS (APPLIED BIOSYSTEMS, CALIFORNIA, USA) 
Target gene Assay Catalog No 
  Mouse Rat  Human 
Bsep Mm00445168_m1  Rn00669268_m1 Hs00184824_m1 
CAR Mm_01283978_m1 - - 
Ccl2 Mm00441242_m1 
  CebpD Mm00786711_s1 - - 
Cyp7a1 Mm00484152_m1 Rn00564065_m1 Hs00167982_m1 
FXR Mm1240553_m1 - - 
GAPDH 4352932E Rn01749022_m1 4352934E 
HNF4 Mm00433964_m1 Rn00573309_m1 - 
Ier3 Mm00519290_g1 
  Klf6 Mm00516184_m1 - - 
Lcn2 Mm01324470_m1 Rn01439062_g1 Hs01008571_m1 
Mrp2 Mm00496899_m1 Rn00563231_m1 Hs00166123_m1 
Mt2 Mm00809556_s1 Rn99999155_g1 Hs02379661_g1 
PXR Mm01344139_m1 - - 
RXR Mm01332431_m1 - - 
SAA3 Mm00441203_m1  - Hs01380779_m1 
Sp1 Mm00489039_m1 - - 
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2.1.7 PROTEIN LYSATES BUFFERS 
TABLE 9: RIPA BUFFER FOR WESTERN BLOT 
RIPA buffer   
50 mM Tris-Cl (pH 7,5) 
 150 mM NaCl 
 1% Nonidet P-40 (NP-40) 
 0,5% sodium deoxycholate 
 0,1% SDS 
 Added prior to use: 
 Protease inhibitor 1:100 
Phosphatase inhibitor 2 1:100 
Phosphatase inhibitor 3 1:100 
 
TABLE 10: LYSIS BUFFER FOR THE LUMINEX ANALYSIS 
Bio-Plex Cell Lysis Kit Per sample 
Bio-Plex  Lysis Buffer 500 µL 
Bio-Plex Factor 1 1:250 
Bio-Plex Factor 2 1:500 
Added prior to use: 
 PMSF (50mM in DMSO) 1:250 
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2.1.8 BUFFERS FOR SDS ELECTROPHORESIS AND WESTERN BLOT 
TABLE 11: BUFFERS FOR SDS ELECTROPHORESIS AND WESTERN BLOT 
Buffer Chemical and amount 
Anode buffer 
Buffer concentrate A (Roth) 80 ml 
Methanol 160 ml 
Dest. Water 560 ml 
Cathode buffer 
Buffer concentrate K (Roth) 40 ml 
Methanol 80 ml 
Dest. Water 280 ml 
Loading buffer (5 x) 
Bromphenol blue 5 mg 
DTT 1 M 2.5 ml 
Glycerol 5 ml 
SDS  0.5 g 
Tris-HCl 1 M 2.25 mL 
PBS (10x) 
KCl 10g 
KH2PO4 10g 
NaCl 400g 
Na2HPO4 46g 
set pH to 7.4 
filled up to 5 L with distilled water 
Ponseau S 
1 g Ponseau S in 500 ml of 3 % 
Trichloroacetic acid   
set pH to 7.4 
Running buffer (10x) 
Glycine 144.0 g 
SDS 10.0 g 
Tris base 30.3 g 
TGP Separation buffer (3M 
Tris-HCl) 
Tris 36.34 g in 100 ml water  
set pH to 8.8 
SGP Stacking buffer (0.47M 
Tris-HCl) 
Tris 5.69 g in 100 ml water  
set pH to 6.7  
Stripping buffer 
Glycine 15 g 
SDS 1 g 
Tween 20 10 ml 
set pH to 2.2  
filled up to 1 L with distilled water 
TBS (10x) 
NaCl 265g 
TRIS 60g 
filled up to 5 L with distilled water 
set pH to 7.4 
TBS-T 
10x TBS 250 ml 
Tween-20 2.5 ml 
Dest. Water 250 ml 
filled up to 2.5 L with distilled water 
5 % BSA solution 
5 g Bovine Albumin Fraction V (BSA) in 
100 ml TBS-T 
10 % SDS 0.5 g SDS in 5 ml water 
10 % APS  0.5 g APS in 5 ml water 
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2.1.9 ANTIBODIES 
2.1.9.1 LIST OF PRIMARY ANTIBODIES 
TABLE 12: PRIMARY ANTIBODIES 
Antigen Origin Company 
Catalog 
No 
Dilution 
BrdU Rat AbD Serotec, Raleigh, USA MCA2060 1:25 (IF) 
DPP4/CD26 Goat  R&D, Minneapolis, USA AF954 1:300 (IF) 
GAPDH Rabbit  
Cell Signaling New England Biolabs GmbH, 
Frankfurt am Main, Germany 
2118 1:1000 (WB) 
HNF-4α Goat Santa Cruz Biotechnology, Inc., California, 
USA 
sc-6556 
1:200 (WB)  
1:50 (IF) 
ICAM1 Rabbit  ProteinTech Group, Chicago, USA 
10020-1-
AP 
1:200 (IF) 
Klf6 Rabbit 
Santa Cruz Biotechnology, Inc., California, 
USA 
sc-7158 1:100 (IF) 
Lipocalin-2/NGAL Goat R&D, Minneapolis, USA AF1857 1:500 (WB) 
p44/42 (ERK1/2) Rabbit  
Cell Signaling New England Biolabs GmbH, 
Frankfurt am Main, Germany 
9102 1:1000 (WB) 
PCNA Mouse 
Cell Signaling New England Biolabs GmbH, 
Frankfurt am Main, Germany 
2586 1:2000 (WB) 
pERK1/2, Alexa Fluor 647 
Conjugate 
Rabbit Cell Signaling New England Biolabs GmbH, 
Frankfurt am Main, Germany 
4284 1:50 (IF) 
Phalloidin, Rhodamine conjugate - Biotium, Hayward, USA 00027 1:100 (IF) 
p-p44/42 (p-ERK1/2) Rabbit  
Cell Signaling New England Biolabs GmbH, 
Frankfurt am Main, Germany 
9101 1:1000 (WB) 
p-SAPK/JNK Rabbit  
Cell Signaling New England Biolabs GmbH, 
Frankfurt am Main, Germany 
4668 1:1000 (WB) 
SAPK/JNK Rabbit  
Cell Signaling New England Biolabs GmbH, 
Frankfurt am Main, Germany 
9252 1:1000 (WB) 
Sp1 Rabbit Abcam, Cambridge, UK ab13370 1:300 (IF) 
 
2.1.9.2 LIST OF SECONDARY ANTIBODIES 
TABLE 13: SECONDARY ANTIBODIES 
Antigen Origin Company 
Catalog 
No 
Dilution 
Alexa Fluor-555 Anti-Rabbit IgG Goat Invitrogen GmbH, Darmstadt, Germany A-21428 1:500 (IF) 
Alexa Fluor-555 Anti-Goat IgG Donkey Invitrogen GmbH, Darmstadt, Germany A-21431 1:500 (IF) 
Alexa Fluor-647 Anti-Goat IgG Rabbit Invitrogen GmbH, Darmstadt, Germany A-21446 1:500 (IF) 
Anti-Goat IgG, HRP-linked 
 
Rabbit 
 
Santa Cruz Biotechnology, Inc., California, 
USA 
sc-2768 
 
1:5000  (WB) 
 
Anti-Mouse IgG, HRP-linked Horse Cell Signaling New England Biolabs GmbH, 
Frankfurt am Main, Germany 
7076 1:1000 (WB) 
Anti-Rabbit IgG, HRP-linked Goat Cell Signaling New England Biolabs GmbH, 
Frankfurt am Main, Germany 7074 
1:1000 (WB) 
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  METHODS 2.2
2.2.1 PRIMARY HEPATOCYTE ISOLATION FROM MOUSE, RAT AND HUMAN LIVERS  
Primary mouse and rat hepatocytes were obtained from male C57BL6/N mice (8-12 
week old) or male Wistar rats (220-300 g body weight), respectively using a two-step perfusion 
technique [171]. The animals were housed according to the animal welfare regulation and all of 
the handling procedures were approved by the animal experimental committees. Prior to the 
isolation of hepatocytes, animals were weighed and anesthetized using an intraperitoneal 
injection containing a mixture of sedative 2% Rompun (20 mg/kg) and anesthetic Ketamin (120 
mg/kg) with a 26G cannula in a 1ml syringe. After ensuring that the animals were fully 
narcotized, that is all reflexes were suppressed, they were placed on an operatic stand under a 
heating lamp and the abdominal cavity was opened for cannulation. Exposed inferior vena cava 
were cannulated with a 24G cannula connected to a peristaltic pump with a rate flow of 15 
ml/min through the portal vein. Successful cannulation of the liver could be observed by an 
instant and even color change of the liver tissue from red-brown to beige. Afterwards, the vena 
cava was incised to ensure proper outflow of the buffers. All buffers used during perfusion are 
described in Table 4. The liver was perfused through the inferior vena cava, first with the EGTA 
buffer warmed up to 37 °C for ca. 15 min at a rate flow of 15 mL/min to remove the blood 
volume and Ca2+ dependent adhesion factors. The perfusion was then continued with the 
collagenase buffer warmed up to 37 °C for ca. 15 min at a rate flow of 15 mL/min to digest 
collagen in the extracellular matrix. Depending on the collagenase enzymatic activity, this step 
lasted between 5-15 min. Following collagen digestion, the liver was excised from the animal 
and transferred onto a Petri dish filled with suspension buffer. The following steps were 
performed in a sterile hood. The liver capsule was opened carefully with forceps and 
dissociated by gentle shaking. The resulting single-cell suspension was filtered through a 100 
µm sieve into a glass beaker. The suspension was then transferred to a 50 ml Falcon tube and 
centrifuged (5min at 50g at 4 °C). As hepatocytes are larger and heavier than other non-
parenchymal cell types, they pellet quickly at the bottom of the tube. After centrifugation, the 
supernatant containing mainly NPC and cell debris was either discarded or used in co-culture 
experiments (for further NPC-enriched fraction purification, see chapter 2.2.2.6). Subsequently, 
the remaining hepatocyte pellet was further purified by washing twice with the suspension 
buffer and re-centrifuged. Finally, the hepatocyte-enriched pellet was re-suspended in 10 ml 
suspension buffer and placed on ice until counting, plating, and/or Percoll purification. Viability 
of hepatocytes was determined by trypan blue vital stain. Briefly, an aliquot of cell suspension 
was diluted 1:5 with the suspension buffer and further mixed with 0.4% trypan blue solution at 
a ratio of 1:1. This mixture was loaded onto a Neubauer chamber hemocytometer. Stained 
cells, representing dead cells, together with the unstained living cells were counted in each of 
the four corner squares. The average number of viable cells was multiplied by 1 x 105 
(accounted for diluting factor and volume of a big square) to obtain the cell number per 
milliliter of cell suspension. On average 90-95% of the cells were viable with a total amount of 
cells ranging 5-7 * 106/mL. 
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Primary human hepatocytes from three donors were obtained from liver sections of 
patients undergoing surgical liver resection. Informed consent was obtained from each patient 
as previously described [171, 172]. The percentage of viable cells was determined by trypan 
blue exclusion; the minimal viability was 65%.  
2.2.1.1.1 PURIFICATION WITH PERCOLL CENTRIFUGATION 
For some experiments, freshly isolated hepatocytes were further purified from the 
remaining non-parenchymal cells, and cell debris removed by one, two or three additional 
Percoll centrifugations steps. For this purpose, Easycoll® (Biochrome, 1.124 g/mL) was diluted 
with sterile PBS to a final density of 1.063 g/mL. Next, 7.5 mL from the hepatocyte-enriched cell 
suspension was gently added on top of the diluted Easycoll® solution and centrifuged for 5 min 
at 28G at 25°C. The resulting cell pellet was washed carefully with 25 mL of sterile PBS and 
centrifuged for 5 min at 50G at 4°C. The cell pellet was then resuspended in 7.5 mL of 
suspension medium. From this purified cell suspension, 2.5 ml were collected and labeled ‘1X 
Percoll’. Cell viability in this fraction was determined by trypan blue exclusion. Two aliquots of 1 
million cells each were collected for quantification of hepatocytes and non-parenchymal cells 
by flow cytometry and hematoxilin & eosin (H&E) staining, respectively (procedures for flow 
cytometry and H&E staining are described below). The remaining cells were used for cultivation 
in collagen sandwich. This procedure was repeated twice with the remaining 5 mL cell 
suspension, herein referred to as ‘2X- or 3X Percoll’. 
2.2.1.1.2 FLUORESCENT ACTIVATED CELL SORTING (FACS) ANALYSIS 
The purity of each hepatocyte preparation before and after the purification steps with 
Easycoll was determined by fluorescence activated cell sorting (FACS) using a BD FACS-Calibur 
flow cytometer, and the data processed using the CellQuest Pro software. A representative 
scatter plot analysis (Figure 45) shows a large and granular hepatocyte population (designated 
here as R1) together with a clearly distinguishable smaller and less granular non-parenchymal 
cell population (designated as R2).   
2.2.1.1.3 PERFUSION WITH SMALL CHEMICAL INHIBITORS 
In some experiments, the small chemical inhibitor SP600125 was added to the 
perfusions buffers (EGTA and collagenase buffers) at a final concentration of 50 µM, using 
DMSO as the vehicle. In these experiments, addition of the JNK inhibitor, SP600125 was applied 
as follows (Figure 17):  
(i) SP600125 was added to the perfusion buffers (EGTA + Collagenase) but not to the cell 
culture medium,  
(ii) SP600125 was added to the culture medium directly upon plating but not to the perfusion 
buffer, 
(iii) SP600125 was added to both perfusion buffers and culture medium.  
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The DMSO was added at 0.5% as a solvent control either to the perfusion solutions or to 
the cell culture medium, as indicated in Figure 17. Primary mouse hepatocytes were cultivated 
with or without the inhibitor for up to 24 hours in sandwich cultures and the gene expression 
profile of selected markers was analyzed via quantitative RT-PCR.  
 
FIGURE 17: EXPERIMENTAL SET-UP FOR PERFUSION WITH JNK INHIBITOR  
2.2.2 IN VITRO CULTURE OF HEPATOCYTES  
Primary hepatocytes were cultured on different extracellular matrix compositions, in a 
hanging drop conformation or in a co-culture with non-parenchymal cells (NPC). During all 
experiments, cells were maintained at 37 °C and 5% CO2. 
2.2.2.1 COLLAGEN MONOLAYER: CONFLUENT AND SUB-CONFLUENT 
To obtain a rat collagen-I stock of 250 μg/mL, 10mg of rat-tail collagen-I was dissolved in 
40 mL of 0.2 % acetic acid resulting in a solution of 250 μg/mL. This stock solution was used to 
pre-coat tissue culture plates used for collagen monolayer cultures and allowed to dry 
overnight under the tissue culture bench. Shortly before plating, all pre-coated plates were 
washed twice with PBS. For conventional culture configurations (monolayer confluent-MC or 
monolayer subconfluent-MS), hepatocytes were plated onto dishes according to the densities 
specified in TABLE 14. The appropriate cell number were seeded in Williams E medium (Table 5) 
with 10% Sera Plus during the first 3h of attachment. Afterwards, unattached cells were 
removed by washing three times with medium, and the final volume of fresh Williams E 
medium was added. For longer culture periods, fresh medium was changed daily. 
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TABLE 14: COLLAGEN MONOLAYER CULTURE SPECIFICATIONS FOR DIFFERENT PLATE FORMATS  
Plate format 
Confluent Condition (MC) Sub-confluent Condition (MS) Medium 
[mL/well] Amount of cells [x 10
6
] Amount of cells [x 10
6
] 
Petri dish (ø6cm) 2 0.3 3 
6-well plate 1 0.125 2 
12-well plate 0.6 0.075 1 
24-well plate 0.3 0.0375 0.5 
 
2.2.2.2 COLLAGEN SANDWICH 
To obtain a rat collagen-I stock of 1 mg/mL, 10mg of rat-tail collagen-I was dissolved in 9 
mL of 0.2 % acetic acid resulting in a solution of1.1 mg/mL. For polymerization of collagen gel, a 
solution of 1.1 mg/mL collagen was mixed with 10x DMEM at a ratio of 9:1, resulting in a yellow 
colored (pH indicator) solution of 1 mg/mL. The solution was then neutralized on ice with 1 M 
NaOH until a visible change of color from yellow to fuchsia was observed. Finally, an 
appropriate amount of collagen solution was evenly distributed in wells and allowed to 
polymerize for 45 min at 37°C. Subsequently, primary hepatocytes were plated onto dishes 
coated with the first collagen gel layer at a density that was dependent on the plate format as 
described in Table 15. The appropriate amount of cells were seeded in William’s E medium 
(Table 5) with 10% Sera Plus during the first 3h of attachment. Afterwards, unattached cells 
were removed by washing three times with culture medium and a second layer of collagen gel 
was added and allowed to polymerize for 40 min at 37 °C. Fresh William’s E medium was added. 
For longer culture periods, fresh medium was changed daily. 
TABLE 15: COLLAGEN SANDWICH CULTURE SPECIFICATIONS FOR DIFFERENT PLATE FORMATS 
Plate format 
1st and 2nd collagen gel layer 
volume (µl/well) 
Amount of cells (x10
6
) Medium (mL/well) 
ø6cm Petri dish 700 2 3 
6-well plate 350 1 2 
12-well plate 200-300 0.3-0.4 1 
24-well plate 100-200 0.1-0.2 0.5 
2.2.2.2.1 CULTURE WITH SMALL CHEMICAL INHIBITORS 
Where applicable, small chemical inhibitors (Table 7) were added to the cell culture 
medium, either during plating and/or after attachment of the primary mouse hepatocytes to 
the collagen sandwich (CS) for up to 24h.  As a vehicle control, DMSO was added at 0.5%. For all 
concentrations used (Table 7), additional DMSO was added to the culture medium so that every 
condition contained the same amount of vehicle representing the maximal concentration used.  
RNA samples were collected at 3 h, 6 h and 24 h timepoints.   
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2.2.2.3 MATRIGEL 
Primary hepatocytes were plated onto MatrigelTM-coated 12-well dishes following the 
“Thin Gel Method” following manufacturer’s instructions. Plates were coated evenly with 
Matrigel at a density of 50 µg/cm2 and incubated for 30min at 37°C. Afterwards, cells were 
seeded at a density of 100,000 cells/cm2 in Williams E medium (Table 5) with 10% Sera Plus 
during the first 3h of attachment. Any unattached cells were then removed by washing three 
times with medium, and the final volume of fresh Williams E medium was added. RNA samples 
were collected after 24h in culture with 500 µL of Qiazol.  
2.2.2.4 LAMININ 
Primary hepatocytes were plated in laminin-coated 12-well dishes following the 
manufacturer’s instructions. Laminin was diluted with Williams E medium at 10 μg/cm2. All 
wells were coated evenly and incubated for 1 h at room temperature. Afterwards, any 
remaining material was aspirated and cells were seeded at a density of 100,000 cells/cm2 in 
William’s E medium (Table 5) with 10% Sera Plus during the first 3h of attachment. Any 
unattached cells were removed by washing three times with medium and a final volume of 
fresh Williams E medium was added. RNA samples were collected after 24 h in culture with 500 
µL of Qiazol.  
2.2.2.5 HEPATOCYTE SPHEROIDS 
Mouse hepatocyte spheroids were prepared using the hanging drop method in 96 well 
GravityPLUS plates. Hepatocyte-enriched cell suspension was diluted to a density of 2000 
cells/40 µL of William’s E medium with additives (Table 5) and 20% Sera Plus. This cell 
suspension was resuspended as a 40 µl drop into each well and cultivated according to the 
manufacturer’s instructions (InSphero®, Schlieren, Switzerland) until day 5. Medium was 
exchanged on day 4 by gently aspirating 20 μl from each drop making sure that the spheroid 
remained untouched in the well. Subsequently, 20 µl of fresh medium was added to each well 
and this procedure was repeated once more resulting using a ratio 1:3 of old to fresh media. 
2.2.2.6 CO-CULTURE WITH NON-PARENCHYMAL CELLS (NPC) 
For co-culture experiments, freshly isolated hepatocytes were plated with a combined non-
parenchymal cell fraction in a ratio of 2 to 1.  The supernatant obtained after the first 
centrifugation step of the liver cell suspension (5 min, 50G at 4°C) was collected into a 50 ml 
tube and centrifuged at 400G, 4°C for 10 min. The cell pellet was resuspended in 2 ml of 
suspension buffer, and the cells were counted using a Neubauer chamber. This cell population 
contains a mixture largely composed of liver sinusoidal endothelial cells, and fewer hepatic 
stellate cells and Kupffer cells [173].  
Co-cultures experiments were performed as follows: 
A) Collagen monolayer confluent (MC) – freshly  isolated hepatocytes were plated onto 
collagen coated plates in William’s E medium with additives (Table 5) with 10% Sera Plus 
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at a density of  75,000 cells/cm2, allowed to attach for 3h, and washed twice with 
William’s E medium. Non-parenchymal cells were then added to the attached 
hepatocytes in William’s E medium with additives (Table 5) with 10% Sera Plus at a 
density of 37,500 cells/cm2, allowed to attach for 3h, washed twice with William’s E 
medium, upon which a final volume of fresh culture medium was added and cells were 
placed into the incubator. 
B) Collagen sandwich (S) – freshly isolated hepatocytes were firstly plated onto a collagen 
gel in William’s E medium with additives (Table 5) with 10% Sera Plus at a density of  
75,000 cells/cm2, allowed to attach for 3 h, and washed twice with William’s E medium. 
Non-parenchymal cells were then added to the attached hepatocytes in William’s E 
medium with additives (Table 5) together with 10% Sera Plus at a density of 37,500 
cells/cm2. Cells were allowed to attach for 3 h, washed twice with William’s E medium, 
upon which a second layer of collagen gel was added to achieve a collagen sandwich as 
described for the hepatocyte cultures. After 40min of polymerization of the second gel 
layer, culture medium was added and cells were placed in the incubator. 
2.2.3 IN VIVO MODELS OF LIVER DAMAGE, INFLAMMATION AND REGENERATION 
All experiments were performed using male C57BL6/N mice (8-12 weeks old, Charles Rivers, 
Sulzfeld, Germany). The mice were fed ad libitum with Ssniff R/M-H, 10 mm standard diet. All 
experiments were approved by the local ethic committee. Experiments were performed as 
follows: 
A) CCl4–induced acute liver damage model (CCl4) – mice  received a single injection of CCl4 
(1.6 g/kg body weight) dissolved in 0.5 ml olive oil as previously described [174]. As 
controls, mice received a single injection of olive oil. The solutions were freshly 
prepared before the injection and mixed by vortexing. The volume injected was 4 ml/kg 
per mice. Liver tissue samples for protein extracts and RNA isolation were collected 
from: (i) 5 independent biological replicates at each of the CCl4–treated timepoint (2h, 
8h, day 1, day 2, day 4,day 6, day 8 and day 16), (ii) 5 independent solvent control mice 
injected with olive oil at each timepoint (day 1 and 3), and (iii) 5 independent untreated, 
control mice.  Additionally, protein extracts and samples for RNA isolation were 
collected from hepatocyte-enriched fraction obtained from 3 independent freshly-
perfused, mice livers after CCl4–treatment at each timepoint (days 1 and 3).  
B) Lipopolysaccharide–induced inflammation model (LPS) – mice received a single 
intraperitoneal injection of LPS (750 ng/kg) dissolved in sterile PBS. Liver tissue samples 
for protein extracts and RNA isolation were collected from: (i) 5 independent biological 
replicates at 24 hours after single injection, and (ii) 3 independent untreated, control 
mice. Additionally, protein extracts and samples for RNA isolation were collected from 
hepatocyte-enriched fraction obtained from 3 independent freshly-perfused mice livers 
24 hours after a single injection with LPS and the corresponding three independent 
freshly perfused untreated, control mice. 
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C) 70% Partial hepatectomy liver regeneration model (PHx) – experiments were 
performed by our collaborators at the Department of General, Visceral and Vascular 
Surgery, University Hospital Jena, Germany [171].  All surgical interventions were 
performed under inhalation of 2% isoﬂurane mixed with an oxygen flow of 0.3 L/min 
(isoflurane vaporizer, Sigma Delta, UK) in an S1 operation room. A precise vessel-
oriented, parenchyma-preserving surgical technique was used for 70% partial 
hepatectomy using a modification of the technique described by Madrahimov for rats 
[175]. The procedure started with a laparotomy via a transverse abdominal incision. The 
whole liver was well exposed by elevating the xiphoid process. Skin and muscle were 
fixed by retractors, and the small bowel was moved out to the left side of the abdomen 
and covered with saline soaked gauze. The liver was freed from the falciform ligament 
and the triangular ligamentum. The liver lobes were positioned so that the hilum of the 
left lateral lobe (LLL) and median lobe (ML) were clearly visible. All subsequent steps 
were performed using a stereo microscope with 10x magnification. A ligature (6-0 silk) 
was applied loosely to the pedicle of LLL. The ligature was tightened, keeping a distance 
of about 3 mm from the cava while the LLL remained in its anatomical position and the 
lobe resected. Next, a cholecystectomy was performed after double ligating the cystic 
duct and cystic artery using a 7-0 prolene suture. For resection of the median lobe, a 
virtual line was drawn between the left side of the cava and the gallbladder. The clamp 
was placed roughly perpendicular to the surface of the left median lobe (LML), about 
3mm lateral to this line and the left median lobe was removed. Proximal to the clamp, a 
piercing suture was positioned according to the vascular anatomy in order to ligate the 
left median hepatic vein and the clamp was removed. The right median lobe (RML) was 
also similarly clamped. After resection, two piercing sutures were placed to ligate the 
right and median hepatic veins as well as the arterial and portal supply. Finally, the 
abdomen was irrigated with warm saline solution and closed with a two layer running 
suture (6-0 prolene). At the end of the anesthesia, animals were allowed to recover on a 
heating pad. Temgesic (0.05 mg/kg) was applied subcutaneously after operation and at 
an interval of 12 hours over the next 3 days. Body weight and activity were monitored 
daily using a scoring system [176]. Briefly, mice with normal activity, physiological 
position, no jaundice, and no signs of bleeding were regarded as healthy (+++); animals 
showing a weaker activity, hunched back position and/or signs of jaundice or bleeding 
were regarded as weak (++); and animals with no spontaneous activity and lying 
position and signs of jaundice or bleeding were regarded as severely ill (+). Liver tissue 
samples for protein extracts and RNA isolation were collected from three independent 
biological replicates at each of the timepoints (1h, 6h, 12h, day 1, day 2, day 3, day 4, 
one week, two weeks, four weeks and three months). Sections of about 0.5 cm2 were 
snap frozen in liquid nitrogen and stored at -80°C for subsequent isolation of proteins or 
RNA.  
For liver tissues samples, mice were anesthetized at the indicated timepoints and the liver 
was resected, washed in ice cold PBS and sectioned for further analysis. Sections of about 0.5 
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cm2 were snap frozen in liquid nitrogen and stored at -80°C for subsequent isolation of RNA and 
proteins (described in chapter 2.2.4.1 and 2.2.7.1  respectively).  
For freshly isolated hepatocyte-enriched fraction, one million cells in suspension medium 
were used for subsequent isolation of RNA and proteins (described in chapter 2.2.4.1 and 
2.2.7.1  respectively).  
2.2.4 RNA ISOLATION AND cDNA SYNTHESIS  
2.2.4.1 RNA ISOLATION FROM PRIMARY HEPATOCYTES AND LIVER TISSUE  
The RNA was isolated from cultured hepatocytes and from mouse liver tissue using the 
Phenol/Chloroform method and QIAzol Lysis Reagent according to the Qiagen manufacturer’s 
description: 
A) Freshly isolated hepatocytes: 1 million cells in suspension medium were centrifuged at 
3,000 rpm, at 4°C for 5 min. The supernatant was quickly removed and the cell pellet 
was lysed in 1 ml of QIAzol by 10 repetitive aspirations in a micropipette.  
B) Primary hepatocytes from in vitro cultures:  culture medium was removed and the cells 
were lysed with 1mL QIAzol with a cell scraper and subsequently micropipetted into a 
pre-cooled, sterile 1.5ml tube that was kept on ice. For liver tissue, snap frozen sections 
were lysed in a 1.5 ml tube with 1 ml QIAzol using a plastic pestle and subsequent 
sonication on ice.  
C) Spheroids: all micro-tissues were collected from three independent plates by gently 
passing the hanging drops into a sterile Petri dish. The spheroids were concentrated by 
swirling the dishes, collected with a micropipette and transferred to a 1.5 ml tube. After 
sedimenting for 10 minutes on ice, the medium was removed and the microtissues were 
lysed in 500 µl QIAzol.   
D) Snap frozen liver tissue: sections of about 0.5 cm2 liver tissue were lysed in 1 ml QIAzol 
and homogenized with a plastic pistol while kept on ice. 
All samples homogenized in QIAzol reagent were subsequently sonicated for 30s on ice. For 
every 1 mL QIAzol, 0.2 ml chloroform was added and the samples maxed vigorously for 15 s. 
Samples were kept at room temperature for 2–3 min for thorough phase separation and later 
centrifuged at 12,000 G for 15 min at 4°C. After centrifugation, the samples separate into 3 
phases: an upper, colorless, aqueous phase containing RNA; a white interphase; and a lower, 
red, organic phase. The upper, aqueous phase was transferred into a new tube containing 0.5 
ml isopropanol (per 1 mlQIAzol) and mixed thoroughly. All tubes were incubated at room 
temperature for 10 min and centrifuged at 12,000 xg for 10 min at 4°C. The supernatant was 
discarded and the RNA pellet was resuspended in 1 mL of 100% ethanol and centrifuged at 
7,500 xg for 5 min at 4°C. The supernatant was discarded and the RNA pellet was resuspended 
in 1mL of 75% ethanol and centrifuged at 7,500 x g for 5 min at 4°C. Finally, supernatant was 
removed and RNA pellet was air-dried for 30 min and re-dissolved in an appropriate volume of 
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RNase-free water (10-30 μL). RNA concentration and integrity were determined 
spectrophotometrically using a Nanodrop 2000. The extracted RNA was stored at -80°C until 
further analysis. 
2.2.4.2 Reverse Transcription Polymerase Chain Reaction (RT-PCR) 
For the complementary DNA synthesis, 2 µg of RNA were transcribed using TGRADIENT 
thermocycler with the High Capacity cDNA reverse transcription kit. The reaction mixture for 
cDNA synthesis is specified in Table 16. The PCR conditions were programmed for 25°C for 10 
min, 37°C for 120 min, followed by 85°C for 5min for all PCR reactions. The resulting cDNA were 
diluted with DEPC-treated water to a final concentration of 10 ng/ μl and stored at -20°C. 
TABLE 16: COMPOSITION OF THE REACTION MIXTURE FOR cDNA SYNTHESIS 
Master mix 
 10x RT-Buffer 2μl 
25x dNTP 0.8μl 
Random primer 2μl 
Reverse transcriptase 1μl 
H2O 4.2μl 
Total volume 1 10μl 
RNA 2μg 
H2O up to  10μl 
Total volume 2 10μl 
Final total volume 20μl 
 
2.2.5 QUANTATIVE REAL TIME PCR (qRT-PCR) 
The quantitative real-time RT-PCR (qRT-PCR) was performed using Taq-Man-PCR 
technology with a 7500 Real-Time PCR System using TaqMan® Universal Master Mix II, with 
UNG. All reagents were purchased from Applied Biosystems. All TaqMan primer probes used 
are listed in Table 8. Samples were run in duplicates. 25ng of transcribed cDNA was mixed with 
17.5 μl of qRT-PCR reaction mixture (Table 17). The conditions for all qRT-PCR reactions are 
specified in Table 18. For all PCR analyses, a no-template negative control was included. PCR 
products were analyzed with the 7500 Real-Time PCR System software. 
 
TABLE 17: COMPOSITION OF THE REACTION MIXTURE FOR qRT-PCR 
Kit µl for 1 sample 
TaqMan Master Mix  10 μl 
DEPC H2O  6.5 μl 
TaqMan primer probe  1 μl 
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TABLE 18: THERMOCYCLER PROGRAM FOR qRT-PCR REACTION 
Stage Temperature [°C] Time Repetitions 
1 50 2 min 1 
2 95 10 min 1 
3 
94 15s 
40 60 30s 
72 35s 
4 
95 15s 
1 
60 20s 
95 15s 
60 15s 
 
The relative mRNA content was normalized to glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) mRNA expression in each sample. For mouse and rat studies, the 
expression levels in freshly isolated hepatocytes and hepatocytes in culture were normalized to 
the levels of healthy liver tissue. For human studies, the expression levels of cultivated 
hepatocytes were normalized to freshly isolated hepatocytes. For calculations of relative gene 
expression, the 2-ΔΔCt method was used [177] as described in Table 19. The results shown 
correspond to means of three independent cell batches or tissues preparations unless 
otherwise described. 
TABLE 19: CALCULATIONS STEPS FOR ANALYZING qRT-PCR RESULTS 
Calculation step Formula 
1. ∆Ct1 = Ct Gene of interest (GOI) – Ct Housekeeper gene (HKG) 
2. ΔCt2 = Ct GOI of control samples – Ct HKG of control samples 
3. ΔΔCt = ΔCt1 – ΔCt2 
4. Calculation of 2
-ΔΔCt
 
2.2.6 AFFYMETRIX GENE ARRAY ANALYSIS 
The RNA samples from the cultivation systems and all three in vivo models were further 
analyzed in time resolved global gene expression profiling [78]. RNA concentration and integrity 
of all samples were determined spectrophotometrically using a Nanodrop 2000 and a 
Bioanalyzer respectively. For global gene expression profiling in murine and human 
hepatocytes, Affymetrix Mouse GenChip® Genome 430 2.0 arrays and GeneChip® Human 
Genome U133 Plus 2.0 array were used, respectively. All labeling reagents and instrumentation 
regarding microarrays were acquired from Affymetrix.  
A total of 100ng RNA were transcribed into cDNA by oligo dT primers, and reverse 
transcribed to biotinylated cRNA with the GeneChip 3’ IVT Express Kit. After 16 hours of in vitro 
transcription, the amplified RNA was purified using magnetic beads and 15 μg of amplified RNA 
was fragmented with the fragmentation buffer using Affymetrix’s protocol. In the next step, 
12.5 μg of labeled and fragmented cRNA was hybridized to Mouse Genome 430 2.0 Affymetrix 
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GeneChips along with a hybridization cocktail and placed in a hybridization oven rotating at 60 
RPM at 45 ºC for 16 h. Microarrays were washed using an Affymetrix fluidics station 450 and 
stained initially with streptavidin-phycoerytherin. For each sample, the signal was further 
enhanced by incubation with biotinylated goat anti-streptavidin followed by a second 
incubation with streptavidin-phycoerytherin, and a second round of intensities were measured. 
Microarrays were scanned with an Affymetrix Gene-Chip Scanner-3000-7G controlled by GCOS 
software. Mouse Genome 430 2.0 Affymetrix GeneChips contain over 45,000 probe sets from 
over 34,000 well-characterized mouse genes. Human Genome U133 Plus 2.0 Affymetrix 
GeneChips contain 54,000 probe sets including more than 38,500 well-characterized genes. 
GeneChips microarray study followed MIAME guidelines issued by the Microarray Gene 
Expression Data group.  
2.2.6.1 MICROARRAY PROCESSING AND STATISTICAL ANALYSIS 
Biostatistical analysis was performed by our collaborators at the Leibniz Institute for 
Natural Product Research and Infection Biology Hans-Knöll-Institute (HKI) in Jena, Germany. 
Affymetrix gene expression data were pre-processed using ‘affyPLM’ packages [178] from the 
Bioconductor Software [179]. The pre-processed dataset was analyzed for differential gene 
expression using linear models with least squares regression and empirical Bayes moderated t-
statistics of the LIMMA (Linear Models for Microarray Data) package [180] of Bioconductor 
software [179] for the statistical programming language R [181]. The obtained p-values were 
adjusted for multiple comparisons using the Benjamini Hochberg false discovery rate correction 
(FDR) [182]. Data obtained from fresh hepatocytes were used as reference. The custom chip 
definition file from Brainarray [183] based on Unigene ID’s was used to annotate the 
microarrays. A dual selection criteria (p-value < 0.05 and an absolute fold change > 2) was 
chosen as significance level to detect differentially expressed genes (DEGs). Processing and 
visualization (Principal Component Analysis) of data were performed using MATLAB tools (The 
MathWorks Inc., Natick, MA). 
2.2.6.2 FUZZY CLUSTERING OF GENE EXPRESSION PROFILES 
The time-profiles of the differentially expressed genes in cultivated mouse hepatocytes 
were scaled between their respective absolute temporal extreme values to focus on 
subsequent cluster analysis on the qualitative behavior of the expression profiles. The time 
series were clustered using fuzzy c-means [184] (fuzzy exponent = 1.5; maximum number of 
iteration = 200; minimum cost function improvement = 10-10). The optimum number N of 
cluster was estimated by repeated calculation (number of iterations = 100) of the fuzzy cluster 
index ‘Separation Index’. 
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2.2.6.3 GENE ONTOLOGY (GO), WIKI AND KEGG PATHWAY ANALYSES 
Genes which show change ratios greater (or less) than 2-fold in the triplicate arrays at 
any one of the timepoints have been considered as up or down-regulated and subjected to 
gene ontology (GO) and pathway analyses. Differentially regulated genes were categorized 
using the manually curated Gene Ontology of the Biobase Knowledge Library (BKL) of the 
ExPlain™ webservice (BioBase GmbH, Wolfenbüttel, Germany).  
2.2.6.4 PROMOTOR ANALYSIS 
To identify transcription factors (TFs) whose binding sites are enriched in a given set of 
promoters, the algorithm PRIMA (PRomoter Integration in Microarray Analysis; [185]) of the 
Expander Software 6.1 (EXPression ANalyzer and DisplayER; [186]) was used. Genes that show a 
fold change greater than 2-fold (p-value cut off is 0.05) were used for analysis. All genes from 
the mouse (Ensembl release 42) were used as the background set; the threshold of the p-value 
was set to 0.01 and the region was scanned from -3000 to +200. The results are shown as a 
snapshot in Figure 34. 
2.2.6.5 SPEARMAN’S RANK CORRELATION ANALYSIS 
To calculate the strength of the relationship between cultivation (MC, MS, S) and the in 
vivo models CCl4, PHx and LPS, we used Spearman’s rank correlation. The changes in gene 
expression at different timepoints in cultivation (MC, MS, S) versus changes in CCl4, PHx and LPS 
were used for the calculation of the correlation coefficients.  
2.2.6.6 METAGENE ANALYSIS 
The ‘inflammation’ and ‘metabolism’ metagenes were obtained as follows: (i) The 
overlap between deregulated genes (2-fold, p≥0.05, FDR adjusted) of all culture systems (MC, 
MS, S) and all in vivo models (CCl4, PHx, LPS) at day 1 was determined. This resulted in 74 genes; 
(ii) of these 74 genes, 19 and 28 belonged to the ‘inflammation’ and 28 ‘metabolism’ clusters, 
respectively, as defined in Table 22 and Table 23. The 19 inflammation- and 28 metabolism-
associated genes were used to calculate the ‘inflammation’ and ‘metabolism’ metagenes, 
respectively; and (iii) for this purpose, the expression level of each gene was normalized in the 
following way: the mean value (of the normalized gene expression values) of the 19 
inflammation-associated genes was defined as the ´inflammation` metagene. The same 
technique was applied to the metabolism-associated genes. This calculation was performed in 
each independent biological replicates (n=3 for cultivation and freshly isolated hepatocytes; 
n=5 for CCl4, PHx and LPS). For the in vitro samples, (MC, MS, S) the metabolism and 
inflammation metagenes were calculated using deregulated genes after 1 day in culture. 
Similarly, in vivo samples (CCl4, PHx and LPS) were analyzed one day after administration of 
CCl4, LPS or after performing PHx. The timepoint of 1 day was chosen because this represents 
the earliest timepoint where a strong correlation (r>0.6) between all genes deregulated in vivo 
and in vitro was obtained (Figure 41). In contrast, for proliferation-associated genes the 
correlation between in vitro and in vivo did not occur before two days after cultivation or in vivo 
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intervention (CCl4, PHx) (Figure 43). This was not unexpected because it is well known that 
proliferation of hepatocytes in mice only occurs approximately 2 days after administration of 
CCl4 or PHx (Hoehme 2010). Therefore, all calculations for the proliferation metagene shown 
were calculated using the expression values of commonly deregulated genes (Table 24) on day 
2 in culture, and in the in vivo models CCl4 and PHx. 
2.2.7 WESTERN BLOT ANALYSIS  
2.2.7.1 PROTEIN COLLECTION AND QUANTIFICATION  
Protein extracts were performed as follows:  
A) Freshly isolated hepatocytes: 1 million cells in suspension medium were centrifuged at 
3,000 rpm, 4°C for 5 min. The supernatant was discarded and pelleted cells were lysed 
with 1 mL of ice-cold RIPA buffer (Table 9) by thorough mixing (3-5 times) with a pipette 
and kept on ice.  
B) Primary hepatocytes from in vitro cultures: culture medium was gently removed and 
cells were lysed with 300 µl of ice-cold RIPA buffer. Cells were scraped and collected in 
1.5 ml tubes kept on ice. 
C) Snap frozen liver tissue: sections of about 0.5 cm2 of liver tissue were lysed with 1 mL of 
ice-cold RIPA buffer and homogenized with a plastic pistol while kept on ice.  
Afterwards, all collected samples were sonicated for 30s while kept on ice. The 
homogenates were further incubated on ice for 30 min, and centrifuged for 10 min at 13.000 
rpm at 4°C. The clear supernatant containing solubilized proteins was collected in pre-chilled 
1.5 ml tube and stored at -20 °C until further analysis. The pellet containing most of the 
collagen and insoluble proteins was discarded. The protein concentration in the collected 
supernatants was determined using a bicinchoninic acid (BCA) protein assay. Protein 
concentration was calculated for the average value of three counts and related to the protein 
standard curve. 
2.2.7.2 SDS/PAGE ELECTROPHORESIS 
30 to 50 µg of protein extract adjusted to 30 µl volume with sterile water were heat 
denaturated under reducing conditions for 5 min at 95 °C with 6 µl Laemli buffer (5x). 
Afterwards, the samples were shortly centrifuged at 13.000 rpm. For electrophoresis, 10% SDS-
PAGE gels with a 1.5 mm x 10 wells or 1.5 mm x 15 wells were used. Components of a 10% SDS-
PAGE gel are listed in the Table 20. To correctly estimate the molecular weight of separated 
proteins expressed in samples, two different protein standard markers (4 µl of both Precision 
plus protein standard and MagicMark TM XP Western Protein Standard) were additionally 
loaded on the 10% SDS-PAGE gel (inserted with a 1.5 mm x 10 wells or 1.5 mm x 15 wells comb) 
in the first two lanes. The remaining samples were then loaded into the following lanes of the 
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gel and casted in the Bio-Rad Mini PROTEAN Tetra System filled with 1X running buffer. The 
electrophoresis was carried out using a Biometra Standard Power Pack P25 for about 3 hours at 
a constant voltage of 25 mA/gel.  
TABLE 20: COMPONENTS OF A 10% SDS GEL 
Separation gel (10%)   Stacking gel   
  1 Gel   1 Gel 
H2O 3.2 ml H2O 2.4 ml 
Acrylamide 2.64 ml Acrylamide 0.5 ml 
Separation buffer 2 ml Stacking buffer 0.4 ml 
10% SDS 80 µl 10% SDS 32.5 µl 
TEMED 3.2 µl TEMED 2.5 µl 
10% APS 80 µl 10% APS 50 µl 
 
2.2.7.3 WESTERN TRANSFER  
Protein transfer was performed using a semi-dry Fastblot B44 blotting system with a 5x8 
cm size gel-membrane sandwich containing from the bottom: 12pieces of Whatman blotting 
paper equilibrated in the anode buffer, PVDF transfer membrane activated in methanol, SDS-
PAGE gel with resolved proteins and 4 pieces of Whatman blotting paper equilibrated in the 
cathode buffer. Blotting was performed with Biometra Standard Power Pack P25 for 40 min at a 
constant current of 250 mA/gel-membrane sandwich. The membranes were then washed in 
distilled water and stained with Ponseau S in Triclorite acid for 1 minute to visualize successful 
transfer of proteins. Finally, Ponseaus S stain was removed by thorough washing of membranes 
with TBS-T for 5 min. 
2.2.7.4 IMMUNODETECTION OF PROTEINS 
For detection of proteins, the blotting membranes were later blocked for 1h with 5% 
BSA in TBS-T buffer (pH 7.2) at room temperature, followed by overnight incubations at 4°C 
with primary antibodies enlisted in Table 12 diluted in 5% BSA-TBS-T. Afterwards, the 
membranes were washed three times in TBS-T buffer at room temperature for 10 min each, 
followed by an incubation step with horseradish peroxidase-labeled secondary antibodies 
(Table 13) ), which were incubated in 5% BSA-TBS-T for 1 h at room temperature. Subsequently, 
the membranes were washed three times in TBS-T, 10 min each, at room temperature. Bands 
were detected by chemiluminescence using the Western Lightning ECL substrate in a Fusion-
FX7 imager equipped with a CCD camera. Membranes were then washed in TBS-T for 5 minutes 
and probed antibodies were stripped of the membranes by 45 min incubation with the 
stripping buffer followed by a washing step of 5 minutes in TBS-T. Complete removal of all 
antibodies was ensured by additional control imaging of the membranes.  
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2.2.8 MULTIPLEX ANALYSIS OF SIGNAL TRANSDUCTION (LUMINEX SCREENING) 
Luminex screening was performed by our collaborators at the Systems Biology of Molecular 
Networks Department at the Institute of Pathology of the Charité Medical University in Berlin, 
Germany. Protein extracts were collected using the Bio-Plex Cell Lysis Kit following the 
manufacturer’s instructions:  
A) Freshly isolated hepatocytes: 1 million cells in suspension medium were centrifuged at 
3,000 rpm, 4°C for 5 min. Supernatant was discarded and pelleted cells where lysed with 
500 μL of lysis buffer with additives (Table 10) by thorough mixing (3-5 times) with a 
pipette and kept on ice.  
B) Primary hepatocytes from in vitro cultures: culture medium was gently removed and 
cells were washed 3 times with ice-cold Bio-Plex Cell Wash Buffer. Afterward cells were 
lysed with 500 μL of lysis buffer with additives, collected with a cell scraper and re-
pipetted into pre-chilled 1.5mL tubes.   
C) Snap frozen liver tissue: sections of about 0.5 cm2 liver were lysed with 500 μL of lysis 
buffer with additives and homogenized with a plastic pistol while kept on ice.  
Afterwards, all collected samples were sonicated for 30 s while kept on ice. The 
homogenates were further incubated on ice for 30 min, and centrifuged for 10 min at 13.000 
rpm at 4 °C. The clear supernatant containing solubilized proteins was collected in pre-chilled 
1.5 ml tube and stored at -20 °C until further analysis. The pellet containing insoluble proteins 
was discarded. The protein concentration in the collected supernatants was determined using a 
bicinchoninic acid (BCA) protein assay. Protein concentration was calculated for the average 
value of three counts and related to the protein standard curve. Afterwards, an aliquot from 
each sample was normalized to a concentration of 1 µg/µl in 100 µl with the lysis buffer with 
additives. Phospho-protein levels were analyzed using the Bio-Plex system with total protein 
amount of 25 µg per sample and Multi-Plex-Assay consisting of antibodies against p-Akt 
(Ser473), p-c-jun (Ser63), p-ERK2(Thy185/Thr187), p-GSK3 /  (Ser9/Ser21), p-Hsp27 (Ser78), p-
JNK (Thy193/Thr185), p-MEK1 (Ser217/Ser221), p-NF B (Ser536), p-p38 (Thr180/Thy182), p-
p70S6K (Thr421/Ser424) and pSTAT3 (Ser727). The assay was performed according to the 
manufacturer’s instructions with minor modifications (beads and detection antibodies were 
diluted 4-fold). All antibodies were purchased from Cell Signaling (Cell Signaling, New England 
Biolabs GmbH, Frankfurt am Main, Germany).   
2.2.9 HEMATOXYLIN-EOSIN STAINING OF HEPATOCYTES 
Primary mouse hepatocytes from standard or Percoll purified preparations were 
allowed to attach to collagen coated glass slides for 3 h, washed two times with sterile PBS, and 
fixed with 4%paraformaldehyde in PBS, 15 min at room temperature. Afterwards, cells were 
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permeabilized with 0.5% triton X-100 in PBS (15 min, room temperature) and washed three 
times in PBS (5 min, room temperature). The slides were briefly soaked in distilled water, 
stained with Hematoxylin (7.5 g/l) for 1 min at room temperature, and washed in distilled water 
for 15 min. The slides were shortly soaked in 1% HCl in 70% ethanol, stained with Eosin (1%) for 
1 min, and washed in distilled water for 10 min. Afterwards, the samples were dehydrated by 
sequential incubation using increasing concentrations of ethanol (50%, 70%,90% and 100%, 2 
min in each solution). Finally, the slides were incubated in Roti-Histol for 2-3 min, mounted 
onto glass slides with Entellan and air-dried overnight. Hepatocytes and non-parenchymal cells 
were identified with bright field microscopy, and 10 randomly selected fields were counted 
(20X magnification).  
2.2.10 IMMUNOFLUORESCENCE  
Primary mouse hepatocytes were plated onto collagen-coated glass slides and allowed to 
attach for 30 min (representing freshly isolated hepatocytes) or cultivated for a period of 1, 3, 5 
or 7 days in MC, MS or S configurations in 12 well culture plates as previously described. After 
the indicated timepoints, the medium was removed, the cells were immediately fixed with 4% 
paraformaldehyde in PBS for 15 min at 37°C. Afterwards, the cells were permeabilized using 
0.5% Triton X-100 in PBS for 15 min at room temperature, and washed three times with PBS, 5 
min each. From here on, all incubations were performed in a humidified chamber. Unspecific 
binding sites were blocked by incubating with a blocking solution containing 3% BSA / 0.1% 
Tween 20 in PBS for 1 h at room temperature. Afterwards, the blocking solution was removed, 
and the cells were incubated overnight at 4 °C with the following antibodies in 0.3% BSA / 0.1% 
Tween®20 in PBS: anti-HNF4α, anti DPPIV. Subsequently, the antibody solutions were removed 
and samples were washed three times for 10 min with PBS at room temperature. Afterwards, 
the samples were incubated for 1 h at room temperature with the following secondary 
antibodies labeled with Alexa 555 or Alexa 647 (for detection of HNF4α or DPPIV, respectively) 
dissolved in 0.3% BSA / 0.1% Tween20 in PBS. For staining the stress fibers (F-actin) and nuclei, 
cells were incubated with a mixture of rhodamine-labeled phalloidin at 2 U/mL and DAPI at 0.5 
ng/µL in PBS for 20 min at room temperature, respectively. Afterwards, slides were washed 
three times with PBS for 10 min each, and mounted onto SuperFrost Plus microscopic slides 
using FluorPreserve™ Reagent, allowed to air dry for 30 min at room temperature, and fixed 
with nail polish. Afterwards, slides were kept at 4°C until imaging. 
For HNF4α staining, the samples were analyzed using an Olympus BX41 epifluorescence 
microscope, and images were acquired using the Cell^F software. For DPPIV and rhodamine 
labeled phalloidin stainings, the images were acquired on a Olympus FV-1000. Detailed 
description of microscopes is provided in Table 3. The excitation and emission wavelengths 
were used as specified by the manufacturer. The colors assigned to DPPIV, rhodamine-labeled 
phalloidin and DAPI were green, red and blue, respectively.  
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3. RESULTS 
  RAPID TRANSCRIPTIONAL RESPONSES ARE INDUCED IN PRIMARY MOUSE 3.1
HEPATOCYTES UPON ISOLATION AND CULTIVATION   
3.1.1 INFLUENCE OF THE EXTRACELLULAR MATRIX CONFIGURATION ON THE 
MORPHOLOGY OF CULTIVATED MOUSE HEPATOCYTES 
To gain insight into the molecular effects of hepatocyte isolation and cultivation, time 
resolved global gene expression profiling using Affymetrix microarrays was carried out in: (i) 
collagen sandwich cultures (S), (ii) confluent (MC) as well as subconfluent (MS) monolayer 
cultures. For this purpose, primary mouse hepatocytes were cultivated in biological triplicates 
under the indicated conditions for up to one week and samples intended for whole genome 
expression profiling were collected at 1, 2, 3, 5 and 7 days after plating.  
Primary hepatocytes in vitro acquire a profoundly distinguishable morphology 
depending on the extracellular matrix used as the culture substratum. In the presented study, 
all three culture systems show well-reported morphological features (Figure 18, A). 
Hepatocytes in MS culture acquire a fibroblast-like morphology that becomes more prominent 
at late timepoints. MC cultures maintain a cuboidal morphology during the first day in culture. 
However EMT features [115, 187] are also observed from day 7 in culture.  
 hepatocytes present the most stable morphology resembling the in vivo phenotype. 
They appear more differentiated, as evidenced by the in vivo-like cuboidal shape and distinct 
bile canaliculi network formation, even after longer periods in culture.  
Confocal microscopy reveals structural details of cultivated hepatocytes (Figure 18, B). 
In MS culture, actin (stained in red) forms stress fibers such as microspikes associated with 
lamellipodia and filopodia [188] indicating typical features of epithelial to mesenchymal 
transition (EMT). The bile canaliculi marker DPPIV (stained in green) is observed as diffusely 
distributed all over the membrane, consistent with a loss of normal hepatocyte polarity in this 
culture configuration. In MC, hepatocytes preserve some degree of polarity, indicated by the 
preferential localization of DPPIV at cell-cell contacts. Nevertheless, microspikes of actin clearly 
occur at cell borders. In sandwich-cultured hepatocytes, actin fibers accumulate around the bile 
canaliculi and also discretely at cell borders. However, they do not form microspikes. Moreover, 
DPPIV staining is strongly visible at bile canaliculi, showing a high degree of colocalization with 
f-actin, which is revealed by the yellow color (merged of red actin and green DPPIV). In 
conclusion, primary hepatocytes showed the expected morphology over the entire cultivation 
period, including bile canaliculi formation by sandwich cultures and epithelial-to-mesenchymal 
transition (EMT) in MC and even more pronounced in MS [115].  
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FIGURE 18: DIFFERENT EXTRACELLULAR MATRIX CAUSES MORPHOLOGICAL CHANGES IN PRIMARY MOUSE 
HEPATOCYTES IN VITRO 
A) Light microscopy shows typical morphology of primary hepatocytes in three culture systems: monolayer 
confluent (MC), monolayer subconfluent (MS) and Sandwich (S) cultures, for the indicated periods of time. 
Magnification of 20X. B) Confocal microscopy reveals structural details in cultivated primary hepatocytes. F-actin in 
red, DPPIV in green and nuclei in blue. Magnification of 40X. 
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3.1.2 GENE ARRAY ANALYSIS REVEALS PROFOUND ALTERATIONS IN CULTURE 
After performing the gene array analysis in primary mouse hepatocytes, the obtained 
dataset was submitted to further gene bioinformatics analysis. One of the tools used to 
interpret the gene array data is a principal component analysis (PCA). The PCA reduces the 
dimensionality of the multivariate data set, making it possible to easily compare similarities and 
differences between samples and to determine whether samples can be grouped [189]. 
 
FIGURE 19: GENE ARRAY ANALYSIS REVEALS PROFOUND ALTERATIONS IN CULTURE 
Alterations of gene expression, illustrated as principal component analysis, of cultivated hepatocytes (MC, MS and 
S), freshly isolated hepatocytes (FH) and liver tissue (Liver).  
 
The PCA of the gene array data (Figure 19) represents directional changes in gene 
expression of primary mouse hepatocytes compared to a reference state of fresh liver tissue 
and freshly isolated hepatocytes (FH). This analysis reveals that the two-monolayer systems 
progressively deviate from fresh liver tissue and freshly isolated hepatocytes. Compared to all 
cultivation systems, only small differences were seen between liver tissue and FH. A different 
track of MC and MS culture illustrate that the state of confluency influences the extent of 
changes in gene expression.  
In conclusion, the global gene expression profiling revealed profound alterations in all 
primary hepatocyte cultivation systems that result in a strong deviation from the in vivo-like 
state. 
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3.1.3 PRIMARY HEPATOCYTES IN VITRO SHOW RAPID EXPRESSIONAL CHANGES THAT 
OVERLAP BETWEEN ALL SYSTEMS 
To determine the extent of expressional changes occurring in culture over time, the 
number of differentially expressed genes using two-fold change as a cut-off value was analyzed. 
The total number of differentially expressed genes (DEGs) (Figure 20) was lowest in sandwich 
cultures (n = 3296, ≥ 2-fold) compared to MC and MS (n = 4002 for MC and n = 4287 for MS; ≥2-
fold).  
 
FIGURE 20: AMONG CULTIVATION SYSTEMS, MONOLAYER SUBCONFLUENT (MS) EXHIBITS THE HIGHEST 
EXPRESSIONAL CHANGES 
Total number of differentially expressed genes (DEGs) in three culture systems: monolayer confluent (MC), 
monolayer subconfluent (MS) and sandwich (S) cultures.  
The PCA analysis suggested that a massive alteration in gene expression occurs already 
at day 1 in culture. To determine the extent of the additional deregulated genes in culture, a 
more detailed analysis of DEGs on a day-by-day basis was employed. Figure 21 represents the 
number of DEGs in all culture systems, which are added to those deregulated at each preceding 
timepoint. It shows that in all culture systems the majority of alteration in the gene expression 
occurs during the first 24h. In line with the total number of DEGs, MS represent a culture system 
with the highest dynamic of changes. In fact, 2257 genes were deregulated by day 1 in MC with 
only 455 and 184 further added genes by day 2 and day 3, respectively. Sandwich cultures also 
show a dynamic expression pattern with 1551 genes of at least two-fold up or down by day 1. It 
should be mentioned that a high fraction of these genes is over ten-fold deregulated. These 
results suggest that the most important transcriptional alterations are determined early on in 
culture, i.e. during the first 24h after isolation.  
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FIGURE 21: MOST OF THE GENE EXPRESSION CHANGES OCCUR WITHIN THE FIRST 24 HOURS OF CULTURE 
Day-by-day analysis of differentially deregulated genes (DEGs) in three culture systems: monolayer confluent (MC), 
monolayer subconfluent (MS) and sandwich (S) culture for the indicated timepoints. The graph represents the 
number of up- or down-regulated genes which are added to those deregulated at each preceding timepoint.  
 
The similar pattern of coordinates in the PCA space for all culture systems suggested 
that common expression profiles might be induced in all systems. Indeed, Venn diagrams reveal 
a high degree of overlap between genes up- or down-regulated (≥ 2-fold) in culture systems on 
Day 1 (Figure 22). Considering the differentiated morphology of sandwich cultures in contrast 
to the EMT-like morphology of monolayers, one may have expected a larger difference.  
In conclusion, cultivation induces strong expressional changes that occur mostly within 
the first 24 hours. Nevertheless, the analysis of the differentially expressed genes proves that 
sandwich cultures offer clear advantages over monolayers maintaining a more stable profile of 
expressional changes.  
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FIGURE 22: CULTIVATION CAUSES CHANGES OF AN OVERLAPING SET OF GENES AT DAY 1 IN ALL CULTURE 
SYSTEMS 
Venn diagram of differentially expressed genes (DEGs, ≥ 2-fold) on day 1 in three culture systems: monolayer 
confluent (MC), monolayer subconfluent (MS) and sandwich (S) cultures. The number of genes in each overlapping 
segment indicates genes commonly deregulated.  
 
3.1.4 ALL CULTURE SYSTEMS EXPRESS SIMILAR PATTERNS OF TOP UP- AND DOWN-
REGULATED GENES     
In the next step, the strongest (i.e. top) up- and down-regulated genes were analyzed. 
An overview of selected most up- and down-regulated genes in sandwich culture is shown in 
Table 21 together with references indicating their functions. The strongest up-regulated gene in 
sandwich culture is lipocalin-2 (Lcn2) with a 247-fold expression already at day 1. The strongest 
down-regulated gene in sandwich culture at day 1 with a more than 26-fold down-regulation is 
Cyp8b1, a member of the cytochrome P450 family.  
TABLE 21: OVERVIEW OF SELECTED MOST UP- AND DOWN-REGULATED GENES IN SANDWICH CULTURE ON DAY 1 
 
Among most up-regulated genes: Sandwich (Day 1) 
N° Symbol Description Fold p-value 
1 Lcn2 Lipocalin 2 [130, 190, 191] 247.1 7.33E-34 
2 Mt4 Metallothionein 4 [192] 117.75 1.90E-21 
3 Mt2 Metallothionein 2 [192, 193] 87.84 1.15E-33 
4 Ier3 Immediate early response 3 [194] 34.67 2.10E-20 
5 Saa3 Serum amyloid A 3 [195, 196] 32.16 1.46E-13 
6 Mt1 Metallothionein 1 [192] 29.14 1.45E-26 
7 Cebpd CCAAT/enhancer binding protein (C/EBP), delta [137] 25.06 1.72E-17 
8 Cpe Carboxypeptidase E [197] 20.23 5.82E-14 
9 Tnfrsf12a Tumor necrosis factor receptor superfamily, member 12a [198] 18.05 1.34E-28 
10 Klf6 Kruppel-like factor 6 [199, 200] 14.74 2.98E-19 
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TABLE 21: CONTINUED 
 
11 Anxa2 Annexin A2 [201] 12.6 6.97E-24 
12 Sprr1a Small proline-rich protein 1A [202, 203] 8.59 7.09E-15 
13 Psat1 Phosphoserine aminotransferase 1 4.42 5.53E-10 
14 Ctgf Connective tissue growth factor [204] 4 7.52E-10 
15 S100a6 S100 calcium binding protein A6 (calcyclin) 2.2 5.55E-05 
 
 
Among most down-regulated genes: Sandwich (Day 1) 
N° Symbol Description Fold p-value 
1 Cyp8b1 Cytochrome P450, family 8, subfamily b, polypeptide 1 -26.78 2.18E-24 
2 Sucnr1 Succinate receptor 1 -20.49 4.01E-23 
3 Car3 Carbonic anhydrase 3 -14.88 7.54E-19 
4 Slc17a3 Solute carrier family 17 (sodium phosphate), member 3 -8.79 9.16E-18 
5 
Abcb11 
(Bsep) 
ATP-binding cassette, sub-family B (MDR/TAP), member 11 [37] -7.77 6.60E-14 
6 Abat 4-aminobutyrate aminotransferase -7.75 2.63E-13 
7 Colec10 Collectin sub-family member 10 -7.75 1.73E-19 
8 Hacl1 2-hydroxyacyl-CoA lyase 1 -7.13 1.53E-23 
9 Apol7a Apolipoprotein L 7a -7.02 9.59E-11 
10 Camk1d Calcium/calmodulin-dependent protein kinase ID -6.74 1.03E-18 
11 Acsm5 Acyl-CoA synthetase medium-chain family member 5 -6.18 2.29E-13 
12 Abca8a ATP-binding cassette, sub-family A (ABC1), member 8a -5.82 1.33E-10 
13 Cyp7a1 Cytochrome P450, family 7, subfamily a, polypeptide 1 [36] -5.42 1.33E-13 
14 
Abcc2 
(Mrp2) 
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 [37] -3.69 1.38E-12 
15 Slco1a1 Solute carrier organic anion transporter family, member 1a1 -2.34 1.03E-08 
 
 
The results of the microarray analyses were confirmed by qRT-PCR (Figure 23) for a 
selected panel of genes (Table 21, red colored for chosen up-regulated and green colored for 
chosen down-regulated). All cultivation systems - sandwich (S), confluent (MC) and 
subconfluent (MS) - expressed similar pattern of up-regulation for Lcn2, Mt2 and Saa3 and 
down-regulation of Bsep, Mrp2 and Cyp7a1.  
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FIGURE 23: TOP UP- AND DOWN-REGULATED GENES ARE SIMILARLY DEREGULATED IN ALL CULTIVATION SYSTEMS 
Quantitative RT-PCR analysis of inflammation- (Lcn2, Mt2 and Saa3) or metabolism-associated genes (Bsep, Mrp2 
and Cyp7a1) in healthy liver tissue (Liver), freshly isolated hepatocytes (FH), hepatocytes in sandwich (S) culture, 
confluent (MC) culture and subconfluent (MS) culture for the indicated time. GAPDH was used as an endogenous 
control. Data are expressed as fold change relative to healthy liver tissue. Values represent mean ± SD (n=3).  
 
 
Furthermore, the strong expression of lipocalin-2 was also detected at the protein level 
(Figure 24).  
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FIGURE 24: LCN2 PROTEIN IS UP-REGULATED IN SANDWICH CULTURE 
Immunoblot analysis using antibody against Lcn2 in healthy liver tissue (Liver), freshly isolated hepatocytes and 
hepatocytes in sandwich (S) culture for the indicated time. GAPDH was used as an endogenous control. Protein 
extract from healthy liver tissue and freshly isolated hepatocytes were used as negative controls, while freshly 
isolated hepatocytes from mice treated for 24h with LPS (750 ng/kg, intraperitoneally) were used as positive 
controls. Representative images for 3 independent experiments are shown. Lcn2 expression is clearly observed in 
sandwich-cultured hepatocytes on day 1. 
 
 
3.1.5 EXPRESSION OF TOP UP- OR DOWN-REGULATED GENES OCCURS EARLY IN 
CULTURE 
As shown previously in Figure 21, the microarray data analysis reveals rapid gene 
expression changes within the first 24 hours in culture. Therefore, the aim of the next 
experiment was to determine the kinetics of the expression changes of the most up- and down-
regulated genes in primary mouse hepatocytes cultivated in a collagen sandwich during the first 
hours after plating.  
The induction of the most up-regulated genes and decrease in expression of the most 
down-regulated genes occur already in freshly isolated hepatocytes or at latest 3h after plating 
(Figure 25). These results confirm the interpretation of the gene array analysis, which suggested 
that the strongest transcriptional alterations already occur during the first hours of cultivation.   
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FIGURE 25: INDUCTION OF UP- AND DOWN-REGULATED GENES OCCURS ALREADY IN FRESHLY ISOLATED 
HEPATOCYTES OR AT THE LATEST AT 3 HOURS AFTER PLATING 
Quantitative RT-PCR analysis of inflammation-associated genes (Lcn2, Mt2 and Saa3) and metabolism-associated 
genes (Bsep, Mrp2 and Cyp7a1) in healthy liver tissue (Liver), freshly isolated hepatocytes (FH) and hepatocytes in 
sandwich (S) for the indicated time. GAPDH was used as an endogenous control. Data are expressed as fold change 
relative to healthy liver tissue. Values represent mean ± SD (n=3). 
 
  FUZZY C-MEANS CLUSTERING ANALYSIS IDENTIFIES FIVE MAIN GENE 3.2
EXPRESSION CLUSTERS  
A clustering analysis allows pattern recognition in a large set of data. Therefore, the 
differentially expressed genes were analyzed based on the time-dependent Fuzzy C-Means 
clustering [184]. This technique identified five main clusters of which 2A and 2B as well as 3A 
and 3B were closely related (Figure 26).  
RESULTS 
65 
 
 
FIGURE 26: FUZZY C-MEANS CLUSTERING ANALYSIS IDENTIFIES FIVE MAIN GENE EXPRESSION CLUSTERS 
The differentially expressed genes were subjected to a Fuzzy C-Means clustering analysis. Five main clusters were 
identified of which 2A and 2B as well as 3A and 3B were closely related. 
The separation of DEGs in distinct clusters allowed for a more precise bioinformatics 
analysis of the biological motifs. Kyoto Encyclopedia of Genes and Genomes (KEGG at 
http://www.genome.ad.jp/kegg/) represents a reference knowledge database that integrates 
current knowledge on molecular interaction and can help to identify biological motifs in gene 
array data [205]. For this purpose, each gene cluster was assessed for over representation of 
KEGG motifs (Figure 27). This analysis resulted in the identification of clearly enriched motifs for 
‘proliferation’ in Cluster 1; whereas, a strong overrepresentation of ‘metabolism’ was detected 
in Clusters 2A and B (Figure 27). This observation is consistent with the well-established loss of 
function induced during cultivation of primary hepatocytes [69]. Clusters 3A and 3B did not 
contain a specific GO or KEGG motif. However, a knowledge-based curation of these clusters 
strongly suggested that they represent a ‘inflammation’ motif (Figure 27 continued). The 
validation of the aforementioned motifs is demonstrated in the following sections.  
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FIGURE 27: ANALYSIS OF KEGG PATHWAY OVERREPRESENTATION IN TIME-DEPENDENT GENE CLUSTERS  
The figure shows a snapshot of the results obtained for overrepresentation of KEGG pathway. The strongest 
overrepresentations of KEGG pathways were observed in the clusters containing down-regulated genes (cluster 2A 
and B), which showed a high enrichment of metabolic pathways. In cluster 1, a high enrichment of KEGG pathways 
associated with proliferation was observed. Gray colored boxes indicate p-values˂10
-5
. 
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FIGURE 27: CONTINUED 
ANALYSIS OF KEGG PATHWAY OVERREPRESENTATION IN TIME-DEPENDENT GENE CLUSTERS 
The figure shows a snapshot of the results obtained for overrepresentation of KEGG pathway. Clusters 3A and 3B 
did not contain a specific GO or KEGG motif. However, a knowledge-based curation of these clusters strongly 
suggested that they represent a ´inflammation` motif asthese clusters contain all of the top up-regulated genes in 
cultivation shown in Table 21. Gray colored boxes indicate p-values˂10
-5
.  
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FIGURE 28: PROLIFERATION, METABOLISM AND INFLAMMATION AMONG BIOLOGICAL MOTIFS ASSIGNED TO 
IDENTIFIED CLUSTERS 
The graphs represent the mean scaled value of all genes contained in each cluster, at each timepoint, for each 
cultivation system. The assignment of gene clusters to ‘proliferation’ and ‘metabolism’ motifs was based on 
enrichment analysis of GO and KEGG terms, while the ‘inflammation’ motif was determined experimentally by 
comparison to well-known liver inflammation models in vivo.   
 
3.2.1 CULTIVATION INDUCES DOWN-REGULATION OF METABOLISM-ASSOCIATED 
GENES  
Identified as closely related, clusters 2A and 2B (Figure 28) exhibit an expression pattern 
of a persistent down-regulation among all three cultivation systems. Only cluster 2A-associated 
genes are maintained in sandwich culture (S). In contrast, cluster 2B represents metabolic 
genes that are not maintained by the collagen sandwich, but rather decrease similarly as in the 
monolayer culture (Figure 28, Cluster 2B). Among those, many of the top down-regulated genes 
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such as Bsep, Mrp2 and Cyp7a1 are assigned to cluster 2B (Table 21). The data analysis using 
KEGG pathways identified an enrichment of metabolism-associated genes in both clusters 2A 
and 2B (Figure 27). KEGG and GO analysis identify cytochrome P450, sterol and cholesterol 
metabolism, as well as coagulation and complement factors among the ‘sandwich culture 
maintained’ genes in cluster 2A. 
Moreover, Transcription Factor Binding Sites analysis (TFBS with PRIMA algorithm [185]) 
of the promoter regions of associated genes identified Hepatocyte Nuclear Factors (HNF-4  
and -1 ) among the overrepresented transcription factors in clusters 2A and B (a snapshot 
shown in Figure 29). Consistently, the expression of HNF4  and HNF1  was markedly down-
regulated during the first hours in culture (Figure 30, A). Likewise, HNF4  nuclear expression 
was clearly reduced in cultivated cells compared to freshly isolated hepatocytes (Fresh Heps) 
(Figure 30, B).  
 
FIGURE 29: ANALYSIS OF TRANSCRIPTION FACTOR BINDING SITE (TFBS) ENRICHMENT IN TIME-
DEPENDENT GENE CLUSTERS  
The figure shows a snapshot of the results obtained for overrepresentation of TFBS. The TFBS with the strongest 
overrepresentation were Sp1, E2F, ETF, all of which were highly enriched in up-regulated gene clusters. 
Conversely, HNF4α was the most overrepresented TFBS in down-regulated gene clusters. Gray colored boxes 
indicated p-value˂10
-5
. 
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FIGURE 30: DECREASE IN EXPRESSION OF TRANSCRIPTION FACTORS (HNF-4α and -1α) REGULATING METABOLISM-
ASSOCIATED GENES IN CULTURE 
A) Quantitative RT-PCR analysis of HNF4α and HNF1α in healthy liver tissue (Liver), freshly isolated hepatocytes 
(FH), hepatocytes in sandwich culture for the indicated time. GAPDH was used as an endogenous control. Data are 
expressed as fold change relative to healthy liver tissue. Values represent mean ± SD (n=3). B) Fluorescence 
microscopy analysis of HNF4α expression (red) in freshly isolated hepatocytes (Fresh Hep) and in hepatocytes in 
monolayer culture (MC) two days after plating. Nuclei are stained blue (DAPI). Scale bars represent 50µm.  
 
Moreover, the expression of nuclear receptors known to regulate many hepatic 
functions was rapidly decreased in culture (Figure 31). Interestingly, nuclear receptors were not 
listed among the down-regulated genes coming out of the gene array data and therefore 
represented a false negative result. This should emphasize the need of manual curation when 
dealing with gene array data and validation of mRNA expression levels via qRT-PCR or on a 
protein level via Western blotting.  
In conclusion, a combination of time-resolved gene clustering and bioinformatics 
analysis (GO and KEGG motifs), together with TFBS enrichment provided important insights into 
the biological processes and revealed that cultivation induces down-regulation of metabolism-
associated. 
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FIGURE 31: DECREASE IN EXPRESSION OF NUCLEAR RECEPTORS REGULATING METABOLISM-ASSOCIATED GENES IN 
CULTURE 
Quantitative RT-PCR analysis of nuclear receptors: pregnane X receptor (PXR), constitutive androstane receptor 
(CAR), retinoid X receptor (RXR), farnesoid X receptor (FXR) in healthy liver tissue (Liver), freshly isolated 
hepatocytes (FH), hepatocytes in sandwich culture for the indicated time. GAPDH was used as an endogenous 
control. Data are expressed as fold change relative to healthy liver tissue. Values represent mean ± SD (n=3).  
 
3.2.2 MONOLAYER CULTURES INDUCE PROLIFERATION INDEPENDENT OF ADDITIONAL 
GROWTH FACTORS 
Cluster 1 (Figure 28) contained genes whose expression was quickly and strongly 
induced in monolayer cultures, particularly in Ms. This is in contrast to S cultures where genes 
are upregulated only at later timepoints. KEGG analysis identified a strong overrepresentation 
of ‘DNA replication pathway’ motif (Figure 27). The intensity of the proliferation cluster 
correlates with the proliferation activity of hepatocytes in the three culture systems as 
evidenced by PCNA expression (Figure 32). The strongest time dependent increase in the 
proliferation cluster was observed in MS compared to MC and S. 
In conclusion, Fuzzy C-Means clustering reveals that cultivation induces a time-
dependent increase in proliferation rate. 
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FIGURE 32: MS CULTURE SHOWS A TIME-DEPENDENT INCREASE IN THE PROLIFERATION MARKER PCNA 
Immunoblot analysis using antibody against proliferating cell nuclear antigen (PCNA) in healthy liver tissue (Liver),  
AML12 cells stimulated with interferon γ, freshly isolated hepatocytes (FH), hepatocytes in sandwich (S) culture, 
confluent (MC) culture and subconfluent (MS) culture for the indicated time. GAPDH was used as an endogenous 
control. Protein extracts from healthy liver tissue and freshly isolated hepatocytes were used as negative controls, 
while AML12 cells stimulated with interferon γ (AML12) were used as positive control. Representative images for 3 
independent experiments are shown. The strongest time dependent increase of PCNA was observed in MS. 
 
3.2.3 CULTIVATION INDUCES AN INFLAMMATORY RESPONSE 
The closely related, clusters 3A and 3B (Figure 28) exhibit a strong increase in expression 
among all three cultivation systems, with cluster 3A showing a permanent and cluster 3B a 
transient up-regulation. Clusters 3A and 3B contain all of the top up-regulated genes in 
cultivation as shown in Table 21. Most of those genes belong to the permanently up-regulated 
cluster 3A (thirteen out of fifteen including Lcn2 and Mt2), with only two (Mt1 and Saa3) 
belonging to the transiently up-regulated cluster 3B. Among the top up-regulated genes in 
cultivation, thirteen out of fifteen have been shown to play a role in inflammation processes 
(Table 21, brackets indicate references for the top up-regulated genes). Therefore, this group of 
genes clearly represents an inflammation cluster. Importantly, a downregulation of Cebp/  and 
a concomitant upregulation of Cebp/  and Cebp/  was observed in cultivated hepatocytes 
(Figure 33). This pattern has been previously shown to occur in vivo during inflammation [138], 
supporting the interpretation of an inflammatory response being triggered in cultivated 
hepatocytes.  
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FIGURE 33: CULTIVATION INDUCES AN INFLAMMATORY RESPONSE  
Quantitative RT-PCR of CCAAT/Enhancer Binding Protein α, -β and -δ (Cebpα, -β and -δ) in healthy liver tissue 
(Liver), freshly isolated hepatocytes (FH), hepatocytes in sandwich culture for the indicated time. GAPDH was used 
as an endogenous control. Data are expressed as fold change relative to healthy liver tissue. Values represent 
mean ± SD (n=3). Sandwich culture induces downregulation of Cebp  and a concomitant upregulation of Cebp  
and Cebp . 
 
The transcription Factor Binding Sites analysis (using PRIMA algorithm) of the promoter 
regions of inflammation gene clusters identified Sp1, Elk1 and ETF among the overrepresented 
transcription factors in the inflammation Cluster 3A but not in 3B. The highest ranked TF for up-
regulated genes in cultivation is Sp1. Although Sp1 is not up-regulated transcriptionally, 
immunostaining shows that its expression increases in hepatocyte nuclei in culture (Figure 34, 
A). Klf6, belonging to the same family of transcription factors, turned out to be one of the 
strongest transcriptionally up-regulated transcription factors (Figure 34, B and C) with an 
enhanced nuclear localization in vitro (Figure 34, D). Klf6 has been reported to cooperate with 
Sp1 in the regulation of gene induction [206]. Hence, it is likely that the Sp1 overrepresentation 
reflects a synergistic effect due to Klf6 upregulation. 
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FIGURE 34: TFBS ANALYSIS IDENTIFIES SP1 AMONG OVERREPRESENTED TRANSCRIPTION FACTORS IN VITRO 
A) Quantitative RT-PCR analysis of Sp1 in healthy liver tissue (Liver), freshly isolated hepatocytes (FH), hepatocytes 
in sandwich culture at day 1 and 3 of culture. GAPDH was used as an endogenous control. Data are expressed as 
fold change relative to healthy liver tissue. Values represent mean ± SD (n=3). B) Fluorescence microscopy analysis 
of Sp1 expression (red) in freshly isolated hepatocytes (Fresh Hep) and in hepatocytes in monolayer culture (MC) 
for the indicated timepoints. Nuclei are stained blue (DAPI). Scale bars represent 50µm.  
 
 
 
FIGURE 35: EXPRESSION OF Klf6 TRANSCRIPTION FACTOR IS INDUCED IN CULTURE 
A) Gene array data on Klf6 expression in all three cultivation systems: sandwich (S) culture, confluent (MC) culture 
and subconfluent (MS) culture for the indicated time in comparison to freshly isolated hepatocytes. B) Quantitative 
RT-PCR analysis of Klf6 in healthy liver tissue (Liver), freshly isolated hepatocytes (FH), hepatocytes in sandwich 
culture at day 1 and 3 of culture. GAPDH was used as an endogenous control. Data are expressed as fold change 
relative to healthy liver tissue. Values represent mean ± SD (n=3). C) Fluorescence microscopy analysis of Klf6 
expression (red) in freshly isolated hepatocytes (Fresh Hep) and in hepatocytes in monolayer culture (MC) for the 
indicated timepoints. Nuclei are stained blue (DAPI). Scale bars represent 50µm.  
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Additionally, a number of genes belonging to cluster 3A increase their expression during 
cultivation, for example, the expression of Ctgf, Ier3 and Ccl2 progresively increases reaching 
their maximum at later timepoints (Figure 36).  
In conclusion, cultivation induces inflammatory response, with genes showing 
permanent or transient up-regulation in vitro. 
 
FIGURE 36: OTHER INFLAMMATORY MARKERS ARE PROGRESSIVELY INDUCED IN CULTURE REACHING THEIR 
MAXIMUM EXPRESSION AT LATER TIMEPOINTS 
A) Gene array data on Ctgf expression in all three cultivation systems: sandwich (S) culture, confluent (MC) culture 
and subconfluent (MS) culture for the indicated time in comparison to freshly isolated hepatocytes. C) Quantitative 
RT-PCR analysis of Ier3 and Ccl2 in healthy liver tissue (Liver), freshly isolated hepatocytes (FH), hepatocytes in 
sandwich culture at day 1 and 3 of culture. GAPDH was used as an endogenous control. Data are expressed as fold 
change relative to healthy liver tissue. Values represent mean ± SD (n=3). 
 
  HEPATOCYTE CULTIVATION INDUCES AN IN VIVO-LIKE INFLAMMATION 3.3
RESPONSE 
The strongest up-regulated gene in sandwich culture, lipocalin-2 (Lcn2), is a pentraxin which 
is known as a key factor in LPS-induced inflammation [130], suggesting that its upregulation 
reflects a stereotypical inflammatory response of hepatocytes as observed in vivo. To test this 
hypothesis, the transcriptional response in vitro was compared to that of the well-established in 
vivo sterile inflammation models: CCl4, partial hepatectomy (PHx), and LPS-induced 
inflammation (described in chapter 2.2.3).  
Time resolved global gene expression profiling revealed that Lcn2 was among the most up-
regulated genes in all three in vivo models of liver damage (Figure 37). Importantly, Lcn2 
upregulation is mostly a consequence of altered expression in hepatocytes, and not the other 
liver cell types. This observation is confirmed by comparing expression changes obtained from 
freshly isolated hepatocytes purified from CCl4- or LPS-exposed livers (Figure 37, CCl4 FH D1 vs. 
Control FH D1 and LPS FH D1 vs. Control FH D1) to untreated livers.  
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FIGURE 37: LCN2 IS UP-REGULATED IN ALL IN VIVO MODELS OF LIVER DAMAGE  
Time resolved global gene expression profiling was performed for different types of liver damage. Lcn2 expression 
was analysed after partial hepatectomy (PHx) or after single injection with CCl4 or LPS on day 1.  Liver or freshly 
isolated hepatocytes (FH) collected from treated animals were compared with representative controls. Gene array 
analysis reveals Lcn2 up-regulation in all in vivo models. 
 
Comparison of differentially expressed genes (DEG) between all three in vitro and three 
in vivo models revealed a large overlap in their expression profiles (Figure 38). Cultivation 
systems (Cult) exhibit a higher magnitude of expressional response than in vivo models of liver 
damage (Figure 38, A). The CCl4 model shows the highest overlap with cultivation systems when 
comparing the total number of deregulated genes (Figure 38, B). In addition, genes altered in 
vivo after one day treatment with CCl4, LPS or PHx show a relatively large (<60%) overlap with 
the in vitro deregulated genes on day 1  (Figure 38, B). 
 
FIGURE 38: IN VITRO AND IN VIVO MODELS EXHIBIT STRONG OVERLAP OF DIFFERENTIALLY EXPRESSED GENES 
(DEG)  
A) Venn diagrams indicating the overlap between DEGs on all cultivation (Cult) systems (MC, MS and S), and day 1 
after partial hepatectomy (PHx), CCl4 or LPS administration. B) Percentage of DEGs on day 1 from each in vivo 
model (LPS, PHx and CCl4) which overlap with DEGs in cultivation on day 1. 
 
Addition of CCl4-induced liver damage to the principal component analysis (PCA) of the 
cultivation gene array data (Figure 19) clearly shows that CCl4-induced liver damage represents 
a model of liver regeneration (Figure 39). As seen in Figure 39, gene expression alternations in 
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the CCl4 model led to liver tissue repair as indicated by the dotted black arrow representing a 
return to the gene expression of the reference state of fresh liver tissue and freshly isolated 
hepatocytes (FH). Primary hepatocytes were also compared to non-parenchymal liver cells (day 
2 in culture), which cluster far away from the other clusters (Figure 39, orange dots).  
 
FIGURE 39: GENE ARRAY ANALYSIS REVEALS STRONG SIMILARITIES BETWEEN CULTIVATION AND IN VIVO LIVER 
DAMAGE MODELS  
Alterations of gene expression, illustrated as principal component analysis, of cultivated hepatocytes (MC, MS and 
S), non-parenchymal cells (NPC), and liver tissue after damage induced by a single injection of CCl4. Black and gray 
circles correspond to freshly isolated hepatocytes after 1 and 3 days, respectively, of CCl4 administration in vivo. 
NPC correspond to a mix ed population of all non-parenchymal cells, 2 days in culture. 
  
In cultivation, the most significant expression changes occur within the first 24 hours. 
Therefore, in the next step a ranking analysis was performed to compare differentially 
expressed genes between Sandwich culture on day 1 and the CCl4 in vivo model on day 1 (Figure 
40). Besides Lcn2, a ranking analysis demonstrates the same set of top up-regulated genes in 
sandwich culture as in the CCl4 in vivo model. Most of the top ten up-regulated genes are 
known to play a key role in inflammation or cellular stress (Table 21, brackets indicate 
references for the top up-regulated genes). 
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In conclusion, a comparison of the different cultivation methods with all three in vivo 
models of liver damage show great similarities with respect to their inflammatory response 
profiles, with Lcn2 among the most up-regulated genes.  
 
FIGURE 40: SANDWICH CULTURE AND CCl4 TREATMENT IN VIVO INDUCE STRONG UP-REGULATION OF THE SAME 
INFLAMMATORY GENES  
Ranking analysis of the top 15 up-regulated genes in sandwich culture (day 1) versus CCl4 (day 1). All 15 genes rank 
top among the 50 strongest up-regulated regulated genes. Lcn2 ranks as the top up-regulated gene in both 
conditions. All top ten of up-regulated genes are known to play a key role in inflammation or cellular stress (Table 
21, brackets indicate references for the top up-regulated genes).  
 
3.3.1 IN VITRO/IN VIVO SIMILARITIES 
To analyze the in vitro/in vivo similarities in a more detailed and unbiased manner, a 
Spearman correlation analysis was performed. Genes altered in vitro during the first 24h were 
correlated with genes altered in vivo in response to CCl4 considering intervals from 2h to 16 
days (Figure 41). The similarity between in vitro and in vivo models is presented as Spearman’s 
rank correlation coefficient (Figure 41). The result demonstrates remarkable time dependent 
differences, with maximal correlations between 8 and 48 h (marked in red and highest on day 
1); this is in direct contrast to the no relevant correlations at later timepoints.  
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FIGURE 41: PRIMARY MOUSE HEPATOCYTES IN CULTURE EXHIBIT MAXIMAL SIMILARITIES IN EXPRESSION 
CHANGES WITH LIVER TISSUE 1 DAY AFTER CCL4 ADMINISTRATION 
Spearman’s rank correlation coefficient of deregulated genes (≥ 2-fold) between cultivation in sandwich culture 
(panel A), MC (panel B) or MS (panel C) versus CCl4 treated liver tissue in a time-resolved manner. Maximal 
correlations are observed between all timepoints in culture versus liver tissue 1 day after CCl4 administration. 
 
A similar correlation analysis was applied to both the LPS and PHx models. Genes 
altered in vitro at the indicated timepoints were correlated with genes altered in vivo in 
response to PHx considering intervals from 2 h to 2 weeks or after 24 hours after a single 
injection with LPS. Similar correlation patterns as seen for the CCl4 model were observed for 
both the PHx and LPS data (Figure 42).  
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It should be considered that in vivo altered genes are mainly due to the altered 
expression in hepatocytes, and by the infiltration of leukocytes, since similar expressiona 
changes were obtained from freshly isolated hepatocytes that were purified from CCl4-exposed 
livers (Figure 39, black and gray dots).  
In conclusion, these results demonstrate that cultivation and different types of liver 
damage can trigger similar expression changes in hepatocytes.  
 
FIGURE 42: PRIMARY MOUSE HEPATOCYTES IN CULTURE SHOW A CORRELATION IN EXPRESSION CHANGES WITH 
LPS-TREATED LIVER, AND EVEN STRONGER SIMILARITIES WITH PHX LIVERS, WITH MAXIMAL CORRELATION AT 12-
48 HOURS AFTER PHX 
Spearman rank correlation analysis between differentially expressed genes in cultivated hepatocytes and liver 
tissue after partial hepatectomy (PHx) (A) or intraperitoneal injection of LPS (B). The legend of the heatmap 
indicates the strength of correlation between cultivation (MC, MS or S) versus each timepoint after PHx or 24h after 
LPS injection in vivo. Maximal correlations are observed between all timepoints in culture versus liver tissue 
between 12 and 48h after PHx.   
 
In the next step, a correlation analysis was applied for “proliferation”-associated genes 
that are listed in Cluster 1. Genes altered in vitro were correlated with genes altered in vivo in 
response to PHx or after a single injection with CCl4 in a time-resolved manner (Figure 43). 
Comparable to the general expression changes presented in the previous paragraph, primary 
hepatocytes in vitro show a similar induction in proliferation as shown for a timeframe from 2-4 
days after PHx and CCl4-treatment. 
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FIGURE 43: PRIMARY MOUSE HEPATOCYTES IN CULTURE SHOW A SIMILAR INDUCTION OF PROLIFERATION AS 
LIVER TISSUE IN VIVO 2-4 DAYS AFTER PHX AND CCl4-TREATMENT 
Spearman rank correlation analysis of GO ‘Cell Cycle’ genes assigned to Cluster 1, between cultivated hepatocytes 
and liver tissue after partial hepatectomy (PHx) (panel A) or CCl4 administration (panel B). The legend of the 
heatmap indicates the strength of correlation between cultivation (MC, MS or S) versus each timepoint after PHx or 
CCl4  in vivo.  
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3.3.2 METAGENE ANALYSIS PRECISELY IDENTIFIES THE SIMILARITIES IN 
PROLIFERATION, INFLAMMATION AND METABOLISM CLUSTERS BETWEEN IN VIVO 
AND IN VITRO MODELS 
To further characterize the clusters of 
highly correlated genes between the in vitro 
and in vivo models, so-called ´metagenes` can 
be calculated (for detailed explanation see 
Chapter 2.2.6.6) and their scores compared. A 
metagene considers genes of a cluster 
normalized in a way that each individual gene 
contributes equally. The score of a metagene 
corresponds to the mean scaled value of all 
genes in each metagene. This analysis resulted 
in three metagenes representing the biological 
motifs proliferation, metabolism, and 
inflammation (Figure 44). The genes 
composing the ‘metabolism’ and 
‘inflammation’ metagenes were determined by 
selecting genes from each Fuzzy cluster (Table 
22 and Table 23 in APPENDIX) which were also 
commonly deregulated in all in vivo models on 
day 1. For the ‘proliferation’ metagene, the 
genes selected correspond to those identified 
on the GO ´Cell Cycle` cluster (Table 24 in 
APPENDIX) which are also deregulated in the in 
vivo models involving liver regeneration. This 
approach was used to compare scores of 
´proliferation`, ´inflammation` and 
´metabolism` metagenes in each condition 
(Figure 26) in reference to healthy liver tissue 
(Healthy liver) and freshly isolated hepatocytes 
(Fresh hep) (Figure 44).  
  
FIGURE 44: IN VITRO AND IN VIVO  MODELS ARE 
CHARACTERIZED BY AN INCREASE IN PROLIFERATION AND 
INFLAMMATORY RESPONSE AND A DECREASE IN 
METABOLISM CLUSTERS 
Comparison of metagene scores for ´proliferation`, 
´metabolism` and ´inflammation` between cultivation (MC, 
MS and S) and the in vivo models CCl4, PHx and LPS. 
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The results illustrate an increase in the proliferation metagenes, not only in all in vitro 
conditions, with a particularly strong increase in MS, but also in CCl4 and PHx, the two in vivo 
models that involve liver regeneration. Likewise, an increase in inflammation and a decrease in 
metabolism metagenes were observed for all studied interventions. 
The results also suggest that sandwich culture show certain advantages over other 
culture systems. Sandwich culture exhibits similar inflammatory response as that triggered in 
other cultivation systems, but exhibited a more in vivo-like profile as its “proliferation” score 
was shown to be lowest among all cultivation systems and its “metabolism” cluster shows great 
recovery towards healthy liver tissue and freshly isolated hepatocytes (Fresh hep).  
In conclusion, these results illustrate that seemingly different stress conditions such as 
hepatocyte isolation and culture, as well as CCl4, LPS or PHx liver damage, induce similar cellular 
responses in hepatocytes. 
  MINOR ROLE OF NPC IMPURITIES AND EXTRACELLULAR MATRIX (ECM) 3.4
3.4.1 CHARACTERIZATION OF THE NON-PARENCHYMAL CELLS (NPC) FRACTION 
As shown in the previous chapter, primary mouse hepatocytes demonstrate a strong 
inflammatory response in culture that is similar to that of a stressed-inflamed liver in vivo. A 
possible explanation for this could be the influence of impurities from the Non Parenchymal 
Cells (NPC). Stellate cells, Kupffer cells or sinusoidal endothelial cells might be activated in 
culture to secrete cytokines and cause the inflammatory transcription response in the 
neighboring hepatocytes.  
In order to assess the influence of other liver cell types, the NPC fraction remaining in 
hepatocytes after the isolation procedure was thoroughly characterized using Fluorescence-
Activated Cell Sorting analysis (FACS) (Figure 45, upper of panel A) and manual counting of H&E 
stained cell suspensions (Figure 45, B). Hepatocytes are larger than NPCs (as evidenced by 
measuring the Forwards Scatter – FSC-H), and due to the high content of various organelles 
such as endoplasmic reticulum, they are characterize by their higher granularity [22] as shown 
with the measure of Side Scatter – SSC-H). The H&E-stained hepatocytes are easily 
distinguished as the large cells with the intensely stained red cytoplasm (Figure 45, B indicated 
with arrows); whereas, non-parenchymal cells show pale blue nuclei with a faintly stained 
cytoplasm (Figure 45, B indicated with arrowheads). Both cell populations were counted 
manually after H&E staining with a resulting score of 86.84% for hepatocytes (Figure 46, panel 
B, row “-“ ) and 13.16% for NPCs. In the second method, population distribution was analyzed 
by their size (FSC-H) and granularity (SSC-H) by FACS in a high throughput manner (Figure 45, 
panel A, upper). FACS analysis identifies the hepatocytes-enriched fraction as large and granular 
(87.55% of the whole population); whereas, non-parenchymal cells are defined as the small and 
non-granular population (9.36% of the whole population). 
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In conclusion, both techniques indicate a relatively high fraction of approximately 10-
13% NPC impurities in the hepatocyte-enriched fraction obtained after the isolation procedure.  
 
FIGURE 45: THE HEPATOCYTE-ENRICHED FRACTION CONTAINS APPROXIMATELY 10-13% OF NPC IMPURITIES  
Characterization of the NPC population in the hepatocyte-enriched fraction after isolation. A) FACS analysis of 
hepatocytes and non-parenchymal cells in suspension. Blue indicates the hepatocyte population, identified as large 
and granular, whereas red indicates non-parenchymal cells which are defined as the small and non-granular 
population. The non-parenchymal cell population is almost completely removed by three Percoll purification steps 
(A lower, 3x Percoll). Values represent mean ± SD (n=3). SSC-H stands for granularity scale and FSC-H stands for 
size scale. B) Bright field microscopy of hematoxilin & eosin stained hepatocyte suspensions, without or with three 
Percoll purification steps. Hepatocytes are easily distinguished as large cells with intense red cytoplasm (arrows) 
whereas non-parenchymal cells appear with pale blue nuclei and faint cytoplasm (arrowheads). The non-
parenchymal cell population is almost completely removed by three Percoll purification steps (B lower, 3x Percoll). 
 
To investigate the role of NPC impurities on the hepatocyte gene expression profile, an 
additional purification step with Percoll was established to obtain a hepatocyte-enriched 
fraction. This fraction was then purified by an additional one (1x), two (2x) or three (3x) 
centrifugation steps in addition to the Percoll solution. After each purification procedure, both 
cell populations were analyzed by FACS and H&E staining (Figure 46). The results demonstrated 
that the fraction of NPC could be eliminated by the additional Percoll centrifugation steps 
(Figure 46). Despite the small residual fraction of approximately 1% NPC that could not be 
removed by further purifications, the difference when compared to the unpurified cells (13% 
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NPCs), indicates that this highly purified hepatocyte preparation offers appropriate conditions 
to study a possible influence of the NPC fraction. 
 
 
FIGURE 46: ADDITIONAL CENTRIFUGATION STEPS OF THE HEPATOCYTE-ENRICHED FRACTION ON TOP OF PERCOLL 
SOLUTION ALMOST COMPLETELY REMOVES THE NPC IMPURITIES  
Quantification of hepatocytes and non-parenchymal cells by (A) FACS or (B) microscopy in conventional or Percoll-
purified freshly isolated cell suspensions. Both techniques indicated almost complete removal of NPC impurities.  
 
3.4.1 INFLUENCE OF NON PARENCHYMAL CELLS (NPC)  
To assess the influence of NPC impurities on hepatocytes gene expression profile, 
hepatocyte-enriched fraction of distinct purities were analyzed for the expression of the 
following selected markers: Lcn2 and Mt2 representing inflammation cluster 3A; Saa3 
representing inflammation cluster 3B; and Bsep, Mrp2 and Cyp7a1 representing metabolism-
associated cluster 2B (Figure 47).  
NPCs had no influence on most of the analyzed metabolism cluster genes. Similarly, the 
inflammation cluster 3A genes Lcn2 and Mt2 showed no major NPC dependency. For Lcn2, a 
slightly decreased expression was observed after Percoll purification but the difference was not 
significant when considering the huge difference between percentage scores of freshly isolated 
hepatocytes and either purified or unpurified cell populations. A different result was obtained 
for the inflammation cluster 3B gene Saa3. In this case, Percoll purification caused a relevant 
decrease in expression.  
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FIGURE 47: ADDITIONAL PURIFICATION STEPS DO NOT RESCUE THE METABOLISM CLUSTER AND DO NOT 
DIMINISH THE INFLAMMATORY RESPONSE IN VITRO  
Quantitative RT-PCR analysis of inflammation- (Lcn2, Mt2 and Saa3) or metabolism-associated genes (Bsep, Mrp2 
and Cyp7a1) in healthy liver tissue (Liver), freshly isolated hepatocytes (FH) and hepatocytes in sandwich culture at 
day 1, either from conventional or Percoll-purified cell suspensions. GAPDH was used as an endogenous control. 
Data are expressed as fold change relative to healthy liver tissue. Values represent mean ± SD (n=3). 
 
 
In order to fully understand the contribution of NPC on hepatocytes’ gene expression 
profile in culture, a population of NPC was added to Percoll purified hepatocytes in a ratio of 
1:2 and plated on sandwich or monolayer confluent culture for the indicated timepoints 
(described in chapter 2.2.2.6). The aforementioned principles were confirmed, whereby NPC 
slightly enhanced Saa3 expression but had no major influence on Lcn2, Mt2, Bsep, Mrp2 or 
Cyp7a1 (Figure 48).  
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FIGURE 48: THE EFFECT OF CO-CULTURE ON INFLAMMATORY AND METABOLISM CLUSTERS  
Quantitative RT-PCR analysis of inflammation- (Lcn2, Mt2 and Saa3) or metabolism-associated genes (Bsep, Mrp2 
and Cyp7a1) in healthy liver tissue (Liver), freshly isolated hepatocytes (FH) and hepatocytes in sandwich (S), 
monolayer confluent (MC) culture, alone or in combination with non-parenchymal cells at a ratio of 2:1 for the 
indicated time. GAPDH was used as an endogenous control. Data are expressed as fold change relative to healthy 
liver tissue. Values represent mean ± SD (n=3). 
In conclusion, non parenchymal cells do not influence hepatocytes’ expression profile in 
culture with respect to the identified gene clusters. However, NPC seem to support the 
upregulation of Saa3. This suggests that genes in Cluster 3B may be dependent upon NPC.  
3.4.2 INFLUENCE OF THE EXTRACELLULAR MATRIX 
3.4.2.1 NO MAJOR INFLUENCE OF DIFFERENT TYPES OF ECM ON 
CULTIVATION-INDUCED GENE EXPRESSION PROFILES 
Another possible cause for the change in the hepatocyte cellular response may be due 
to the cell attachment onto a collagen matrix. Therefore, the aim of the next experiment was to 
validate the influence of the extracellular matrix. Hepatocytes were cultivated on different 
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extracellular matrixes for the indicated timepoints and the gene expression profiles of selected 
markers (Lcn2 and Mt2 representing inflammation cluster 3A; Saa3 representing inflammation 
cluster 3B; Bsep, Mrp2 and Cyp7a1 representing metabolism-associated cluster 2B were 
analyzed (Figure 49).   
A comparison of collagen sandwich and monolayer confluent culture to other types of 
commercially available matrices, such as MatrigelTM and laminin demonstrated similar 
alterations of metabolism and inflammation gene clusters as observed for the collagen 
matrixes. The results show that the systemic alteration in gene expression occurs 
independently of the specific type of extracellular matrix.  
 
 
FIGURE 49: SYSTEMIC ALTERATIONS IN GENE EXPRESSION OCCURS INDEPENDENT FROM THE SPECIFIC TYPE OF 
EXTRACELLULAR MATRIX 
Quantitative RT-PCR analysis of inflammation- (Lcn2, Mt2 and Saa3) or metabolism-associated genes (Bsep, Mrp2 
and Cyp7a1) in healthy liver tissue (Liver), freshly isolated hepatocytes (FH) and hepatocytes in sandwich (S), 
monolayer confluent (MC) culture, or cultured in matrigel or laminin for the indicated time. GAPDH was used as an 
endogenous control. Data are expressed as fold change relative to healthy liver tissue. Values represent mean ± SD 
(n=3). 
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3.4.2.1 SPHEROIDS 
In sandwich cultures, hepatocytes are kept between two layers of collagen type-I, which 
is isolated from rat-tail and does not represent the natural matrix of hepatocytes in the liver. A 
method for aggregating spheroids, on the other hand, offers conditions where cells can 
produce their own matrix [72]. The aim of the next experiment was to validate the effect of the 
natural extracellular matrix. Primary mouse hepatocytes were used to generate spheroids for 
the the indicated timepoints (described in chapter 2.2.2.5) and the gene expression profile for 
the previously described, selected markers was analyzed (Figure 51).  
In both cultivation systems (sandwich and spheroids), hepatocytes established a polar 
phenotype as shown with DPPIV staining of the bile canaliculi (Figure 18 and Figure 50).  
 
FIGURE 50: PRIMARY MOUSE HEPATOCYTES ESTABLISH A POLAR PHENOTYPE IN SPHEROIDS CULTURE 
Morphology of primary mouse hepatocytes in spheroids. Confocal microscopy of primary mouse hepatocytes in 
spheroids reveals structural details: nuclei marked with DAPI (blue), F-actin marked with phalloidin (gray), bile 
canalicular enzyme dipeptidyl peptidase IV (DPPIV in green) and Intercellular Adhesion Molecule 1 (ICAM1 in red). 
Magnification of 40X. Hepatocyte polarity is clearly observed in all timepoints, as revealed by bile canalicular-like 
structures similar to those formed in sandwich culture (Figure 18).  
Analysis of gene clusters markers show that the same principles are valid in both culture 
systems, whereby genes of the metabolism and inflammation clusters are down and up-
regulated, respectively (Figure 51). However, the degree of downregulation of some 
metabolism cluster genes (e.g. Mrp1 and Cyp7a1) is ameliorated in the spheroids compared to 
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sandwich, which may represent an advantage of the latter system. Consistently, expression of 
HNF4α, whose binding site is overrepresented in the metabolism cluster genes, was better 
maintained in spheroids than in sandwich culture. However Cebpδ, a transcription factor 
responsible for expression of inflammation genes (Poli 1998), is higher in spheroids, illustrating 
that this culture type does not ameliorate the inflammation response. 
 
FIGURE 51: COMPARISON OF THE SPHEROIDS SYSTEM AND SANDWICH CULTURE 
Quantitative RT-PCR analysis of inflammation- (Lcn2, Mt2, Saa3 and Cebp ) or metabolism-associated genes (Bsep, 
Mrp2, Cyp7a1 and HNF4 ) in healthy liver tissue (Liver), freshly isolated hepatocytes (FH) and hepatocytes in 
sandwich (S), monolayer confluent (MC) culture, or spheroids (Sph) for the indicated time. GAPDH was used as an 
endogenous control. Data are expressed as fold change relative to healthy liver tissue. Values represent mean ± SD 
(n=3). 
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In conclusion, the presented results show that the systemic alterations in gene expression 
are independent from the specific type of extracellular matrix. Additionally, the spheroid 
culture may represent a certain advantages over monolayer or sandwich cultures in regards to 
some gene clusters.  
 
  JNK SIGNALING DRIVES INFLAMMATION  3.5
3.5.1 STRESS SIGNALING PATHWAYS ARE QUICKLY ACTIVATED DURING ISOLATION OF 
HEPATOCYTES 
After describing the stereotypic gene expression response of isolated hepatocytes in 
detail, the next step was to investigate how signaling proteins were altered during the isolation 
procedure and cultivation. For this reason, a time resolved Luminex Bead-Based Multiplex 
Assay was performed. Primary mouse hepatocytes were cultivated on monolayer confluent and 
sandwich (S) culture for the indicated timepoints and protein lysates were analyzed with the 
use of specific antibodies (described in chapter 2.2.8). 
Luminex analysis reveals a strong alteration of p-ERK, p-JNK, p-MEK1 and p-p38 signaling 
in freshly isolated hepatocytes (Figure 52).  In culture, most activities decreased once more, but 
usually not back to the levels found in healthy liver tissue.  
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FIGURE 52: STRESS SIGNALING PATHWAYS ARE QUICKLY ACTIVATED DURING ISOLATION OF HEPATOCYTES 
Luminex analysis of signal transduction pathway-associated proteins, comparing healthy liver tissue, freshly 
isolated hepatocytes, and hepatocytes in monolayer confluent (MC) or sandwich (S) culture for the indicated time. 
The heatmap represents fold change compared to healthy liver tissue, from three independent biological 
replicates. 
 
Additionally, a strong increase in ERK and JNK activation in freshly isolated hepatocytes 
was validated by Western blot (Figure 53). 
In conclusion, stress-signaling pathways are activated quickly during isolation of 
hepatocytes suggesting that interventions to block or prevent the activation of these stress 
pathways should be applied at early stages directly upon isolation or cultivation.  
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FIGURE 53: ERK1/2 AND JNK SIGNALING ARE ACTIVATED DURING PERFUSION 
Validation of Luminex screening. Immunoblot analysis of ERK1/2 and JNK signaling activation in healthy liver tissue 
(Liver), freshly isolated hepatocytes (FH), hepatocytes in sandwich (S) culture for the indicated time. GAPDH was 
used as an endogenous control. Protein extract from healthy liver tissue and freshly isolated hepatocytes were 
used as negative controls, while freshly isolated hepatocytes from mice treated for 24h with LPS (750 ng/kg, 
intraperitoneally) were used as positive control. Representative images from 3 independent experiments are 
shown.  
 
3.5.2 A SCREENING USING CHEMICAL INHIBITORS REVEALS THE CONTRIBUTION OF 
SPECIFIC SIGNAL TRANSDUCTION PATHWAYS IN CULTIVATION-INDUCED GENE 
EXPRESSION 
The rapid activation of stress signaling pathways during isolation is a potential 
explanation for the transcriptional response described above for the primary hepatocytes in 
culture. Therefore, the aim of next experiments was to ameliorate gene expressional changes 
using small chemical inhibitors of the specific signaling pathways. For this purpose, primary 
mouse hepatocytes were cultivated in the presence of a battery of inhibitors (Table 7) for 24 
hours in sandwich culture and the gene expression profile of the previously described, selected 
markers was analyzed (Figure 54 and Figure 55). These compounds were added to the 
hepatocytes in suspension directly prior to plating (in culture medium) and re-added with fresh 
serum-free medium after 3 hours of attachment, to ensure that the pathways remain inhibited 
during the critical 24 hour period where most transcriptional alterations occur. DMSO was used 
as the solvent control at concentration of 0.5%.  
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Of all the inhibitors tested, the most profound effect was observed for the JNK inhibitor 
SP600125, particularly for genes representing the inflammation response, such as Lcn2 
(representative of Cluster 3A), and Saa3 (representative of Cluster 3B) (Figure 54). After 24 
hours, a consistent concentration-dependent decrease of inflammation genes was observed, 
indicating that the JNK pathway is critical for the inflammation response. Other inhibitors also 
repressed the induction of Saa3, showing that the transiently-induced inflammation gene 
cluster (Cluster 3B) may be controlled by pathways other than JNK. 
 
FIGURE 54: THE JNK PATHWAY IS CRITICAL FOR THE INFLAMMATION RESPONSE 
Quantitative RT-PCR analysis of inflammation-associated genes (Lcn2 and Saa3) in healthy liver tissue (Liver), 
freshly isolated hepatocytes (FH) and hepatocytes in sandwich culture (S) on day 1 in the presence of inhibitors at 
different concentrations (low, middle and high) for the indicated pathways. DMSO was used as the solvent control 
at a concentration of 0.5%. GAPDH was used as an endogenous control. The inhibitors and concentrations used are 
described in Table 7. Data are expressed as fold change relative to healthy liver tissue. Values represent mean ± SD 
(n=3). 
In contrast, none of the tested inhibitors was able to rescue the profound repression of 
metabolism-associated genes (Figure 55), indicating that yet undiscovered pathways control 
this response.  
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FIGURE 55: SO FAR UNDISCOVERED PATHWAYS CONTROL THE METABOLISM GENE CLUSTER 
Quantitative RT-PCR analysis of metabolism-associated genes (Bsep, Mrp2 and Cyp7a1) in healthy liver tissue 
(Liver), freshly isolated hepatocytes (FH) and hepatocytes in sandwich culture (S) on day 1 in the presence of 
inhibitors at different concentrations (low, middle and high) for the indicated pathways. DMSO was used as the 
solvent control at a concentration of 0.5%. GAPDH was used as an endogenous control. The inhibitors and 
concentrations used are described in Table 7. Data are expressed as fold change relative to healthy liver tissue. 
Values represent mean ± SD (n=3). 
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3.5.3 ACTIVATION OF JNK SIGNALING OCCURS ALREADY DURING PERFUSION WITH 
EGTA BUFFER 
The results presented in the previous chapter highlighted the potential importance of 
the JNK signaling pathway, in particular its early activation, on the changes observed in the 
inflammation and metabolism clusters in freshly isolated hepatocytes. Therefore, the aim of the 
next experiments was to determine the step during the isolation process that was responsible 
for the observed JNK activation. For this purpose, mouse livers at different stages of the 
perfusion process were analyzed, namely (i) after 5 minutes of EGTA buffer, (ii) 5 minutes, plus 
15 minutes collagenase buffer perfusion, and (iii) 20 minutes of EGTA buffer perfusion (Figure 
56).  
The result shows that EGTA buffer perfusion alone is sufficient to induce JNK activation 
(and ERK1/2, which was used as a positive control). Activation occurs between 5 and 20 
minutes of EGTA perfusion. Combined EGTA plus collagenase perfusion causes a similar 
activation.  
In conclusion, activation of JNK signaling occurs between 5 and 20 minutes of perfusion 
with EGTA buffer, suggesting that interventions with inhibitors should already start early, 
ideally during perfusion. 
 
FIGURE 56: EGTA BUFFER PERFUSION ALONE IS SUFFICIENT TO INDUCE JNK ACTIVATION  
Immunoblot analysis of JNK signaling and ERK1/2 signaling (positive control) activation in healthy liver tissue 
(Liver), livers after 5 minutes of EGTA buffer perfusion (5 min EGTA), 5 minutes EGTA buffer plus 15 minutes 
collagenase buffer perfusion (EGTA + Coll.), or 20 minutes of EGTA  buffer perfusion, freshly isolated hepatocytes 
(FH), hepatocytes in monolayer confluent (MC) or sandwich (S) culture on day 1. GAPDH was used as an 
endogenous control. Representative images for 3 independent experiments are shown.  
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3.5.4 JNK INHIBITOR REDUCES THE CULTIVATION-INDUCED INFLAMMATORY 
RESPONSE 
JNK signaling was identified as the signaling pathway that is activated early during the 
isolation procedure influencing induction of inflammatory response in primary mouse 
hepatocytes in vitro.  
In the next step, the significance of JNK and its role in modulating the gene expression 
response of primary mouse hepatocytes was addressed by performing early interventions 
during perfusion with the JNK inhibitor-SP600125. For this reason, addition of JNK inhibitor 
SP600125 was applied as follows (Figure 17): (i) SP600125 was added to the perfusion buffers 
(EGTA + Collagenase) but not to the cell culture medium, (ii) not to the perfusion buffer but to 
the culture medium directly upon plating, and (iii) to both perfusion buffers and culture 
medium. DMSO was added at 0.5% as a solvent control either to the perfusion solutions or to 
the cell culture medium, as indicated in the insert box. Primary mouse hepatocytes were 
cultivated with or without the inhibitor for up to 24 hours in sandwich culture and the gene 
expression profile of previously described, selected markers was analyzed (Figure 57 and Figure 
58).  
SP600125, when added alone to the perfusion buffers, clearly reduced Lcn2 levels in 
hepatocytes of all three independent biological replicates (Figure 57). However, Lcn2 
expression increased during the cultivation period once the inhibitor was removed. When 
SP600125 was added only to the culture medium, a decrease in Lcn2 was also seen but this 
effect lasted longer compared to the ´buffers only` experiment. Consistent with these 
observations, the presence of SP600125 in the perfusion buffers as well as in the culture 
medium caused the strongest and most permanent decrease in Lcn2 expression. 
In contrast, the JNK inhibitor did not influence the expression of the metabolism cluster 
biomarkers Bsep and Mrp2 in hepatocytes in all three independent biological replicates (Figure 
58).  
In conclusion, these results indicate that early activation of JNK during perfusion modulates 
the induction of an inflammatory response of primary mouse hepatocytes in vitro.   
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FIGURE 57: INTERVENTION WITH THE JNK INHIBITOR REDUCES THE INFLAMMATORY RESPONSE 
Quantitative RT-PCR analysis of inflammation-associated genes (Lcn2 and Mt2) in healthy liver tissue (Liver), 
freshly isolated hepatocytes (FH), hepatocytes in sandwich (S) culture for the indicated time, in the presence or 
absence of the JNK inhibitor (SP600125) at 50 µM, using DMSO as a vehicle. The addition of the JNK inhibitor 
SP600125 was applied as follows (Figure 17): (i) SP600125 was added to the perfusion buffers (EGTA + 
Collagenase) but not to the cell culture medium, (ii) not to the perfusion buffer but to the culture medium directly 
upon plating and (iii) to both perfusion buffers and culture medium and maintained throughout the cultivation 
time until 24h. DMSO was added at 0.5% as a solvent control either to the perfusion solutions or to the cell culture 
medium, as indicated in the insert box. GAPDH was used as an endogenous control. Data are expressed as fold 
change relative to healthy liver tissue. Each graph represents an independent biological replicate. Values represent 
mean ± SD (n=3).  
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FIGURE 58: INTERVENTION WITH THE JNK INHIBITOR DOES NOT RESCUE METABOLISM DOWN-REGULATION 
Quantitative RT-PCR analysis of metabolism-associated genes (Bsep and Mrp2) in healthy liver tissue (Liver), freshly 
isolated hepatocytes (FH), hepatocytes in sandwich (S) culture for the indicated time, in the presence or absence of 
the JNK inhibitor SP600125 at 50 µM, using DMSO as a vehicle. The addition of the JNK inhibitor SP600125 was 
applied as follows (Figure 17): (i) SP600125 was added to the perfusion buffers (EGTA + Collagenase) but not to the 
cell culture medium, (ii) not to the perfusion buffer but to the culture medium directly upon plating and (iii) to 
both perfusion buffers and culture medium and maintained throughout the cultivation time until 24h. DMSO was 
added at 0.5% as a solvent control either to the perfusion solutions or to the cell culture medium, as indicated in 
the insert box. GAPDH was used as an endogenous control. Data are expressed as fold change relative to healthy 
liver tissue. Each graph represents an independent biological replicate. Values represent mean ± SD (n=3). 
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 COMPARISON TO RAT AND HUMAN PRIMARY HEPATOCYTES 3.6
3.6.1 CULTIVATION-INDUCED INFLAMMATORY RESPONSE AND METABOLISM 
DECREASE ARE SIMILAR IN HEPATOCYTES OF MICE AND RATS 
Although primary mouse hepatocytes represent a fundamental tool for biomedical 
research, it is important to extrapolate mouse in vitro data to other species such as rat and 
human. Therefore, the aim of the next study was to validate the effect of cultivation conditions 
on primary rat hepatocytes’ gene expression regarding inflammation and metabolism gene 
clusters. For this purpose, primary rat hepatocytes were cultivated in monolayer Confluent(MC) 
and sandwich (S) culture for the indicated timepoints and the gene expression profile of 
selected markers was analyzed.   
Similarl to the mouse hepatocytes (Figure 18, A), primary rat hepatocytes in vitro (Figure 
59) acquire a profoundly distinguishable morphology depending on the extracellular matrix 
used as culture substratum. Similar to mouse hepatocytes, MC culture maintain a cuboidal 
morphology during the first day in culture; however, after longer cultivation periods EMT-
features are visible. In contrast, sandwich-cultured hepatocytes presents the most stable 
morphology resembling an epithelial-like phenotype. Sandwich cultures appear more 
differentiated, as seen by their in vivo-like cuboidal shape and distinct bile canaliculi network 
even after longer periods in culture. 
 
FIGURE 59: EXTRACELLULAR MATRIX CAUSES MORPHOLOGICAL CHANGES IN PRIMARY RAT HEPATOCYTES IN 
VITRO 
Light microscopy of primary rat hepatocytes in two culture systems: monolayer confluent and sandwich culture for 
the indicated periods of time. Magnification of 20X.  
qRT-PCR analysis of selected genes indicate that the same principles observed in the 
mouse model were identified in primary rat hepatocytes, namely induction of inflammation and 
repression of metabolism-associated genes (Figure 60). These results confirm the occurrence of 
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the aforementioned principles of inflammation induction and metabolism decrease in primary 
rat in vitro culture, and support a similar stress response of mouse and rat primary hepatocytes 
that includes features of inflammation and a decline in expression of metabolism-associated 
genes.  
 
FIGURE 60: SIMILAR TO THE MOUSE MODEL, PRIMARY RAT HEPATOCYTES EXHIBIT INDUCTION OF INFLAMMATION 
AND LOSS OF METABOLISM IN VITRO 
Quantitative RT-PCR analysis of inflammation- (Lcn2 and Mt2) or metabolism-associated genes (Bsep, Mrp2 and 
Cyp7a1) in healthy liver tissue (Liver), freshly isolated hepatocytes (FH), hepatocytes in sandwich (S) culture or 
monolayer confluent (MC) culture for the indicated times. GAPDH was used as an endogenous control. Data are 
expressed as fold change relative to healthy liver tissue. Values represent mean ± SD (n=3). 
 
3.6.2 HUMAN PRIMARY HEPATOCYTES ARE MORE STABLE THAN RODENT 
HEPATOCYTES 
It has been shown that the isolation procedure causes strong expressional changes in 
primary rodent hepatocytes during cultivation that affects functionality of these in vitro 
systems that are used in both basic and applied research. However, it is not known whether the 
same processes are triggered during isolation and culture of primary human hepatocytes. 
Therefore, the aim of the next study was to gain detailed insight into the molecular 
mechanisms orchestrating gene expression of human hepatocytes in culture. For this purpose, 
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time-resolved global gene expression profiling using Affymetrix microarrays was carried out in 
primary human hepatocytes cultivated in sandwich (S) and monolayer confluent (MC) culture 
for up to one week.   
Similar to the mouse hepatocytes (Figure 18, A) and rat hepatocytes in vitro (Figure 59), 
primary human hepatocytes (Figure 61) acquire a distinguishable morphology depending on the 
extracellular matrix used as the culture substratum. MC cultures maintain a relatively cuboidal 
but flattened morphology. On the other hand, sandwich-cultured hepatocytes appear more 
differentiated, as evidenced by their in vivo-like cuboidal shape and distinct bile canaliculi 
network, even after longer periods in culture. 
 
FIGURE 61: DIFFERENT EXTRACELLULAR MATRIX CAUSES MORPHOLOGICAL CHANGES IN PRIMARY HUMAN 
HEPATOCYTES IN VITRO 
Light microscopy reveals the morphology of primary human hepatocytes in two culture systems: monolayer 
confluent and sandwich culture for the the indicated culture periods. Magnification of 20X.  
 
Principal component analysis (PCA) of the gene array data (Figure 62) represents 
directional changes in gene expression of cultivated primary human hepatocytes compared to a 
reference state of freshly isolated hepatocytes (Fresh Hep, FH). PCA analysis reveals that the 
sandwich and monolayer confluent systems progressively deviate, with a slight shift of change, 
from freshly isolated hepatocytes. The observed direction of time-dependent changes shows a 
similar trend to the data obtained with mouse hepatocytes (Figure 19).  
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FIGURE 62: GENE ARRAY ANALYSIS REVEALS PROFOUND TIME-DEPENDENT ALTERATIONS OF CULTIVATED 
PRIMARY HUMAN HEPATOCYTES 
Alterations of gene expression of cultivated primary human hepatocytes in monolayer confluent (MC) and 
sandwich (S) cultures illustrated as principal component plot (PCA).  
 
Therefore, the aim of the next study was to validate the effect of cultivation conditions 
on primary human hepatocytes’ gene expression regarding the inflammation and metabolism 
gene clusters.  For this purpose, primary human hepatocytes were cultivated in monolayer 
confluent (MC) and sandwich (S) culture for the indicated timepoints and gene expression 
profiles of selected markers were analyzed (Figure 63). 
The principles of inflammatory response and decline in metabolism were also observed 
in human hepatocytes (Figure 63).  However, humans differ in three aspects. First, the maximal 
expression levels of inflammation-associated genes Lcn2 and Mt2 were lower in humans than in 
mice (Figure 23) and rats (Figure 60). Second, induction of inflammation genes was transient in 
human, but permanent in rodents. Third, sandwich cultures of human hepatocytes allowed a 
partial recovery of some metabolism-associated genes such as Bsep and Cyp7a1, which was not 
the case for mice or rats.  
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FIGURE 63: HUMAN PRIMARY HEPATOCYTES ARE MORE STABLE THAN RODENT HEPATOCYTES 
Quantitative RT-PCR analysis of inflammation- (Lcn2, Mt2 and Saa3) or metabolism-associated genes (Bsep, Mrp2 
and Cyp7a1) in freshly isolated hepatocytes (FH), hepatocytes in sandwich (S) culture or monolayer confluent (MC) 
culture for the indicated time. GAPDH was used as an endogenous control. Each graph represents an independent 
biological replicate. Data are expressed as fold change relative to in freshly isolated hepatocytes. Values represent 
mean ± SD (n=3).  
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FIGURE 63: CONTINUED 
HUMAN PRIMARY HEPATOCYTES ARE MORE STABLE THAN RODENT HEPATOCYTES 
Quantitative RT-PCR analysis of inflammation- (Lcn2, Mt2 and Saa3) or metabolism-associated genes (Bsep, Mrp2 
and Cyp7a1) in freshly isolated hepatocytes (FH), hepatocytes in sandwich (S) culture or monolayer confluent (MC) 
culture for the indicated time. GAPDH was used as an endogenous control. Each graph represents an independent 
biological replicate. Data are expressed as fold change relative to in freshly isolated hepatocytes. Values represent 
mean ± SD (n=3).  
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FIGURE 63: CONTINUED 
HUMAN PRIMARY HEPATOCYTES ARE MORE STABLE THAN RODENT HEPATOCYTES 
Quantitative RT-PCR analysis of inflammation- (Lcn2, Mt2 and Saa3) or metabolism-associated genes (Bsep, Mrp2 
and Cyp7a1) in freshly isolated hepatocytes (FH), hepatocytes in sandwich (S) culture or monolayer confluent (MC) 
culture for the indicated time. GAPDH was used as an endogenous control. Each graph represents an independent 
biological replicate. Data are expressed as fold change relative to in freshly isolated hepatocytes. Values represent 
mean ± SD (n=3).  
 
 
In conclusion, global gene expression profiling exposed similarities in gene expression 
alterations between cultivated rodent and human hepatocytes.   
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4. DISCUSSION 
  GENE ARRAY ANALYSIS REVEALS PROFOUND ALTERATIONS IN CULTURE 4.1
Hepatocyte in vitro systems represent a well-accepted tool in many fields of research. 
Despite their widespread use, research with primary hepatocytes remains challenging [171, 
207]. Complex cellular networks regulate regeneration, detoxification and differentiation of 
hepatocytes. Disrupting hepatocytes from their normal microenvironment, as during toxic 
compound insult or hepatectomy, causes major alterations in cell physiology [4]. Relevant for 
the field of in vitro studies, isolation and cultivation of hepatocytes induces massive 
transcriptional responses [78]. To date, great efforts have been spent to control or attenuate 
the alteration of hepatocytes in vitro. However, expression levels or activities comparable to 
the liver in vivo have rarely been achieved, and the precise mechanisms controlling de-
differentiation are still poorly understood. Therefore, to obtain a comprehensive overview of 
the expression alterations caused by various culture conditions and after radically different 
interventions, a time-resolved gene array analysis of mouse hepatocytes in sandwich and 
monolayer cultures was carried out, and compared to livers in vivo after treatment with CCl4, 
lipopolysaccharide (LPS), or partial hepatectomy (PHx). Global gene expression profiling 
exposed profound alterations within the first 24 hours that orchestrate cellular response of 
primary mouse hepatocytes in vitro. All cultivation systems - sandwich (S), confluent (MC) and 
subconfluent (MS) - expressed similar patterns of up-regulation of Lcn2, Mt2 and Saa3 and 
down-regulation of Bsep, Mrp2 and Cyp7a1 (Table 21). These features were not dependent on 
the culture configuration, including confluent or sub-confluent conditions, 2 or 3D matrix and 
type of extracellular matrix, including self-generated ECM in spheroids. Most importantly, this 
study identified a stereotypic gene expression response, which occurs similarly after different 
types of stress - isolation by collagenase perfusion, intoxication with CCl4 or LPS as well as PHx - 
namely an upregulation of inflammation and proliferation as well as a downregulation of 
metabolism-associated genes.  
The degree of overlap of these expression responses was remarkable considering the 
different nature of the stimuli. For example, more than 80% of up- or down-regulated genes 
after CCl4 exposure were also altered in culture after hepatocyte isolation, PHx and LPS 
treatment (Figure 38). Gene cluster analysis of deregulated genes revealed the molecular 
architecture of this stereotypic expression response consisting of an inflammation, metabolism 
and proliferation motif (Figure 28). The alterations of the metagenes follow a characteristic 
time schedule: (i) in vitro, most alterations occur within 24h and remain deregulated (Figure 
21), (ii) in vivo, alterations are also maximal after approx. 24h (CCl4 and PHx) but later return to 
control levels (Figure 41 and Figure 42). This explains why the in vitro/in vivo correlation of the 
gene expression alterations is maximal after 24h.  
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In order to obtain some insight into the mechanisms controlling the aforementioned 
transcriptional responses, Luminex analysis was performed to dissect the signaling activities 
throughout the culture time (Figure 52). JNK and ERK2 were identified as the strongest and 
earliest phosphorylated signaling proteins, with responses already observed during the isolation 
procedure (Figure 53). Stress signaling pathways have been previously demonstrated to play 
pivotal roles in de-differentiation processes of primary hepatocytes, thus contributing to the 
described alterations [61, 100].  
  MONOLAYER CULTURES INDUCE PROLIFERATION INDEPENDENT OF 4.2
ADDITIONAL GROWTH FACTORS 
Of all presented transcriptional alterations, activation of proliferative response is, 
perhaps, the best understood. It has been recently described that the activation of 
MAPK/ERK1/2 and Akt signaling of primary mouse hepatocytes in monolayers causes a 
“proliferation primed state” with more than 1000 genes strongly up or down-regulated [78]. 
This “proliferation primed state” leads to a phenotype of enhanced basal BrdU incorporation, 
epithelial-to-mesenchymal transition (EMT)-like de-differentiation, and resistance to apoptosis 
[115, 208]. However, this phenotype could be ameliorated by a 3D collagen sandwich culture, 
where a differentiated polarized phenotype and sensitivity to TGFβ-induced apoptosis was 
achieved [115]. ERK2 signaling was already observed during the isolation procedure (Figure 53). 
However, this activation is absent or much weaker in the sandwich culture, and only monolayer 
systems exhibit renewed activation of ERK1/2 signaling at 48h representing a link to the 
induction of proliferation and EMT-features observed in confluent and subconfluent 
configurations (compare results from [78, 115] and Figure 53). The results presented in my 
thesis also demonstrate that the subconfluent cultures exhibited the highest expression of the 
proliferation metagene; sandwich cultures were lowest; and confluent monolayer cultures and 
the in vivo samples ranked intermediate. In addition, from the presented results, the sandwich 
culture system offers clear advantages over monolayers by maintaining a more stable profile of 
expressional changes and preserving more of the in vivo-like features. 
  HEPATOCYTE CULTIVATION INDUCES AN IN VIVO-LIKE INFLAMMATION 4.3
RESPONSE  
To date, studies characterizing liver cultivation systems, focusing especially on 
monolayer configurations, point out the relevance of EMT as a feature of hepatocyte de-
differentiation in vitro [78, 115]. However, a particularly important aspect revealed during my 
thesis is the strong activation of inflammation, which has not yet been described for cultivated 
hepatocytes. Most of the top up-regulated genes in culture are well-known inflammation-
associated factors (Inserts with References in Table 21) [130, 137, 192, 194, 195]. The top 
marker of the inflammatory cluster - Lcn2 - was the most up-regulated gene in all five systems. 
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Likewise, a time-dependent and strong increase in expression of Lcn2 during culturing has been 
previously reported for rat primary hepatocytes [209]. A strong inflammatory response was also 
evidenced by the at least 5-fold induction of inflammatory factors in all models, such as Mt2 
and Saa3 among the top ten up-regulated genes. Additionally, upregulation of the 
inflammation-associated transcription factor C/EBPδ and downregulation of C/EBPα shortly 
after isolation and during culture support previously published results [60]. A possible 
explanation for these alterations is the stress signaling triggered during the isolation procedure 
of hepatocytes. NPC are known as major regulators of liver function. Pro-inflammatory 
cytokines produced by NPC initiate an acute phase response and affect liver functions [25]. 
During ongoing liver injury, damage-associated molecular patterns molecules (DAMPs) cause an 
increased production of inflammatory cytokines and reactive oxygen species (ROS) by NPC 
[210]. This results in activation of the C/EBP family of transcription factors and subsequent 
induction of an acute phase response [137]. According to this hypothesis, the isolation 
procedure sensed as an ongoing tissue injury could cause activation of non-parenchymal cell 
population and trigger the release of ROS and/or cytokines that in turn activate stress signaling 
in hepatocytes. In addition, treatment in vivo with LPS and pro-inflammatory cytokines 
(including IL-6, IL-1 and TNF) induces expression of C/EBPδ and concurrently down-regulates 
C/EBPα [137, 138, 211, 212]. Similar patterns of downregulation of C/EBPα have also been 
reported during liver regeneration [148, 149]. This would suggest that the observed stress 
response and subsequent wave of inflammation occurs very early on, starting during the 
isolation procedure, indicating a potential time frame for intervention. However, the results 
presented in my thesis do not allow a precise identification of a mechanism, which induces the 
inflammatory response during isolation and in culture. Further experiments using knockout 
mice (signaling or liver cell type specific), depletion of certain NPC population (irradiation of 
infiltrating monocytes or depletion of KC by administration of clodronade liposomes) or specific 
antibodies to deplete their respective cytokines could address this question in more detail.  
A central result in this study was that the isolation and cultivation of hepatocytes lead to 
an in vivo-like inflammation profile. In order to quantify the inflammation response, I used a 
normalized mean value of all genes from the inflammation cluster (´inflammation metagene`). 
Comparison of cultivation with all three in vivo models of liver damage show great similarities in 
their inflammatory response profiles, with Lcn2 among the most up-regulated, with the 
strongest response in the three culture systems followed by CCl4, PHx and LPS (Figure 37). Lcn2 
has been shown to be highly up-regulated during several pathologic conditions [130, 191] and is 
known to be involved in the regulation of cell proliferation [213], the immune response [214], 
inflammatory reactions [215], and cytokine-dependent renal regeneration [216]. In both 
primary hepatocytes and HepG2 cell line, induction of Lcn2 occurs in response to IL-1β via NF-
ĸB signaling [209], suggesting that Lcn2 expression correlates with liver damage and the 
resulting inflammatory responses in a cytokine-dependent manner. Lcn2 is also strongly 
induced during liver injury such as partial hepatectomy [217] and after CCl4 intoxication [190]. 
Furthermore, Lcn2 has been shown to exert protective effects during acute liver injury after 
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CCl4 intoxication [190]. In conclusion, Lcn2 positively correlates to inflammation and has been 
suggested as a reliable indicator of liver damage. In line with this knowledge, the liver seems to 
respond to injury and stress with a general feature of inflammation. This has also been shown in 
my study, where seemingly different stress conditions such as hepatocyte isolation and culture, 
as well as CCl4, LPS or PHx liver damage, induce similar cellular responses in hepatocytes such as 
inflammation. It sheds a new light on the consistency of the hepatocyte response, which exerts 
a similar gene expression pattern despite the model of liver injury. In contrast to the behavior 
of hepatocytes in vitro, culture-induced activation of hepatic stellate cells (HSC) showed a low 
correlation to the in vivo-activated HSC after bile duct ligation or CCl4 treatment [218]. This 
discrepancy emphasizes that the almost identical gene expression patterns of both in vivo 
fibrotic models should be considered the gold standard for the study of HSC activation. 
However, the high correlation between the cultivated hepatocytes and the in vivo models of 
liver injury shown in my study leads to the conclusion that the hepatocyte in vitro systems 
commonly used in pharmacology, hepatology and toxicology [171] represent an inflamed and 
not a healthy liver.  
  OVERREPRESENTED TRANSCRIPTION FACTORS FOR THE UP-REGULATED GENE 4.4
CLUSTERS 
Having identified the molecular architecture of transcriptional responses, I next 
identified overrepresented transcription factors regulating the aforementioned alterations 
using a bio-statistical approach by means of transcription factor binding site (TFBS) analysis. The 
inflammation and proliferation gene clusters were shown to be enriched for Sp1, Elk1, E2F, ETF, 
similarly as already reported [78]. Moreover, TFBS analysis suggests that most up-regulated 
genes contain GC-rich promoters. The highest ranked TF for up-regulated genes - Sp1 - belongs 
to the mammalian family of ‘Krüppel-like’ transcription factors. It represents a ubiquitous TF 
maintaining the basal transcription of ‘house-keeping’ genes that lack a TATA-box but instead 
binds to GC-rich sequences (GGGGCGGGG) [219, 220]. Surprisingly, Sp1 is not transcriptionally 
up-regulated in hepatocytes in vitro, but immunostaining shows that its expression increases in 
hepatocyte nuclei in culture. It has been shown that Sp1 co-operates with other ‘Krüppel-like’ 
transcription factor, such as Klf6 to regulate gene expression [206]. Klf6 has been shown to play 
a role in tissue injury as indicated by its rapid induction among the immediate-early genes in in 
vivo activated HSC [199, 200]. Indeed, Klf6 turned out to be one of the strongest 
transcriptionally up-regulated TF with an enhanced nuclear localization in hepatocytes in vitro. 
This result suggests that Klf6 may be one of the driving TFs for other partner binding CG-rich 
promoters to activate upregulation of target genes involved in tissue repair. Additionally, Klf6 
increases in the CCl4 model of liver damage, proposing a possible role in the upregulation of 
inflammation genes in vivo. Furthermore, phosphorylation of Sp1 by ERK1/2 is required for 
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mediating EGF-induced Apo lipoprotein A-I gene transcription in the HepG2 cell line [221]. 
Therefore, it is tempting to speculate that ERK1/2 signaling activation during the isolation 
procedure leads to the activation of Klf6-Sp1 co-operation resulting in an induction of genes 
involved in both inflammation and proliferation processes. Further studies using targeted 
knock-down via siRNA technology or knock-out mice could explain the contribution of these 
transcription factors in more detail.  
Manually curated analysis of deregulated genes and TFBS lead to the identification of 
other TF that could be responsible for the observed transcriptional alterations. Most of stress-
signaling pathways are activated rapidly during isolation. In culture, most activities decreased 
once more, but usually not back to the levels found in healthy liver tissue. However, induction 
of phosphorylated c-jun has been shown to appear later in culture (Figure 52). c-Jun is a 
transcription factor that is a member of a dimeric complex known as AP-1. It is implicated in 
various, often opposing cellular responses [222]. In hepatocytes, c-Jun is a positive regulator of 
cell proliferation, as the lack of c-Jun impairs liver regeneration [223]. The AP-1 (activator 
protein-1) family consists of several groups of proteins: JUN, FOS, activating transcription factor 
(ATF) and MAF, making it possible to form many different combinations of homo- and 
heterodimers [224]. The mitogen-activated protein kinase (MAPK) signaling pathways are 
principal regulators of AP-1 activity [225]. Therefore, it is likely that induction of MAPK signaling 
during the isolation procedure could result in a subsequent activation of c-jun and its target 
genes. This hypothesis is additionally supported by the TFBS analysis, which showed an 
enrichment of ATF family among transcription factors controlling the up-regulated gene 
clusters. Moreover, preliminary data obtained from a proteomic analysis of cytosolic and 
nuclear extracts of monolayer confluent cultures on day one suggested a significant enrichment 
of MAF transcription factor - MafF and MafK - in the nucleus of hepatocytes in vitro. Therefore, 
it is likely that the family of proteins forming AP-1 complexes represent the main group of 
transcription factors activated in culture and regulating the up-regulated gene clusters. 
However, the results presented in my thesis do not allow a precise identification of the 
transcription factors regulating these clusters. Further studies using targeted knock-down via 
siRNA technology or knock-out mice for suggested transcription factors or analysis with 
chromatin immune-precipitation could address this question in more detail. 
  POSSIBLE FACTORS INFLUENCING GENE EXPRESSION PROFILE OF 4.5
HEPATOCYTES IN CULTURE  
Although the massive activation of stress pathways early upon isolation can explain the 
transcriptional alterations observed during the first hours in culture, it is intriguing that these 
expression alterations do not return to basal levels, even after several days in culture when the 
aforementioned stress pathways are long terminated. A possible explanation is that the initial 
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events lead to the induction of growth factors, cytokines or signaling adaptors that generate a 
feed-forward loop of gene expression. Among these candidate effectors is Connective tissue 
growth factor (Ctgf), chemokine Ccl2, and Immediate early response 3 (Ier3). They represent 
inflammatory markers, whose transcriptional expression progressively increases in culture 
(Figure 36). Ctgf is a secreted protein and a downstream mediator of the pro-fibrogenic effects 
of TGF-β signaling [226]. It is strongly up-regulated in fibrotic tissue and during wound healing 
[204]. CTGF plays a crucial role in invasive processes of human breast cancer by integrin-
dependent activation of the ERK1/2 pathway [227]. Moreover, CTGF has been shown to induce 
IL-6 expression via αvβ5 integrin receptor, JNK/p38 and AP-1/NF-κB signaling pathways in 
human synovial fibroblasts [228]. All together, the results suggest that Ctgf may further 
influence gene expression of hepatocytes by activating various signaling pathways. Ccl2 is 
another cytokine that is induced during late timepoints in culture. This chemokine activates a 
myriad of signaling cascades including Akt, ERK and p38 via its cognate receptor Ccr2, a G-
coupled protein, resulting in enhanced migration and infiltration of monocytes/macrophages 
[229, 230]. Another candidate is the Immediate-early response 3 (Ier3) gene associated with 
cycle progression and proliferation [194] that becomes induced in response to a variety of 
stimuli, including growth factors, cytokines, and cellular stress, e.g. NF-κB in response to TNF 
[231]. Additionally, upon ERK1/2-mediated phosphorylation, Ier3 prolongs ERK1/2 activation 
contributing to the phosphorylation of ERK substrates [232]. A probable explanation for these 
permanent alterations in culture is the possibility that cell fate can be determined long before it 
is apparent in cellular behavior [233]. The increasing amount of studies show that the dynamics 
of early signaling cause long-term cellular responses. For example, the duration of ERK 
activation is critical for cell signaling decisions in PC12 cells [234]. In these cells, sustained 
stimulation of ERK signaling with nerve growth factor (NGF) leads to neurite outgrowth, 
whereas transient ERK activation following epidermal growth factor (EGF) stimulation results in 
proliferation. Therefore, Ctgf, Ier3 and Ccl2 could represent a set of genes affected 
transcriptionally by early signaling events, e.g. during isolation. Furthermore, these late-induced 
genes may exert a positive feed-forward loop in cultivated hepatocytes that promotes an 
inflammatory response after the initial burst of stress signaling has waned. However, it remains 
to be determined how these factors are precisely regulated during cultivation and their precise 
contribution to the aforementioned alterations.   
The liver microenvironment is complex and exposes hepatocytes to a plethora of 
cellular interactions and signals, whereas in vitro culture systems represent an artificial 
environment and do not contain many of the interactions present in vivo. Therefore, disruption 
of the normal liver architecture during the isolation procedure and the adaptation to the in 
vitro environment may be responsible for many of the aforementioned transcriptional 
alterations in vitro. For example, Wnt/β-catenin signaling is a key pathway controlling liver 
metabolism. β-catenin - mediated gene transcription is activated after binding of secreted 
DISCUSSION 
113 
 
ligands (Wnts) [235] and has been shown to have a major role in determining the final 
patterning of the adult liver [236]. Therefore, it is likely that hepatocytes in vitro are lacking 
certain ligands, such as Wnts that when present in vivo guard transcriptional control over liver 
zonation. Consequently, shortage of important factors during cultivation could represent 
another possible link to the repressed metabolic functions and ongoing transcriptional 
alterations in vitro.   
  MINOR ROLE OF NPC IMPURITIES ON THE EXPRESSION OF TARGET GENES 4.6
DURING CULTIVATION 
The strong inflammatory response observed in culture could result from the influence of 
Non Parenchymal Cells (NPC) residuals in culture. NPC are known to secrete cytokines and 
cause the inflammatory transcriptional response in the neighboring hepatocytes in vivo [150]. 
My analysis revealed that the hepatocyte-enriched fraction obtained after the isolation 
procedure contains a relatively high fraction of approximately 10-13% of NPC impurities. 
Nevertheless, further removal of these impurities by additional Percol centrifugation steps (end 
content of approximately 1% NPC) had only a minor effect on most of the marker genes. 
However, Saa3 turned out to be the only marker affected by this approach indicating that 
although the inflammation gene clusters are similarly affected in all in vitro models, the specific 
genes may be regulated by different mechanisms. The opposite approach of adding NPC to 
normal sandwich and monolayer confluent culture confirmed the aforementioned principles, 
whereby NPC slightly enhanced Saa3 expression but had no major influence on other markers: 
Lcn2, Mt2 as well as Bsep, Mrp2 and Cyp7a1. Such divergence could be explained by the 
responsiveness of acute phase proteins (Saa3 and Lcn2 for example) to different cytokines 
controlling their expression. TNF, IL-1 β and IL-6 represent major triggers for the synthesis of 
acute phase proteins in the liver [237]. Saa3 represents type I of acute phase proteins that 
become induced by IL-1-like cytokines such as IL-1α, -β and TNF. In contrast, the IL-6 family of 
cytokines induces acute phase proteins type II. However, the effect of IL-6 can further synergize 
with IL-1-like cytokines leading to the induction of type I markers but not the other way round 
[238]. In line with this, responsiveness of Saa3 only to the IL-1 family of cytokines could explain 
its dependence on NPC residuals. Activated macrophages are known to produce TNF, IL-1 β and 
IL-6 [3] and, therefore macrophages may be the effector cell type that up-regulates Saa3 in 
vitro. However, further studies using Küpffer cell depletion or cytokine-antagonizing antibodies 
prior to isolation and culture may reveal the precise regulatory mechanisms responsible for 
these alterations.   
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  JNK SIGNALING DRIVES INFLAMMATION  4.7
The activation timing of signaling pathways suggests that interventions with kinase 
inhibitors during perfusion and plating may abrogate inflammation and rescue metabolism. 
Therefore, in order to determine how certain signaling pathways contribute to the 
aforementioned transcriptional changes, I performed a series of experiments with different 
small molecule inhibitors to repress signaling pathways. Of all the inhibitors tested, only the JNK 
inhibitor - SP600125 – had an effect in vitro and clearly reduced the inflammatory response by 
suppressing the upregulation of both Lcn2 and Saa3 in both inflammation clusters (Figure 54), 
indicating that the JNK pathway is critical for the inflammation response. Additionally, the 
transiently-induced inflammation gene cluster represented by Saa3 was also influenced by the 
presence of p38 and NF-ĸB inhibitors suggesting that this cluster may be controlled by 
pathways other than JNK. This suggests that the upregulation of Lcn2 and Saa3 depends on 
various cytokines. Yet, both markers are induced in response to IL-1β indicating their 
association with type I acute phase proteins [209, 238]. Moreover, Saa3 expression is affected 
by various signaling pathways and it is the only inflammatory marker affected by the content of 
non-parenchymal cells. Taken together, this suggests that although inflammation gene clusters 
are similarly affected in all in vitro models, the specific marker genes are controlled by different 
mechanisms. To further assess the importance of the JNK signaling pathway, I added JNK inhibitors 
early on during the liver perfusion procedure. However, only addition of the JNK inhibitor into 
the perfusion buffers as well as to the cell culture medium clearly reduced the inflammatory 
response by suppressing the upregulation of inflammation clusters (Figure 57). However, none 
of the tested inhibitors were able to rescue the profound repression of metabolism-associated 
genes (Figure 55 and Figure 58). These results demonstrate that early activation of JNK during 
perfusion is responsible for the inflammatory response of primary mouse hepatocytes in vitro. 
Furthermore, the molecular structure of this stereotypical stress response provides possibilities 
of intervention by small molecule inhibitors. Nevertheless, the lack of response of genes from 
the metabolism cluster shows that the underlying signaling network is complex and still far 
from being fully understood. 
  CULTIVATION INDUCES DOWN-REGULATION OF THE METABOLISM-4.8
ASSOCIATED GENES  
In contrast to the inflammation response, downregulation of the metabolism-associated 
genes in culture has been previously described [69, 239]. Transcriptional control of Bsep, and 
Mrp2 is known to be regulated by a group of nuclear receptors (NRs), including FXR, RAR, PXR, 
and CAR [95-98]. Similarly, the superfamily of cytochrome P450 is a key gene target of the 
nuclear receptors [83]. Therefore, strong downregulation of Bsep, Mrp2 and Cyp7a1 in all 
cultivation systems (Table 21) most likely results from the observed decrease of nuclear 
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receptors (Figure 31). This seems very plausible since binding of nuclear receptor agonists (e.g. 
bile acids) or antagonists can directly alter gene expression [37, 98], suggesting that stimuli 
triggering such changes occur early during the isolation procedure. Bile acid feedback is known 
to regulate CYP7A1 transcription through the nuclear receptor farnesoid X receptor (FXR) [240] 
and hepatocyte nuclear factor-4 (HNF-4) [241]. On the other hand, activation of JNK can lead to 
a decreased expression of nuclear receptors [161, 162]. Therefore, repression of Cyp7a1 could be 
partially explained as a response to the activation of MAPK kinases during the isolation procedure. 
This hypothesis is supported by studies where expression of Cyp7a1 was shown to be strongly 
down-regulated by bile acid- activated JNK in primary rat hepatocytes [242] and by HGF-induced 
activation of MAPK kinases, ERK1/2 and JNK, in primary human hepatocytes [243]. Another link 
to stress signaling has been confirmed by the treatment of HepG2 cells with bile acids that led 
to the inhibition of the transactivation potential of HNF4α via activation of MAPK signaling, thus 
leading to the repression of CYP7A1 transcription [244]. As ERK and JNK kinases become 
activated early during isolation, it is tempting to speculate that there is a causal link to the 
expression of NRs, HNF4α and Cyp7a1. However, addition of a JNK inhibitor during perfusion and 
culture did not ameliorate downregulation of these metabolism-associated genes. This indicates 
that perhaps the simultaneous activation of ERK signaling may be sufficient to trigger such 
downregulation and it remains to be determined how the underlying signaling networks are 
regulating these complex responses.   
Comparison of the ´metabolism metagene` reveals a comparable strong downregulation 
of metabolism-associated genes in both in vitro and in in vivo models of CCl4, LPS and PHx. This 
suggests that a decrease in expression of metabolism-associated genes may represent a general 
feature of liver stress responses. Liver regeneration induces a coordinated downregulation of 
metabolism-associated genes to prevent cellular damage [245]. However, the protein expression 
of Bsep and Mrp2 remains stable 24 h after the procedure in the model of partial hepatectomy 
[166, 167] and similarly unchanged in the model of CCl4-induced liver damage [164, 168]. The 
much slower decrease at the protein level is due to the relatively long half-life of these factors. 
Downregulation of hepatic transporters is mediated in vivo and in vitro by pro-inflammatory 
cytokines (TNF, IL-1β and IL-6) [97, 155-159]. In line with the strong effect of cytokines on 
inflammation- and metabolism-associated genes, it is tempting to speculate that tissue injury 
sensed during the isolation procedure leads to a release of cytokines from NPC. This release in turn 
influences gene expression of hepatocytes triggering in parallel the inflammatory response and the 
decrease in metabolic functions. However, further experiments are needed to fully dissect the role 
of the isolation procedure on cytokine release and signaling activation that may explain the 
described alterations. 
TFBS analysis suggested HNF4  and -1  as the most overrepresented TFs regulating the 
metabolism gene cluster. Immunostaining and qRT-PCR revealed a decrease in expression and 
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loss of nuclear HNF4 , respectively, within a few hours after isolation. Since HNF4  is 
fundamental for the expression of liver-specific metabolism-associated genes, loss of 
metabolism may be mediated via a loss of this transcription factor  [87]. Additionally, 
expression of HNF4  is mostly regulated by the nuclear receptor family of transcription factors 
[37, 98]. These factors were shown to be rapidly and persistently repressed shortly after 
isolation and during culture. It remains unclear how disruption of the normal liver architecture 
during the isolation procedure and culture microenvironment modulate HNF4α expression. 
Nevertheless, it seems likely that the isolation procedure plays a critical role. This hypothesis is 
supported by an in vitro study where ERK2 activation causes downregulation of HNF4  
expression in human hepatoma cells at the transcriptional level via mechanisms that involve 
loss of C/EBP  [116]. Stress signaling pathways have been previously demonstrated to play 
pivotal roles in the de-differentiation processes of primary hepatocytes [61, 100] suggesting 
that ERK1/2 activation during isolation down-regulates expression of HNF4  in isolated 
hepatocytes. However, the results presented in my thesis do not allow a precise identification 
of mechanism regulating the downregulation of HNF4  and consequently metabolism-
associated genes. Therefore, further studies using HNF4  over-expression in vitro or 
deactivation of the ERK1/2 signaling by use of small molecule inhibitors during isolation could 
address this question in detail.  
  SYSTEMIC ALTERATIONS IN GENE EXPRESSION ARE INDEPENDENT FROM THE 4.9
SPECIFIC TYPE OF EXTRACELLULAR MATRIX  
Currently, there is much expectation surrounding the development of organotypic 
hepatocyte in vitro systems [171]. Spheroids or micro-tissues are considered particularly 
attractive because they produce their own extracellular matrix [72]. Mouse spheroids allowed a 
better maintenance of some metabolism-associated genes compared to sandwich culture, 
which may represent an advantage of the latter system [75]. However, in my thesis I 
demonstrate that a spheroid culture system did not avoid the stereotypical gene expression 
response. In contrast, even a stronger upregulation of the inflammation cluster gene Saa3 and 
C/EBPδ was observed. Different types of commercially available matrixes including MatrigelTM 
and Laminin, as an approach to create a more in vivo-like environment and to achieve a better 
comparison to the spheroid system, did not ameliorate the overall gene expression response. 
All together, these results show that systemic alterations in gene expression of primary 
hepatocytes occur independently from the specific type of extracellular matrix in vitro.  
 COMPARISON TO RAT AND HUMAN PRIMARY HEPATOCYTES 4.10
A remarkable feature of the described stereotypical expression response is that its basic 
features were conserved across species including human. This is noteworthy considering 
several publications that challenged the usefulness of animal data to study human 
inflammatory diseases and to predict human safety [246, 247]. Nevertheless, my study 
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demonstrates that both human and rodent hepatocytes respond to the isolation procedure 
with a conserved stress response that includes features of inflammation and a decline in 
expression of metabolism-associated genes. However, there is a major quantitative difference 
and some alterations in human hepatocytes are only transient. This illustrates the need for a 
similar comprehensive human study comprising isolated hepatocytes and liver tissue, both 
healthy and inflamed, ex vivo.  
 CONCLUSIONS AND FUTURE PERSPECTIVES 4.11
Elucidation of the molecular anatomy of gene expression patterns in stressed 
hepatocytes presented in my thesis has several implications. First, the broadly applied 
hepatocyte in vitro systems do not represent a model system for the healthy liver but rather a 
critically inflamed state. In this context, it was a surprise that the stress-induced response of 
inflammation and metabolism in sandwich cultures and spheroids could not be avoided, despite 
the polarized and well-differentiated morphology of hepatocytes observed in those systems. 
Second, unveiling the molecular anatomy of gene expression also demonstrates that cultivated 
hepatocytes may be used to study pathological situations. For example, expressional patterns 
of primary mouse hepatocytes in sandwich cultures resemble those observed in stressed-
inflamed liver tissue such as after hepatectomy or in response to CCl4 or LPS. 
In conclusion, the identification of remarkable similarities of inflamed livers in vivo and 
cultivated hepatocytes opens new paths for mechanistic studies on liver inflammation and a 
more accurate use of hepatocyte in vitro systems. 
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5. APPENDIX 
 
TABLE 22: GENES INCLUDED INTO THE METAGENE ANALYSIS FOR THE PROCESS OF INFLAMMATION 
Inflammation metagene 
UniGene-ID Symbol Description 
Mm.4533 Apoa4 4903. Apolipoprotein A-IV 
Mm.3460 Cd14 527. CD14 antigen 
Mm.195663 Cdkn1a 103. Cyclin-dependent kinase inhibitor 1A (P21) 
Mm.347407 Cebpd 2447. CCAAT/enhancer binding protein (C/EBP), delta 
Mm.290991 Cpne8 5684. Copine VIII 
Mm.149403 Cyb561 14819. Cytochrome b-561 
Mm.387108 Ero1l 5828. ERO1-like (S. cerevisiae) 
Mm.582 Fabp4 1866. Fatty acid binding protein 4, adipocyte 
Mm.25613 Ier3 14610. Immediate early response 3 
Mm.9537 Lcn2 1356. Lipocalin 2 
Mm.192991 Mt1 235. Metallothionein 1 
Mm.147226 Mt2 687. Metallothionein 2 
Mm.14173 Orm2 17944. Orosomucoid 2 
Mm.326167 Pkm2 1518. Pyruvate kinase, muscle 
Mm.14277 Saa3 6241. Serum amyloid A 3 
Mm.28405 Sgk1 827. Serum/glucocorticoid regulated kinase 1 
Mm.371583 Slpi 8132. Secretory leukocyte peptidase inhibitor 
Mm.338790 Srgn 7359. Serglycin 
Mm.330731 Tgm2 672. Transglutaminase 2, C polypeptide 
 
 
TABLE 23: GENES INCLUDED INTO THE METAGENE ANALYSIS FOR THE PROCESS OF METABOLISM 
Metabolism metagene 
UniGene-ID Symbol Description 
Mm.290727 2810007J24Rik 24930. RIKEN cDNA 2810007J24 gene 
Mm.355174 9130409I23Rik 11043. RIKEN cDNA 9130409I23 gene 
Mm.344148 Abca8a 5877. ATP-binding cassette, sub-family A (ABC1), member 8a 
Mm.81793 Acacb 409. Acetyl-Coenzyme A carboxylase beta 
Mm.255026 Acss2 1948. Acyl-CoA synthetase short-chain family member 2 
Mm.29125 Agxt2l1 7039. Alanine-glyoxylate aminotransferase 2-like 1 
Mm.423137 Arrdc3 11201. Arrestin domain containing 3 
Mm.300 Car3 5696. Carbonic anhydrase 3 
Mm.29110 Ces1f 11870. Carboxylesterase 1F 
Mm.13036 Cml1 27190. Camello-like 1 
Mm.15537 Cyp1a2 788. Cytochrome P450, family 1, subfamily a, polypeptide 2 
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Mm.142581 Cyp2c55 12853. Cytochrome P450, family 2, subfamily c, polypeptide 55 
Mm.378235 Dbp 9722. D site albumin promoter binding protein 
Mm.236443 Fasn 600. Fatty acid synthase 
Mm.281298 Gadd45g 9861. Growth arrest and DNA-damage-inducible 45 gamma 
Mm.299 Inmt 17669. Indolethylamine N-methyltransferase 
Mm.218561 Keg1 20751. Kidney expressed gene 1 
Mm.46561 Lect1 8337. Leukocyte cell derived chemotaxin 1 
Mm.37907 Lrit1 
16575. Leucine-rich repeat, immunoglobulin-like and transmembrane 
domains 1 
Mm.112365 Mus musculus 49479. Transcribed locus 
Mm.25466 Mus musculus 57050. Transcribed locus 
Mm.381253 Mus musculus 85232. Transcribed locus 
Mm.436775 Mus musculus 39287. Transcribed locus 
Mm.442553 Mus musculus 64241. Transcribed locus 
Mm.415302 Ppargc1b 
4892. Peroxisome proliferative activated receptor, gamma, coactivator 
1 beta 
Mm.290079 Serpina6 12573. Serine (or cysteine) peptidase inhibitor, clade A, member 6 
Mm.103665 Slco1a1 8288. Solute carrier organic anion transporter family, member 1a1 
Mm.200370 Upp2 12824. Uridine phosphorylase 2 
 
TABLE 24: GENES INCLUDED INTO THE METAGENE ANALYSIS FOR THE PROCESS OF PROLIFERATION 
Proliferation metagene 
UniGene-ID Symbol Description 
Mm.180363 2610039C10Rik 26517. RIKEN cDNA 2610039C10 gene 
Mm.282751 Anln 6119. Anillin, actin binding protein 
Mm.248360 Anxa1 1138. Annexin A1 
Mm.38469 Apbb1 
3502. Amyloid beta (A4) precursor protein-binding, family B, 
member 1 
Mm.277585 App 52. Amyloid beta (A4) precursor protein 
Mm.239329 Arhgef2 6165. Rho/rac guanine nucleotide exchange factor (GEF) 2 
Mm.22085 Arl3 8439. ADP-ribosylation factor-like 3 
Mm.389890 Atf5 13964. Activating transcription factor 5 
Mm.2443 Bak1 1105. BCL2-antagonist/killer 1 
Mm.8552 Birc5 1439. Baculoviral IAP repeat-containing 5 
Mm.2185 Bub1 
4377. Budding uninhibited by benzimidazoles 1 homolog (S. 
cerevisiae) 
Mm.285993 Calm1 2303. Calmodulin 1 
Mm.288630 Calm3 6639. Calmodulin 3 
Mm.194368 Ccdc99 14212. Coiled-coil domain containing 99 
Mm.4189 Ccna2 1886. Cyclin A2 
Mm.260114 Ccnb1 2082. Cyclin B1 
Mm.22592 Ccnb2 7995. Cyclin B2 
Mm.273049 Ccnd1 130. Cyclin D1 
Mm.27291 Ccnd3 1460. Cyclin D3 
Mm.289747 Cdc20 2740. Cell division cycle 20 homolog (S. cerevisiae) 
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Mm.285723 Cdca3 22333. Cell division cycle associated 3 
Mm.28038 Cdca8 19026. Cell division cycle associated 8 
Mm.281367 Cdk1 1054. Cyclin-dependent kinase 1 
Mm.272394 Cdkn3 22330. Cyclin-dependent kinase inhibitor 3 
Mm.273502 Cenph 20925. Centromere protein H 
Mm.9916 Cep55 17042. Centrosomal protein 55 
Mm.45127 Cgref1 26130. Cell growth regulator with EF hand domain 1 
Mm.279308 Chek2 3241. Checkpoint kinase 2 
Mm.22448 Ckap2 13712. Cytoskeleton associated protein 2 
Mm.329078 Cul7 3281. Cullin 7 
Mm.292470 Dbf4 13346. DBF4 homolog (S. cerevisiae) 
Mm.25410 Dsn1 
23140. DSN1, MIND kinetochore complex component, homolog 
(S. cerevisiae) 
Mm.249280 Esco2 14947. Establishment of cohesion 1 homolog 2 (S. cerevisiae) 
Mm.197520 Fbxo5 17159. F-box protein 5 
Mm.4704 Foxg1 1050. Forkhead box G1 
Mm.39293 Haus1 22071. HAUS augmin-like complex, subunit 1 
Mm.57223 Hells 2436. Helicase, lymphoid specific 
Mm.157190 Hmga2 2932. High mobility group AT-hook 2 
Mm.29755 Incenp 7501. Inner centromere protein 
Mm.306511 Insl6 24005. Insulin-like 6 
Mm.42203 Kif11 2695. Kinesin family member 11 
Mm.224306 Klhl13 7688. Kelch-like 13 (Drosophila) 
Mm.4964 Lif 280. Leukemia inhibitory factor 
Mm.288179 Lig1 2611. Ligase I, DNA, ATP-dependent 
Mm.16711 Mcm2 
1112. Minichromosome maintenance deficient 2 mitotin (S. 
cerevisiae) 
Mm.378965 Mcm7 1623. Minichromosome maintenance deficient 7 (S. cerevisiae) 
Mm.246750 Mnat1 9085. Menage a trois 1 
Mm.4619 Msh2 491. MutS homolog 2 (E. coli) 
Mm.185800 Mus musculus 38861. Transcribed locus 
Mm.254588 Mus musculus 36480. Transcribed locus 
Mm.359575 Mus musculus 
42964. Transcribed locus, weakly similar to NP_001034869.1 
cyclin-I2 [Homo sapiens] 
Mm.218233 Myh10 355. Myosin, heavy polypeptide 10, non-muscle 
Mm.29786 Ncaph 11665. Non-SMC condensin I complex, subunit H 
Mm.288980 Nedd9 
5014. Neural precursor cell expressed, developmentally down-
regulated gene 9 
Mm.29071 Nek9 5029. NIMA (never in mitosis gene a)-related expressed kinase 9 
Mm.222184 Nup37 14890. Nucleoporin 37 
Mm.299887 Nup43 13615. Nucleoporin 43 
Mm.290015 Nusap1 19262. Nucleolar and spindle associated protein 1 
Mm.247480 Ofd1 9441. Oral-facial-digital syndrome 1 gene homolog (human) 
Mm.246412 Oip5 27136. Opa interacting protein 5 
Mm.28659 Pes1 3379. Pescadillo homolog 1, containing BRCT domain (zebrafish) 
Mm.3193 Pkia 19495. Protein kinase inhibitor, alpha 
Mm.16525 Plk1 1667. Polo-like kinase 1 (Drosophila) 
Mm.1237 Pmp22 472. Peripheral myelin protein 22 
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Mm.14501 Ppm1g 
6914. Protein phosphatase 1G (formerly 2C), magnesium-
dependent, gamma isoform 
Mm.227274 Prc1 9981. Protein regulator of cytokinesis 1 
Mm.19111 Prkaca 415. Protein kinase, cAMP dependent, catalytic, alpha 
Mm.18344 Psmc3ip 
14139. Proteasome (prosome, macropain) 26S subunit, ATPase 3, 
interacting protein 
Mm.389499 Psrc1 18606. Proline/serine-rich coiled-coil 1 
Mm.273804 Racgap1 4275. Rac GTPase-activating protein 1 
Mm.330492 Rad51 1505. RAD51 homolog (S. cerevisiae) 
Mm.12091 Rassf1 8632. Ras association (RalGDS/AF-6) domain family member 1 
Mm.180734 Rpa1 4185. Replication protein A1 
Mm.274399 Sept8 5339. Septin 8 
Mm.428571 Sept9 5434. Septin 11 
Mm.439776 Sesn3 9125. Sestrin 3 
Mm.23298 Smpd3 4579. Sphingomyelin phosphodiesterase 3, neutral 
Mm.379024 Tacc3 10608. Transforming, acidic coiled-coil containing protein 3 
Mm.18213 Tgfb2 500. Transforming growth factor, beta 2 
Mm.206505 Timp2 1683. Tissue inhibitor of metalloproteinase 2 
Mm.259893 Topbp1 4830. Topoisomerase (DNA) II binding protein 1 
Mm.407737 Tpx2 
10171. TPX2, microtubule-associated protein homolog (Xenopus 
laevis) 
Mm.275095 Trip13 7851. Thyroid hormone receptor interactor 13 
Mm.151594 Trnp1 27510. TMF1-regulated nuclear protein 1 
Mm.273570 Trrap 302. Transformation/transcription domain-associated protein 
Mm.335454 Wdr6 6905. WD repeat domain 6 
Mm.2806 Xpc 1656. Xeroderma pigmentosum, complementation group C 
Mm.335237 Zwilch 14280. Zwilch, kinetochore associated, homolog (Drosophila) 
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